Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,O-linked Glycosylation R-HSA-5173105,0.7925024454386185,1.7303651262888347,0.008620689655172414,0.60851697524235,0.37,13/49,7.84%,Adamts17;St6galnac3;Sema5b;Adamts20;Galnt18;Galnt14;Spon1;Galnt10;Galntl6;Adamts18;Adamts3;St3gal3;Cfp
prerank,Synaptic Adhesion-Like Molecules R-HSA-8849932,0.8698012970976002,1.7301481809335484,0.009259259259259259,0.3052357632773458,0.37,6/20,3.41%,Gria3;Ptprs;Gria4;Grin2a;Gria1;Ptprf
prerank,Eukaryotic Translation Elongation R-HSA-156842,-0.9177358446496058,-1.6947432979345947,0.0,0.0,0.0,70/83,6.71%,Rpl6;Eef1a1;Rps29;Rps2;Rpl23;Rps7;Rpl37;Rpl5;Rpl3;Rpl19;Rplp2;Rpsa;Rpl21;Rps5;Rpl18a;Rpl7;Rpl22;Rps11;Rps28;Rpl14;Rpl11;Rps25;Rps23;Rps24;Rpl27;Rpl29;Rpl28;Fau;Rps27a;Rps8;Rps6;Rpl4;Rpl27a;Rps4x;Rps15;Rpl7a;Rps17;Rpl8;Rps27;Rpl38;Rps21;Rpl12;Rpl23a;Rplp1;Rpl9;Rpl37a;Rps3;Rps20;Rpl41;Rps10;Rpl13a;Rps15a;Eef1b2;Rps16;Rpl39;Eef1g;Rps14;Rpl22l1;Rps12;Rpl15;Eef1a2;Rpl30;Rpl18;Rpl31;Rps9;Eef2;Rpl26;Rpl36;Uba52;Rpl34
prerank,Cellular Response To Starvation R-HSA-9711097,-0.8939419604283293,-1.6904163052847923,0.0,0.0,0.0,79/131,7.91%,Rpl6;Rps29;Rps2;Rpl23;Rps7;Rpl37;Atp6v0c;Rpl5;Rpl3;Rpl19;Rplp2;Rpsa;Rpl21;Rps5;Rpl18a;Rpl7;Rpl22;Atp6v1d;Rps11;Rps28;Rpl14;Rpl11;Rps25;Rps23;Rps24;Rpl27;Rpl29;Rpl28;Fau;Rps27a;Rps8;Rps6;Rpl4;Rpl27a;Rps4x;Rps15;Rpl7a;Rps17;Rpl8;Rps27;Atp6v1a;Rpl38;Rps21;Rpl12;Rpl23a;Rplp1;Rpl9;Rpl37a;Rps3;Rps20;Lamtor2;Rpl41;Rps10;Atp6v1g2;Rpl13a;Rps15a;Atp6v0e2;Rps16;Rpl39;Rps14;Rpl22l1;Sesn1;Rraga;Rps12;Rpl15;Rpl30;Rpl18;Rpl31;Rps9;Rpl26;Rpl36;Rheb;Uba52;Rpl34;Atp6v1f;Rpl36a;Rpl35a;Lamtor3;Rpl32
prerank,Selenocysteine Synthesis R-HSA-2408557,-0.9143896398476148,-1.687942049914999,0.0,0.0,0.0,65/82,6.71%,Rpl6;Rps29;Rps2;Rpl23;Rps7;Rpl37;Rpl5;Rpl3;Rpl19;Rplp2;Rpsa;Rpl21;Rps5;Rpl18a;Rpl7;Rpl22;Rps11;Rps28;Rpl14;Rpl11;Rps25;Rps23;Rps24;Rpl27;Rpl29;Rpl28;Fau;Rps27a;Rps8;Rps6;Rpl4;Rpl27a;Rps4x;Rps15;Rpl7a;Rps17;Rpl8;Rps27;Rpl38;Rps21;Rpl12;Rpl23a;Rplp1;Rpl9;Rpl37a;Rps3;Rps20;Rpl41;Rps10;Rpl13a;Rps15a;Rps16;Rpl39;Rps14;Rpl22l1;Rps12;Rpl15;Rpl30;Rpl18;Rpl31;Rps9;Rpl26;Rpl36;Uba52;Rpl34
prerank,Selenoamino Acid Metabolism R-HSA-2408522,-0.9113943207870637,-1.6873783617944296,0.0,0.0,0.0,65/90,6.71%,Rpl6;Rps29;Rps2;Rpl23;Rps7;Rpl37;Rpl5;Rpl3;Rpl19;Rplp2;Rpsa;Rpl21;Rps5;Rpl18a;Rpl7;Rpl22;Rps11;Rps28;Rpl14;Rpl11;Rps25;Rps23;Rps24;Rpl27;Rpl29;Rpl28;Fau;Rps27a;Rps8;Rps6;Rpl4;Rpl27a;Rps4x;Rps15;Rpl7a;Rps17;Rpl8;Rps27;Rpl38;Rps21;Rpl12;Rpl23a;Rplp1;Rpl9;Rpl37a;Rps3;Rps20;Rpl41;Rps10;Rpl13a;Rps15a;Rps16;Rpl39;Rps14;Rpl22l1;Rps12;Rpl15;Rpl30;Rpl18;Rpl31;Rps9;Rpl26;Rpl36;Uba52;Rpl34
prerank,Peptide Chain Elongation R-HSA-156902,-0.9170769624623181,-1.6863466042478419,0.0,0.0,0.0,67/79,6.71%,Rpl6;Eef1a1;Rps29;Rps2;Rpl23;Rps7;Rpl37;Rpl5;Rpl3;Rpl19;Rplp2;Rpsa;Rpl21;Rps5;Rpl18a;Rpl7;Rpl22;Rps11;Rps28;Rpl14;Rpl11;Rps25;Rps23;Rps24;Rpl27;Rpl29;Rpl28;Fau;Rps27a;Rps8;Rps6;Rpl4;Rpl27a;Rps4x;Rps15;Rpl7a;Rps17;Rpl8;Rps27;Rpl38;Rps21;Rpl12;Rpl23a;Rplp1;Rpl9;Rpl37a;Rps3;Rps20;Rpl41;Rps10;Rpl13a;Rps15a;Rps16;Rpl39;Rps14;Rpl22l1;Rps12;Rpl15;Rpl30;Rpl18;Rpl31;Rps9;Eef2;Rpl26;Rpl36;Uba52;Rpl34
prerank,Viral mRNA Translation R-HSA-192823,-0.9151060059009148,-1.6846526148521839,0.0,0.0,0.0,65/83,6.71%,Rpl6;Rps29;Rps2;Rpl23;Rps7;Rpl37;Rpl5;Rpl3;Rpl19;Rplp2;Rpsa;Rpl21;Rps5;Rpl18a;Rpl7;Rpl22;Rps11;Rps28;Rpl14;Rpl11;Rps25;Rps23;Rps24;Rpl27;Rpl29;Rpl28;Fau;Rps27a;Rps8;Rps6;Rpl4;Rpl27a;Rps4x;Rps15;Rpl7a;Rps17;Rpl8;Rps27;Rpl38;Rps21;Rpl12;Rpl23a;Rplp1;Rpl9;Rpl37a;Rps3;Rps20;Rpl41;Rps10;Rpl13a;Rps15a;Rps16;Rpl39;Rps14;Rpl22l1;Rps12;Rpl15;Rpl30;Rpl18;Rpl31;Rps9;Rpl26;Rpl36;Uba52;Rpl34
prerank,Nonsense Mediated Decay (NMD) Independent Of Exon Junction Complex (EJC) R-HSA-975956,-0.9126741988741683,-1.6842552851310417,0.0,0.0,0.0,65/85,6.71%,Rpl6;Rps29;Rps2;Rpl23;Rps7;Rpl37;Rpl5;Rpl3;Rpl19;Rplp2;Rpsa;Rpl21;Rps5;Rpl18a;Rpl7;Rpl22;Rps11;Rps28;Rpl14;Rpl11;Rps25;Rps23;Rps24;Rpl27;Rpl29;Rpl28;Fau;Rps27a;Rps8;Rps6;Rpl4;Rpl27a;Rps4x;Rps15;Rpl7a;Rps17;Rpl8;Rps27;Rpl38;Rps21;Rpl12;Rpl23a;Rplp1;Rpl9;Rpl37a;Rps3;Rps20;Rpl41;Rps10;Rpl13a;Rps15a;Rps16;Rpl39;Rps14;Rpl22l1;Rps12;Rpl15;Rpl30;Rpl18;Rpl31;Rps9;Rpl26;Rpl36;Uba52;Rpl34
prerank,L13a-mediated Translational Silencing Of Ceruloplasmin Expression R-HSA-156827,-0.9040374879871698,-1.6828090553945474,0.0,0.0,0.0,75/99,7.91%,Rpl6;Rps29;Rps2;Rpl23;Rps7;Rpl37;Rpl5;Rpl3;Rpl19;Rplp2;Rpsa;Rpl21;Rps5;Rpl18a;Rpl7;Rpl22;Rps11;Rps28;Rpl14;Rpl11;Rps25;Rps23;Rps24;Rpl27;Rpl29;Rpl28;Fau;Rps27a;Rps8;Rps6;Rpl4;Rpl27a;Rps4x;Rps15;Rpl7a;Rps17;Eif4a1;Rpl8;Rps27;Rpl38;Rps21;Rpl12;Rpl23a;Rplp1;Rpl9;Rpl37a;Rps3;Rps20;Rpl41;Rps10;Rpl13a;Rps15a;Eif1ax;Rps16;Rpl39;Rps14;Rpl22l1;Rps12;Rpl15;Eif3c;Rpl30;Eif3f;Rpl18;Rpl31;Rps9;Eif3h;Rpl26;Rpl36;Eif4h;Uba52;Rpl34;Rpl36a;Eif4a2;Rpl35a;Rpl32
prerank,Formation Of A Pool Of Free 40S Subunits R-HSA-72689,-0.9076153405498935,-1.6810032008996258,0.0,0.0,0.0,69/90,6.71%,Rpl6;Rps29;Rps2;Rpl23;Rps7;Rpl37;Rpl5;Rpl3;Rpl19;Rplp2;Rpsa;Rpl21;Rps5;Rpl18a;Rpl7;Rpl22;Rps11;Rps28;Rpl14;Rpl11;Rps25;Rps23;Rps24;Rpl27;Rpl29;Rpl28;Fau;Rps27a;Rps8;Rps6;Rpl4;Rpl27a;Rps4x;Rps15;Rpl7a;Rps17;Rpl8;Rps27;Rpl38;Rps21;Rpl12;Rpl23a;Rplp1;Rpl9;Rpl37a;Rps3;Rps20;Rpl41;Rps10;Rpl13a;Rps15a;Eif1ax;Rps16;Rpl39;Rps14;Rpl22l1;Rps12;Rpl15;Eif3c;Rpl30;Eif3f;Rpl18;Rpl31;Rps9;Eif3h;Rpl26;Rpl36;Uba52;Rpl34
prerank,Eukaryotic Translation Termination R-HSA-72764,-0.9143400595430142,-1.6804508314766573,0.0,0.0,0.0,66/82,6.71%,Rpl6;Rps29;Rps2;Rpl23;Rps7;Rpl37;Rpl5;Rpl3;Rpl19;Rplp2;Rpsa;Rpl21;Rps5;Rpl18a;Rpl7;Rpl22;Rps11;Rps28;Rpl14;Rpl11;Rps25;Rps23;Rps24;Rpl27;Rpl29;Rpl28;Fau;Rps27a;Rps8;Rps6;Rpl4;Rpl27a;Rps4x;Rps15;Rpl7a;Rps17;Rpl8;Rps27;Rpl38;Rps21;Rpl12;Rpl23a;Rplp1;Rpl9;Rpl37a;Rps3;Rps20;Rpl41;Rps10;Rpl13a;Rps15a;Rps16;Rpl39;Trmt112;Rps14;Rpl22l1;Rps12;Rpl15;Rpl30;Rpl18;Rpl31;Rps9;Rpl26;Rpl36;Uba52;Rpl34
prerank,Influenza Infection R-HSA-168255,-0.8850302162240122,-1.6785288133075256,0.0,0.0,0.0,71/136,6.73%,Rpl6;Rps29;Rps2;Rpl23;Rps7;Rpl37;Rpl5;Rpl3;Rpl19;Rplp2;Rpsa;Rpl21;Rps5;Rpl18a;Rpl7;Rpl22;Rps11;Rps28;Rpl14;Rpl11;Rps25;Rps23;Rps24;Rpl27;Ran;Rpl29;Rpl28;Fau;Rps27a;Rps8;Rps6;Rpl4;Rpl27a;Rps4x;Rps15;Rpl7a;Rps17;Rpl8;Rps27;Rpl38;Rps21;Rpl12;Rpl23a;Rplp1;Rpl9;Rpl37a;Rps3;Rps20;Rpl41;Hsp90aa1;Rps10;Calr;Rpl13a;Rps15a;Clta;Rps16;Rpl39;Rps14;Rpl22l1;Rps12;Rpl15;Polr2f;Rpl30;Rpl18;Rpl31;Rps9;Rpl26;Rpl36;Uba52;Rpl34;Polr2i
prerank,Cap-dependent Translation Initiation R-HSA-72737,-0.9000572556532449,-1.6761261780719139,0.0,0.0,0.0,75/104,7.91%,Rpl6;Rps29;Rps2;Rpl23;Rps7;Rpl37;Rpl5;Rpl3;Rpl19;Rplp2;Rpsa;Rpl21;Rps5;Rpl18a;Rpl7;Rpl22;Rps11;Rps28;Rpl14;Rpl11;Rps25;Rps23;Rps24;Rpl27;Rpl29;Rpl28;Fau;Rps27a;Rps8;Rps6;Rpl4;Rpl27a;Rps4x;Rps15;Rpl7a;Rps17;Eif4a1;Rpl8;Rps27;Rpl38;Rps21;Rpl12;Rpl23a;Rplp1;Rpl9;Rpl37a;Rps3;Rps20;Rpl41;Rps10;Rpl13a;Rps15a;Eif1ax;Rps16;Rpl39;Rps14;Rpl22l1;Rps12;Rpl15;Eif3c;Rpl30;Eif3f;Rpl18;Rpl31;Rps9;Eif3h;Rpl26;Rpl36;Eif4h;Uba52;Rpl34;Rpl36a;Eif4a2;Rpl35a;Rpl32
prerank,GTP Hydrolysis And Joining Of 60S Ribosomal Subunit R-HSA-72706,-0.9020763175165101,-1.676010639376841,0.0,0.0,0.0,75/100,7.91%,Rpl6;Rps29;Rps2;Rpl23;Rps7;Rpl37;Rpl5;Rpl3;Rpl19;Rplp2;Rpsa;Rpl21;Rps5;Rpl18a;Rpl7;Rpl22;Rps11;Rps28;Rpl14;Rpl11;Rps25;Rps23;Rps24;Rpl27;Rpl29;Rpl28;Fau;Rps27a;Rps8;Rps6;Rpl4;Rpl27a;Rps4x;Rps15;Rpl7a;Rps17;Eif4a1;Rpl8;Rps27;Rpl38;Rps21;Rpl12;Rpl23a;Rplp1;Rpl9;Rpl37a;Rps3;Rps20;Rpl41;Rps10;Rpl13a;Rps15a;Eif1ax;Rps16;Rpl39;Rps14;Rpl22l1;Rps12;Rpl15;Eif3c;Rpl30;Eif3f;Rpl18;Rpl31;Rps9;Eif3h;Rpl26;Rpl36;Eif4h;Uba52;Rpl34;Rpl36a;Eif4a2;Rpl35a;Rpl32
prerank,Influenza Viral RNA Transcription And Replication R-HSA-168273,-0.8867556772932731,-1.6756172291866138,0.0,0.0,0.0,68/124,6.73%,Rpl6;Rps29;Rps2;Rpl23;Rps7;Rpl37;Rpl5;Rpl3;Rpl19;Rplp2;Rpsa;Rpl21;Rps5;Rpl18a;Rpl7;Rpl22;Rps11;Rps28;Rpl14;Rpl11;Rps25;Rps23;Rps24;Rpl27;Rpl29;Rpl28;Fau;Rps27a;Rps8;Rps6;Rpl4;Rpl27a;Rps4x;Rps15;Rpl7a;Rps17;Rpl8;Rps27;Rpl38;Rps21;Rpl12;Rpl23a;Rplp1;Rpl9;Rpl37a;Rps3;Rps20;Rpl41;Hsp90aa1;Rps10;Rpl13a;Rps15a;Rps16;Rpl39;Rps14;Rpl22l1;Rps12;Rpl15;Polr2f;Rpl30;Rpl18;Rpl31;Rps9;Rpl26;Rpl36;Uba52;Rpl34;Polr2i
prerank,Nonsense Mediated Decay (NMD) Enhanced By Exon Junction Complex (EJC) R-HSA-975957,-0.89543789851812,-1.6711927304054377,0.0,0.0,0.0,70/104,7.91%,Rpl6;Rps29;Rps2;Rpl23;Rps7;Rpl37;Rpl5;Rpl3;Rpl19;Rplp2;Rpsa;Rpl21;Rps5;Rpl18a;Rpl7;Rpl22;Rps11;Rps28;Rpl14;Rpl11;Rps25;Rps23;Rps24;Rpl27;Rpl29;Rpl28;Fau;Rps27a;Rps8;Rps6;Rpl4;Rpl27a;Rps4x;Rps15;Rpl7a;Rps17;Rpl8;Rps27;Rpl38;Rps21;Rpl12;Rpl23a;Rplp1;Rpl9;Rpl37a;Rps3;Rps20;Rpl41;Rps10;Rpl13a;Rps15a;Rps16;Rpl39;Rps14;Rpl22l1;Rps12;Rpl15;Rpl30;Rpl18;Rpl31;Rps9;Rpl26;Rpl36;Uba52;Rpl34;Magoh;Rpl36a;Rbm8a;Rpl35a;Rpl32
prerank,Response Of EIF2AK4 (GCN2) To Amino Acid Deficiency R-HSA-9633012,-0.9101297163166902,-1.6708570612774671,0.0,0.0,0.0,65/86,6.71%,Rpl6;Rps29;Rps2;Rpl23;Rps7;Rpl37;Rpl5;Rpl3;Rpl19;Rplp2;Rpsa;Rpl21;Rps5;Rpl18a;Rpl7;Rpl22;Rps11;Rps28;Rpl14;Rpl11;Rps25;Rps23;Rps24;Rpl27;Rpl29;Rpl28;Fau;Rps27a;Rps8;Rps6;Rpl4;Rpl27a;Rps4x;Rps15;Rpl7a;Rps17;Rpl8;Rps27;Rpl38;Rps21;Rpl12;Rpl23a;Rplp1;Rpl9;Rpl37a;Rps3;Rps20;Rpl41;Rps10;Rpl13a;Rps15a;Rps16;Rpl39;Rps14;Rpl22l1;Rps12;Rpl15;Rpl30;Rpl18;Rpl31;Rps9;Rpl26;Rpl36;Uba52;Rpl34
prerank,SRP-dependent Cotranslational Protein Targeting To Membrane R-HSA-1799339,-0.9009280258102127,-1.6682538946753562,0.0,0.0,0.0,67/99,6.71%,Rpl6;Rps29;Rps2;Rpl23;Rps7;Rpl37;Rpl5;Rpl3;Rpl19;Rplp2;Rpsa;Rpl21;Rps5;Rpl18a;Rpl7;Rpl22;Rps11;Rps28;Rpl14;Rpl11;Rps25;Rps23;Rps24;Rpl27;Rpl29;Rpl28;Fau;Rps27a;Rps8;Rps6;Rpl4;Rpl27a;Rps4x;Rps15;Rpl7a;Rps17;Rpl8;Srp14;Rps27;Rpl38;Rps21;Rpl12;Rpl23a;Rplp1;Rpl9;Rpl37a;Rps3;Rps20;Rpl41;Rps10;Rpl13a;Rps15a;Rps16;Rpl39;Spcs2;Rps14;Rpl22l1;Rps12;Rpl15;Rpl30;Rpl18;Rpl31;Rps9;Rpl26;Rpl36;Uba52;Rpl34
prerank,Major Pathway Of rRNA Processing In Nucleolus And Cytosol R-HSA-6791226,-0.8744599577450387,-1.6627144234178524,0.0,0.0,0.0,73/161,7.91%,Rpl6;Rps29;Rps2;Rpl23;Rps7;Rpl37;Rpl5;Rpl3;Rpl19;Rplp2;Rpsa;Rpl21;Rps5;Rpl18a;Rpl7;Rpl22;Rps11;Rps28;Rpl14;Rpl11;Rps25;Rps23;Rps24;Rpl27;Rpl29;Rpl28;Fau;Rps27a;Rps8;Rps6;Rpl4;Rpl27a;Rps4x;Rps15;Rpl7a;Rps17;Rpl8;Rps27;Rpl38;Rps21;Rpl12;Rpl23a;Rplp1;Rpl9;Rpl37a;Rps3;Rps20;Rpl41;Rps10;Rpl13a;Rps15a;Rps16;Rpl39;Rps14;Rpl22l1;Rps12;Rpl15;Csnk1e;Pdcd11;Rpl30;Rpl18;Rpl31;Rps9;Rpl26;Rpl36;Emg1;Uba52;Rpl34;Rpp21;Snu13;Rpl36a;Rpl35a;Rpl32
prerank,rRNA Processing R-HSA-72312,-0.8695566509906836,-1.6575465744782327,0.0,0.0,0.0,77/175,8.07%,Rpl6;Rps29;Rps2;Rpl23;Rps7;Rpl37;Rpl5;Rpl3;Rpl19;Rplp2;Rpsa;Rpl21;Rps5;Rpl18a;Rpl7;Rpl22;Rps11;Rps28;Rpl14;Rpl11;Rps25;Rps23;Rps24;Rpl27;Rpl29;Rpl28;Fau;Rps27a;Rps8;Rps6;Rpl4;Rpl27a;Rps4x;Rps15;Rpl7a;Rps17;Rpl8;Rps27;Rpl38;Rps21;Rpl12;Rpl23a;Rplp1;Rpl9;Rpl37a;Rps3;Rps20;Rpl41;Rps10;Rpl13a;Thumpd1;Rps15a;Rps16;Rpl39;Trmt112;Rps14;Rpl22l1;Rps12;Rpl15;Csnk1e;Pdcd11;Rpl30;Rpl18;Rpl31;Rps9;Rpl26;Rpl36;Emg1;Uba52;Rpl34;Nop10;Rpp21;Snu13;Rpl36a;Rpl35a;Rpl32;Gar1
prerank,rRNA Processing In Nucleus And Cytosol R-HSA-8868773,-0.8701523540409886,-1.657203649382809,0.0,0.0,0.0,77/171,8.07%,Rpl6;Rps29;Rps2;Rpl23;Rps7;Rpl37;Rpl5;Rpl3;Rpl19;Rplp2;Rpsa;Rpl21;Rps5;Rpl18a;Rpl7;Rpl22;Rps11;Rps28;Rpl14;Rpl11;Rps25;Rps23;Rps24;Rpl27;Rpl29;Rpl28;Fau;Rps27a;Rps8;Rps6;Rpl4;Rpl27a;Rps4x;Rps15;Rpl7a;Rps17;Rpl8;Rps27;Rpl38;Rps21;Rpl12;Rpl23a;Rplp1;Rpl9;Rpl37a;Rps3;Rps20;Rpl41;Rps10;Rpl13a;Thumpd1;Rps15a;Rps16;Rpl39;Trmt112;Rps14;Rpl22l1;Rps12;Rpl15;Csnk1e;Pdcd11;Rpl30;Rpl18;Rpl31;Rps9;Rpl26;Rpl36;Emg1;Uba52;Rpl34;Nop10;Rpp21;Snu13;Rpl36a;Rpl35a;Rpl32;Gar1
prerank,Diseases Associated With O-glycosylation Of Proteins R-HSA-3906995,0.8047356461750287,1.6412544786527372,0.05319148936170213,0.5057944451603973,0.649,8/27,7.84%,Adamts17;Sema5b;Adamts20;Notch2;Spon1;Adamts18;Adamts3;Cfp
prerank,Apoptotic Cleavage Of Cellular Proteins R-HSA-111465,0.8087199123410609,1.6329569337999885,0.023923444976076555,0.41029289631570653,0.68,8/24,15.22%,Tjp2;Satb1;Rock1;Mapt;Tjp1;Stk26;Sptan1;Ptk2
prerank,Translation R-HSA-72766,-0.8454682981338124,-1.6307262896073904,0.0,0.0,0.0,97/245,7.91%,Rpl6;Eef1a1;Rps29;Rps2;Rpl23;Rps7;Rpl37;Rpl5;Rpl3;Rpl19;Rplp2;Rpsa;Rpl21;Rps5;Rpl18a;Rpl7;Rpl22;Rps11;Rps28;Rpl14;Rpl11;Rps25;Rps23;Rps24;Rpl27;Rpl29;Rpl28;Fau;Rps27a;Rps8;Rps6;Rpl4;Rpl27a;Rps4x;Rps15;Rpl7a;Rps17;Eif4a1;Aurkaip1;Rpl8;Srp14;Rps27;Rpl38;Rps21;Rpl12;Rpl23a;Rplp1;Mrpl36;Mrps26;Rpl9;Rpl37a;Rps3;Rps20;Rpl41;Rps10;Mrpl52;Rpl13a;Rps15a;Eif1ax;Eef1b2;Mrpl18;Mrps24;Rps16;Rpl39;Mrpl54;Spcs2;Trmt112;Eef1g;Rps14;Rpl22l1;Mrpl44;Mrpl14;Rps12;Rpl15;Eif3c;Eef1a2;Rpl30;Eif3f;Rpl18;Rpl31;Mrpl23;Mrpl41;Rps9;Eef2;Eif3h;Rpl26;Rpl36;Eif4h;Uba52;Rpl34;Mrps21;Rpl36a;Eif4a2;Mrpl9;Rpl35a;Mrpl39;Rpl32
prerank,Interaction Between L1 And Ankyrins R-HSA-445095,0.8228137184324761,1.623399305752561,0.026905829596412557,0.353643484113006,0.709,6/20,5.87%,Sptbn4;Scn1a;Ank3;Sptb;Scn8a;Kcnq2
prerank,Metabolism Of Amino Acids And Derivatives R-HSA-71291,-0.8455511912977207,-1.6227756398951536,0.0,0.0,0.0,81/226,7.91%,Rpl6;Rps29;Rps2;Rpl23;Rps7;Rpl37;Rpl5;Rpl3;Rpl19;Rplp2;Rpsa;Rpl21;Serinc1;Rps5;Rpl18a;Rpl7;Rpl22;Rps11;Rps28;Rpl14;Rpl11;Rps25;Rps23;Rps24;Rpl27;Rpl29;Rpl28;Fau;Rps27a;Rps8;Rps6;Rpl4;Rpl27a;Psmc3;Rps4x;Rps15;Rpl7a;Rps17;Rpl8;Rps27;Rpl38;Psmb5;Rps21;Rpl12;Rpl23a;Rplp1;Rpl9;Rpl37a;Rps3;Rps20;Psma7;Rpl41;Rps10;Phgdh;Rpl13a;Rps15a;Psmc2;Rps16;Rpl39;Rps14;Rpl22l1;Rps12;Rpl15;Rpl30;Ckb;Psma5;Rpl18;Rpl31;Oaz1;Rps9;Rpl26;Rpl36;Sem1;Psma4;Uba52;Glul;Rpl34;Aldh6a1;Rpl36a;Rpl35a;Rpl32
prerank,"Formation Of Ternary Complex, And Subsequently, 43S Complex R-HSA-72695",-0.9034563843314745,-1.5820552071689953,0.0,0.0006021788723010453,0.013,31/45,6.25%,Rps29;Rps2;Rps7;Rpsa;Rps5;Rps11;Rps28;Rps25;Rps23;Rps24;Fau;Rps27a;Rps8;Rps6;Rps4x;Rps15;Rps17;Rps27;Rps21;Rps3;Rps20;Rps10;Rps15a;Eif1ax;Rps16;Rps14;Rps12;Eif3c;Eif3f;Rps9;Eif3h
prerank,Ribosomal Scanning And Start Codon Recognition R-HSA-72702,-0.8925289302035277,-1.5813410500423095,0.0,0.0006658708684098097,0.014,33/52,6.48%,Rps29;Rps2;Rps7;Rpsa;Rps5;Rps11;Rps28;Rps25;Rps23;Rps24;Fau;Rps27a;Rps8;Rps6;Rps4x;Rps15;Rps17;Eif4a1;Rps27;Rps21;Rps3;Rps20;Rps10;Rps15a;Eif1ax;Rps16;Rps14;Rps12;Eif3c;Eif3f;Rps9;Eif3h;Eif4h
prerank,"mRNA Activation Upon Binding Of Cap-Binding Complex And eIFs, Subsequent Binding To 43S R-HSA-72662",-0.8925056560268239,-1.5809634964200547,0.0,0.0006146500323782859,0.014,33/52,6.48%,Rps29;Rps2;Rps7;Rpsa;Rps5;Rps11;Rps28;Rps25;Rps23;Rps24;Fau;Rps27a;Rps8;Rps6;Rps4x;Rps15;Rps17;Eif4a1;Rps27;Rps21;Rps3;Rps20;Rps10;Rps15a;Eif1ax;Rps16;Rps14;Rps12;Eif3c;Eif3f;Rps9;Eif3h;Eif4h
prerank,Translation Initiation Complex Formation R-HSA-72649,-0.8925056560268239,-1.5809634964200547,0.0,0.0006146500323782859,0.014,33/52,6.48%,Rps29;Rps2;Rps7;Rpsa;Rps5;Rps11;Rps28;Rps25;Rps23;Rps24;Fau;Rps27a;Rps8;Rps6;Rps4x;Rps15;Rps17;Eif4a1;Rps27;Rps21;Rps3;Rps20;Rps10;Rps15a;Eif1ax;Rps16;Rps14;Rps12;Eif3c;Eif3f;Rps9;Eif3h;Eif4h
prerank,Protein-protein Interactions At Synapses R-HSA-6794362,0.6854065480320709,1.5792818900237864,0.021505376344086023,0.4248977380662591,0.834,20/79,8.23%,Gria3;Ptprs;Dlgap2;Shank2;Il1rapl2;Gria4;Grin2a;Dlgap1;Nlgn1;Gria1;Ptprf;Shank3;Epb41l1;Ntrk3;Mpp3;Dlgap3;Lrfn1;Shank1;Cask;Stx1a
prerank,SARS-CoV-2 Modulates Host Translation Machinery R-HSA-9754678,-0.9096175481228731,-1.5790039254426729,0.0,0.0006313442307885603,0.014,30/42,6.11%,Rps29;Rps2;Rps7;Rpsa;Rps5;Rps11;Rps28;Rps25;Rps23;Rps24;Fau;Rps27a;Rps8;Rps6;Rps4x;Rps15;Rps17;Rps27;Rps21;Rps3;Rps20;Rps10;Snrpg;Rps15a;Rps16;Rps14;Rps12;Snrpf;Snrpd2;Rps9
prerank,O-glycosylation Of TSR Domain-Containing Proteins R-HSA-5173214,0.8311282240112818,1.5780036374513584,0.05504587155963303,0.367827942208285,0.836,7/18,7.84%,Adamts17;Sema5b;Adamts20;Spon1;Adamts18;Adamts3;Cfp
prerank,O-linked Glycosylation Of Mucins R-HSA-913709,0.8121202079527404,1.5701233882277843,0.057692307692307696,0.342697996763893,0.85,7/22,9.92%,St6galnac3;Galnt18;Galnt14;Galnt10;Galntl6;St3gal3;Galnt9
prerank,Defective B3GALTL Causes PpS R-HSA-5083635,0.839248010584169,1.5652918332972812,0.048672566371681415,0.3155514507591487,0.86,7/17,7.84%,Adamts17;Sema5b;Adamts20;Spon1;Adamts18;Adamts3;Cfp
prerank,Golgi Associated Vesicle Biogenesis R-HSA-432722,-0.8856016066154264,-1.5576486373007732,0.0,0.003196180168367086,0.065,5/47,4.01%,Fth1;Vamp2;Hspa8;Clta;Necap1
prerank,Visual Phototransduction R-HSA-2187338,-0.9264204556337832,-1.554778265960619,0.0,0.0036370326053832363,0.077,3/32,0.53%,Calm1;Ttr;Apoe
prerank,Uptake And Actions Of Bacterial Toxins R-HSA-5339562,-0.9233795364476403,-1.5461540356267123,0.001287001287001287,0.005966202980951895,0.116,4/25,3.03%,Calm1;Hsp90ab1;Vamp2;Hsp90aa1
prerank,SARS-CoV-2-host Interactions R-HSA-9705683,-0.8224810113521384,-1.5322883057082703,0.0,0.01082577153801755,0.187,37/134,6.49%,Hsp90ab1;Rps29;Rps2;Rps7;Rpsa;Rps5;Rps11;Rps28;Rps25;Rps23;Rps24;Fau;Rps27a;Rps8;Rps6;Ywhag;Rps4x;Rps15;Rps17;Rps27;Ywhah;Rps21;Ywhab;Rps3;Rps20;Hsp90aa1;Rps10;Snrpg;Rps15a;Rps16;Cnbp;Rps14;Rps12;Snrpf;Snrpd2;Rps9;Map1lc3b
prerank,Iron Uptake And Transport R-HSA-917937,-0.8759904370847351,-1.5283295376638864,0.0,0.01248507878268393,0.212,11/39,6.78%,Fth1;Ubb;Atp6v0c;Atp6v1d;Rps27a;Atp6v1a;Atp6v1g2;Atp6v0e2;Slc22a17;Uba52;Atp6v1f
prerank,trans-Golgi Network Vesicle Budding R-HSA-199992,-0.8522861203975006,-1.5268279940992127,0.0011441647597254005,0.013075282506956262,0.226,5/59,4.01%,Fth1;Vamp2;Hspa8;Clta;Necap1
prerank,DDX58/IFIH1-mediated Induction Of Interferon-Alpha/Beta R-HSA-168928,-0.8681532720381263,-1.524996592584418,0.001215066828675577,0.013944119361993662,0.239,8/39,6.60%,Hsp90ab1;Ubb;Hmgb1;Rps27a;Nfkb2;Hsp90aa1;Nfkbib;Uba52
prerank,Metabolism Of Vitamins And Cofactors R-HSA-196854,-0.8052958259160148,-1.4833149265868462,0.002188183807439825,0.06401492280072364,0.668,4/88,3.03%,Calm1;Ttr;Apoe;Hsp90aa1
prerank,Metabolism Of Fat-Soluble Vitamins R-HSA-6806667,-0.9113136931344128,-1.4779801976834113,0.008974358974358974,0.07244675048298728,0.71,2/18,0.53%,Ttr;Apoe
prerank,Amyloid Fiber Formation R-HSA-977225,-0.8638621438545507,-1.47784020058087,0.0036452004860267314,0.07051752461559455,0.711,10/36,6.60%,Ttr;Ubb;Apoe;Itm2b;Rps27a;Cst3;H2az1;Psenen;H2bc4;Uba52
prerank,VEGFR2 Mediated Vascular Permeability R-HSA-5218920,-0.9162358821038411,-1.476665799644182,0.007662835249042145,0.07093277040323447,0.724,2/17,3.03%,Calm1;Hsp90aa1
prerank,Long-term Potentiation R-HSA-9620244,-0.8978715049448837,-1.4760951250634526,0.00875,0.06996083257425734,0.728,3/22,0.67%,Nrgn;Calm1;Nefl
prerank,SARS-CoV-2 Infection R-HSA-9694516,-0.7752377354913917,-1.4683855333967106,0.0,0.08408617326279078,0.794,40/202,6.60%,Hsp90ab1;Ubb;Rps29;Rps2;Rps7;Ddx5;Rpsa;Rps5;Rps11;Rps28;Rps25;Rps23;Rps24;Fau;Rps27a;Rps8;Rps6;Ywhag;Rps4x;Rps15;Rps17;Rps27;Ywhah;Rps21;Ywhab;Rps3;Rps20;Hsp90aa1;Rps10;Snrpg;Rps15a;Rps16;Cnbp;Rps14;Rps12;Snrpf;Snrpd2;Rps9;Map1lc3b;Uba52
prerank,Retinoid Metabolism And Transport R-HSA-975634,-0.9124326741479444,-1.466564673336464,0.009067357512953367,0.08616693852280699,0.81,2/17,0.53%,Ttr;Apoe
prerank,Autophagy R-HSA-9612973,-0.7877649009959252,-1.4641161718026243,0.0010905125408942203,0.08979744282555148,0.829,23/112,7.69%,Hsp90ab1;Ubb;Eef1a1;Gabarapl1;Dynll2;Dynll1;Rps27a;Park7;Tomm5;Lamtor2;Hsp90aa1;Hspa8;Vdac1;Rraga;Gabarapl2;Tomm7;Gabarap;Map1lc3b;Rheb;Uba52;Sqstm1;Vps28;Lamtor3
prerank,RHOB GTPase Cycle R-HSA-9013026,0.6496835816789394,1.4623730829247394,0.04929577464788732,0.5570471240173547,0.98,8/51,5.97%,Tjp2;Myo9b;Arhgef28;Stk10;Dlc1;Myo9a;Rock1;Abr
prerank,Platelet Degranulation R-HSA-114608,-0.8169748822428367,-1.4619376116928031,0.0034285714285714284,0.09263967170174059,0.85,12/65,7.77%,Calm1;Ttr;Tuba4a;Ppia;Tmsb4x;Timp3;Vegfc;Aplp2;Fam3c;Manf;Sod1;Pdgfa
prerank,RHOBTB2 GTPase Cycle R-HSA-9013418,-0.8750860303899884,-1.4611160114556878,0.012515644555694618,0.09247130350752956,0.858,6/23,7.76%,Hsp90ab1;Actg1;Hsp90aa1;Cct2;Cdc37;Cct6a
prerank,Activated NOTCH1 Transmits Signal To Nucleus R-HSA-2122948,-0.8698776662529756,-1.4605616156491377,0.012903225806451613,0.09178955935377181,0.862,5/25,8.39%,Ubb;Rps27a;Psenen;Uba52;Aph1a
prerank,Translocation Of SLC2A4 (GLUT4) To Plasma Membrane R-HSA-1445148,-0.8242056459200416,-1.4583845759857108,0.010575793184488837,0.0950284581942765,0.871,5/43,2.63%,Calm1;Vamp2;Ywhag;Ywhah;Ywhab
prerank,Regulation Of Expression Of SLITs And ROBOs R-HSA-9010553,-0.7708078523041395,-1.4571859740530086,0.0,0.09563605766199104,0.876,79/149,7.91%,Rpl6;Ubb;Rps29;Rps2;Rpl23;Rps7;Rpl37;Rpl5;Rpl3;Rpl19;Rplp2;Rpsa;Rpl21;Rps5;Rpl18a;Rpl7;Rpl22;Rps11;Rps28;Rpl14;Rpl11;Rps25;Rps23;Rps24;Rpl27;Rpl29;Rpl28;Fau;Rps27a;Rps8;Rps6;Rpl4;Rpl27a;Psmc3;Rps4x;Rps15;Rpl7a;Rps17;Rpl8;Rps27;Rpl38;Psmb5;Rps21;Rpl12;Rpl23a;Rplp1;Rpl9;Rpl37a;Rps3;Rps20;Psma7;Rpl41;Rps10;Rpl13a;Rps15a;Psmc2;Rps16;Elob;Rpl39;Rps14;Rpl22l1;Rps12;Rpl15;Rpl30;Psma5;Rpl18;Rpl31;Rps9;Rpl26;Rpl36;Sem1;Psma4;Uba52;Rpl34;Magoh;Rpl36a;Rbm8a;Rpl35a;Rpl32
prerank,RIPK1-mediated Regulated Necrosis R-HSA-5213460,-0.8863313610226391,-1.456995090423572,0.011494252873563218,0.09402096661946512,0.877,5/20,7.28%,Ubb;Rps27a;Hsp90aa1;Uba52;Cdc37
prerank,Response To Elevated Platelet Cytosolic Ca2+ R-HSA-76005,-0.810045063631372,-1.4568318987047857,0.0033783783783783786,0.09251528310477519,0.879,12/69,7.77%,Calm1;Ttr;Tuba4a;Ppia;Tmsb4x;Timp3;Vegfc;Aplp2;Fam3c;Manf;Sod1;Pdgfa
prerank,HSP90 Chaperone Cycle For Steroid Hormone Receptors (SHR) In Presence Of Ligand R-HSA-3371497,-0.8630085873619082,-1.451634240788892,0.006060606060606061,0.10379062400077385,0.907,12/32,9.76%,Hsp90ab1;Dynll2;Dynll1;Hsp90aa1;Hspa8;Dnaja1;Hspa2;Capza2;Dctn6;Dnaja2;Dctn3;Ptges3
prerank,Regulated Necrosis R-HSA-5218859,-0.8564947934083017,-1.4504831681617125,0.008717310087173101,0.1049725839610759,0.91,9/30,7.28%,Ubb;Hmgb1;Rps27a;Hsp90aa1;Bax;Il18;Uba52;Cycs;Cdc37
prerank,SARS-CoV Infections R-HSA-9679506,-0.757454809854762,-1.4482700970853388,0.0,0.10805547569210265,0.919,58/260,10.31%,Hsp90ab1;Ubb;Atp1b1;Rps29;Rps2;Rps7;Ddx5;Rpsa;Rps5;Rps11;Rps28;Rps25;Rps23;Rps24;Fau;Rps27a;Rps8;Rps6;Ywhag;Rps4x;Rps15;Rps17;Rps27;Fkbp1a;Ywhah;Rps21;Ywhab;Rps3;Rps20;Hsp90aa1;Rps10;Snrpg;Rps15a;Rps16;Cnbp;Rps14;Rps12;Snrpf;Sap18;Nck1;Snrpd2;Ap2m1;Rps9;Map1lc3b;Uba52;Atp1b2;Atp1a3;Ywhae;Hmg20b;Zcrb1;Ifngr2;Ddx20;Ddost;Gja1;Dad1;Ptges3;Canx;Rps27l
prerank,MET Promotes Cell Motility R-HSA-8875878,0.7671005524006635,1.4479223121721174,0.0811965811965812,0.550531952976216,0.985,5/18,10.17%,Tns3;Lamb1;Dock7;Lamc1;Sos1
prerank,Signaling By ROBO Receptors R-HSA-376176,-0.7588384122225568,-1.4471283644480168,0.0,0.10865002396241574,0.925,82/183,7.91%,Rpl6;Ubb;Rps29;Rps2;Rpl23;Rps7;Rpl37;Rpl5;Rpl3;Rpl19;Rplp2;Rpsa;Rpl21;Rps5;Pfn2;Rpl18a;Rpl7;Rpl22;Rps11;Rps28;Rpl14;Rpl11;Rps25;Rps23;Rps24;Rpl27;Rpl29;Rpl28;Fau;Rps27a;Rps8;Rps6;Rpl4;Rpl27a;Psmc3;Rps4x;Rps15;Rpl7a;Rps17;Rpl8;Rps27;Rpl38;Psmb5;Rps21;Rpl12;Rpl23a;Rplp1;Rpl9;Rpl37a;Rps3;Rps20;Psma7;Rpl41;Rps10;Rpl13a;Rps15a;Psmc2;Rps16;Elob;Rpl39;Rps14;Rpl22l1;Rps12;Rpl15;Nck1;Rpl30;Psma5;Rpl18;Rpl31;Rps9;Rpl26;Rpl36;Sem1;Psma4;Uba52;Cdc42;Rpl34;Magoh;Rpl36a;Rbm8a;Rpl35a;Rpl32
prerank,Regulation Of Necroptotic Cell Death R-HSA-5675482,-0.8865929411215456,-1.4452941462720783,0.01297016861219196,0.11117577314042304,0.932,5/19,7.28%,Ubb;Rps27a;Hsp90aa1;Uba52;Cdc37
prerank,Fanconi Anemia Pathway R-HSA-6783310,-0.8772559343263923,-1.4417500170684385,0.017994858611825194,0.11771628414040475,0.943,4/21,8.11%,Ubb;Rps27a;Uba52;Rpa3
prerank,HDR Thru Homologous Recombination (HRR) R-HSA-5685942,-0.8547012106312063,-1.441743850200272,0.013513513513513514,0.11561420763789751,0.943,6/29,8.11%,Ubb;Rps27a;Sem1;Uba52;Pcna;Rpa3
prerank,Role Of GTSE1 In G2/M Progression After G2 Checkpoint R-HSA-8852276,-0.8163230106080159,-1.441670799160263,0.009205983889528193,0.11373541710241943,0.943,23/45,14.37%,Hsp90ab1;Ubb;Rps27a;Psmc3;Psmb5;Psma7;Hsp90aa1;Psmc2;Psma5;Sem1;Psma4;Uba52;Psmd2;Psmc5;Psmd4;Psmd7;Psmb3;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4
prerank,Plasma Lipoprotein Clearance R-HSA-8964043,-0.894123064279824,-1.4394535580589523,0.011523687580025609,0.11840561704192092,0.948,7/20,6.60%,Ubb;Apoe;Rps27a;Clta;Nceh1;Ap2m1;Uba52
prerank,Signaling By BRAF And RAF1 Fusions R-HSA-6802952,-0.8219665726141107,-1.4389479925741484,0.007963594994311717,0.11768082574716554,0.949,3/47,2.63%,Calm1;Pebp1;Ywhab
prerank,RAF Activation R-HSA-5673000,-0.8526547592283757,-1.437474979031118,0.008610086100861008,0.11991002598323854,0.957,2/29,2.63%,Calm1;Ywhab
prerank,Recognition Of DNA Damage By PCNA-containing Replication Complex R-HSA-110314,-0.8779563557470974,-1.4374724742648208,0.017195767195767195,0.11794428785236576,0.957,5/18,8.11%,Ubb;Rps27a;Uba52;Pcna;Rpa3
prerank,Signaling By B Cell Receptor (BCR) R-HSA-983705,-0.7947717779155693,-1.4373879698695295,0.0022002200220022,0.11619661450805505,0.957,34/80,14.45%,Calm1;Ubb;Ppia;Rps27a;Psmc3;Rasgrp1;Psmb5;Fkbp1a;Psma7;Psmc2;Nck1;Psma5;Orai2;Nfkbib;Sem1;Psma4;Uba52;Ppp3ca;Psmd2;Psmc5;Psmd4;Psmd7;Psmb3;Clstn1;Ppp3r1;Lyn;Psmb1;Psma3;Psmd6;Hras;Psme3;Psma1;Psmc4;Ppp3cb
prerank,Downstream Signaling Events Of B Cell Receptor (BCR) R-HSA-1168372,-0.8038251569747114,-1.437186819568763,0.003355704697986577,0.11477499895612389,0.957,30/65,14.45%,Calm1;Ubb;Ppia;Rps27a;Psmc3;Rasgrp1;Psmb5;Fkbp1a;Psma7;Psmc2;Psma5;Nfkbib;Sem1;Psma4;Uba52;Ppp3ca;Psmd2;Psmc5;Psmd4;Psmd7;Psmb3;Ppp3r1;Psmb1;Psma3;Psmd6;Hras;Psme3;Psma1;Psmc4;Ppp3cb
prerank,RAS Processing R-HSA-9648002,-0.916242932430073,-1.4366515407229874,0.009296148738379814,0.11408032653031064,0.959,1/15,0.04%,Calm1
prerank,Mitotic G2-G2/M Phases R-HSA-453274,-0.7689719793107813,-1.4358009699046257,0.0,0.11427573401977091,0.961,35/136,13.08%,Hsp90ab1;Ubb;Tuba4a;Dynll1;Rps27a;Tuba1a;Ywhag;Psmc3;Psmb5;Psma7;Hsp90aa1;Cetn2;Psmc2;Nme7;Csnk1e;Psma5;Sem1;Psma4;Uba52;Ywhae;Ppp2r1a;Psmd2;Psmc5;Tubb4b;Tubb4a;Dctn3;Psmd4;Psmd7;Rbx1;Psmb3;Ppp2ca;Psmb1;Psma3;Psmd6;Psme3
prerank,Regulation Of PLK1 Activity At G2/M Transition R-HSA-2565942,-0.8047471229183835,-1.4345567926036067,0.00904977375565611,0.11549832881144698,0.965,15/66,9.62%,Ubb;Tuba4a;Dynll1;Rps27a;Tuba1a;Ywhag;Hsp90aa1;Cetn2;Csnk1e;Uba52;Ywhae;Ppp2r1a;Tubb4b;Tubb4a;Dctn3
prerank,Cellular Response To Hypoxia R-HSA-1234174,-0.8004503500774084,-1.4343738941954975,0.007909604519774011,0.11429921915533642,0.965,26/59,14.37%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Elob;Psma5;Cited2;Sem1;Psma4;Uba52;Psmd2;Psmc5;Higd1a;Psmd4;Psmd7;Rbx1;Psmb3;Psmb1;Psma3;Psmd6;Psme3;Limd1;Psma1;Psmc4
prerank,G2/M Transition R-HSA-69275,-0.7690332899506697,-1.4342165303640397,0.0,0.11285336153307904,0.965,35/135,13.08%,Hsp90ab1;Ubb;Tuba4a;Dynll1;Rps27a;Tuba1a;Ywhag;Psmc3;Psmb5;Psma7;Hsp90aa1;Cetn2;Psmc2;Nme7;Csnk1e;Psma5;Sem1;Psma4;Uba52;Ywhae;Ppp2r1a;Psmd2;Psmc5;Tubb4b;Tubb4a;Dctn3;Psmd4;Psmd7;Rbx1;Psmb3;Ppp2ca;Psmb1;Psma3;Psmd6;Psme3
prerank,DNA Damage Bypass R-HSA-73893,-0.8357286634325527,-1.432007464181064,0.01845018450184502,0.11639036767705845,0.968,5/29,8.11%,Ubb;Rps27a;Uba52;Pcna;Rpa3
prerank,Paradoxical Activation Of RAF Signaling By Kinase Inactive BRAF R-HSA-6802955,-0.8492171874451755,-1.431444413432974,0.018159806295399514,0.11588436096165236,0.97,3/29,2.63%,Calm1;Pebp1;Ywhab
prerank,Post NMDA Receptor Activation Events R-HSA-438064,-0.8116399560474755,-1.4314371398327495,0.009070294784580499,0.11425218686360092,0.97,3/53,0.67%,Nrgn;Calm1;Nefl
prerank,Peroxisomal Protein Import R-HSA-9033241,-0.8252787056601623,-1.4311657313048523,0.007352941176470588,0.1133164246729405,0.97,4/39,8.69%,Ubb;Rps27a;Uba52;Mpv17
prerank,Cellular Response To Chemical Stress R-HSA-9711123,-0.7700269502967951,-1.4310278674945993,0.0,0.112026844622766,0.97,52/133,14.37%,Ubb;Rps27a;Psmc3;Cox6c;Psmb5;Prdx5;Cox8a;Psma7;Phgdh;Cox5b;Psmc2;Sesn1;Srxn1;Cox7a2l;Cox4i1;Gstp1;Cox6b1;Cox6a1;Psma5;Cox7c;Sem1;Cox5a;Map1lc3b;Psma4;Uba52;Sqstm1;Sod1;Cycs;Sin3b;Psmd2;Psmc5;Cox7b;Cox20;Sco2;Psmd4;Psmd7;Csnk2b;Gclm;Rbx1;Psmb3;P4hb;Psmb1;Psma3;Psmd6;Prdx1;Psme3;Cox14;Mul1;Psma1;Hmox2;Tbl1xr1;Psmc4
prerank,TAK1-dependent IKK And NF-kappa-B Activation R-HSA-445989,-0.8381709599453863,-1.4296881018185899,0.01680672268907563,0.11376673734430955,0.973,6/30,6.60%,Ubb;Hmgb1;Rps27a;Nfkb2;Nfkbib;Uba52
prerank,Attenuation Phase R-HSA-3371568,-0.9058622524346307,-1.4282627608210974,0.012178619756427604,0.1155596696429611,0.973,8/15,6.51%,Hsp90ab1;Ubb;Hsbp1;Hsp90aa1;Hspa8;Mrpl18;Hspa2;Dnajb6
prerank,C-type Lectin Receptors (CLRs) R-HSA-5621481,-0.7797355450185388,-1.4281638893916522,0.0010799136069114472,0.11426344101912334,0.974,30/88,14.78%,Calm1;Ubb;Rps27a;Psmc3;Psmb5;Nfkb2;Psma7;Psmc2;Psma5;Sem1;Psma4;Uba52;Ppp3ca;Psmd2;Psmc5;Psmd4;Psmd7;Psmb3;Ppp3r1;Lyn;Psmb1;Psma3;Psmd6;Hras;Psme3;Ube2n;Psma1;Psmc4;Ppp3cb;Ube2v1
prerank,HSF1 Activation R-HSA-3371511,-0.892054244568885,-1.427672561118028,0.013404825737265416,0.113955583838404,0.974,9/17,8.11%,Hsp90ab1;Ubb;Eef1a1;Hsbp1;Hsp90aa1;Mrpl18;Dnajb6;Ywhae;Rpa3
prerank,RUNX1 Regulates Transcription Of Genes Involved In Differentiation Of HSCs R-HSA-8939236,-0.7945606705187117,-1.4276607890955262,0.0067039106145251395,0.11253559148365995,0.974,25/59,14.37%,Ubb;Lmo1;Rps27a;Psmc3;Psmb5;Psma7;H2az1;Psmc2;H2bc4;Psma5;Sem1;Psma4;Uba52;Psmd2;Psmc5;Psmd4;Psmd7;Psmb3;Psmb1;Psma3;Psmd6;Psme3;H2aj;Psma1;Psmc4
prerank,Ras Activation Upon Ca2+ Influx Thru NMDA Receptor R-HSA-442982,-0.8832628329127364,-1.427159709793679,0.016352201257861635,0.11212253974600825,0.974,2/19,0.67%,Calm1;Nefl
prerank,Oxygen-dependent Proline Hydroxylation Of Hypoxia-inducible Factor Alpha R-HSA-1234176,-0.7998370318893414,-1.425206262257178,0.011337868480725623,0.11532883440857904,0.976,24/53,14.37%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Elob;Psma5;Sem1;Psma4;Uba52;Psmd2;Psmc5;Psmd4;Psmd7;Rbx1;Psmb3;Psmb1;Psma3;Psmd6;Psme3;Limd1;Psma1;Psmc4
prerank,Protein Localization R-HSA-9609507,-0.7588691597949653,-1.4247430252608198,0.008592910848549946,0.11483888497947752,0.976,25/122,12.03%,Ubb;Slc25a4;Vamp2;Prnp;Rps27a;Dnajc19;Cox17;Tomm5;Timm8b;Vdac1;Chchd10;Chchd2;Tomm7;Uba52;Atad1;Emd;Timm13;Mpv17;Timm22;Pam16;Ndufb8;Vapa;Timm10;Bcs1l;Sec61g
prerank,Metalloprotease DUBs R-HSA-5689901,-0.8888792336052848,-1.4245659166461073,0.016150740242261104,0.1139191370578968,0.977,4/18,6.60%,Ubb;Rps27a;H2ac25;Uba52
prerank,Circadian Clock R-HSA-400253,-0.8009041768065874,-1.4241685799530057,0.009324009324009324,0.1135991746588302,0.978,5/53,6.60%,Ubb;Rps27a;Csnk1e;Ppp1ca;Uba52
prerank,Kinesins R-HSA-983189,0.7343848727880488,1.4230202282097306,0.1,0.5840850838380801,0.993,4/19,12.41%,Kif26b;Kif3c;Kif1c;Kif1b
prerank,CLEC7A (Dectin-1) Signaling R-HSA-5607764,-0.7846109399094485,-1.4223438171696792,0.0054525627044711015,0.11663520963612589,0.982,28/76,14.78%,Calm1;Ubb;Rps27a;Psmc3;Psmb5;Nfkb2;Psma7;Psmc2;Psma5;Sem1;Psma4;Uba52;Ppp3ca;Psmd2;Psmc5;Psmd4;Psmd7;Psmb3;Ppp3r1;Psmb1;Psma3;Psmd6;Psme3;Ube2n;Psma1;Psmc4;Ppp3cb;Ube2v1
prerank,Interleukin-1 Signaling R-HSA-9020702,-0.7750064373938144,-1.422269828418806,0.00544069640914037,0.11545104129736954,0.982,29/84,14.78%,Ubb;Hmgb1;Rps27a;Psmc3;Psmb5;Nfkb2;Psma7;Psmc2;Psma5;Nfkbib;Sem1;Psma4;Uba52;Sqstm1;Psmd2;Psmc5;Psmd4;Psmd7;Usp14;Rbx1;Psmb3;Psmb1;Psma3;Psmd6;Psme3;Ube2n;Psma1;Psmc4;Ube2v1
prerank,Transport Of Inorganic Cations/Anions And Amino Acids/Oligopeptides R-HSA-425393,-0.7922960019785921,-1.4219611141014747,0.009174311926605505,0.11478994356623806,0.982,2/52,1.35%,Calm1;Slc15a2
prerank,Synthesis Of IP3 And IP4 In Cytosol R-HSA-1855204,-0.9052137095242082,-1.420211812684056,0.012129380053908356,0.11741369905863458,0.983,1/15,0.04%,Calm1
prerank,Citric Acid (TCA) Cycle And Respiratory Electron Transport R-HSA-1428517,-0.7548066769252215,-1.419090719145983,0.0010570824524312897,0.11845237411857414,0.985,64/128,18.09%,Ndufa3;Ndufa1;Uqcrq;Mdh2;Cox6c;Idh3b;Ndufs8;Ndufs5;Cox8a;Atp5pb;Cox5b;Uqcrb;Vdac1;Ndufs2;Cox7a2l;Cox4i1;Cox6b1;Ndufb1;Cox6a1;Cox7c;Bsg;Ndufa2;Uqcr10;Ndufs7;Ndufb3;Uqcrc1;Ndufb11;Ndufb10;Cox5a;Cycs;Uqcrh;Glo1;Ndufa13;Cox7b;Cox20;Sco2;Ldlr;Ldha;Ndufb8;Hagh;Uqcr11;Dlat;Ndufa8;Ndufa7;Ndufv1;Uqcrc2;Cox14;Ndufc2;Slc16a1;Sdhd;Ndufv2;Fahd1;Ldhb;Ndufb6;Cox19;Ndufc1;Ndufb4;Idh3a;Suclg1;Surf1;Ndufaf3;Ndufa5;Sdhb;Idh2
prerank,HSF1-dependent Transactivation R-HSA-3371571,-0.8619613901781384,-1.4180314138868026,0.01808785529715762,0.119659239561788,0.986,8/24,6.51%,Hsp90ab1;Ubb;Hsbp1;Hsp90aa1;Hspa8;Mrpl18;Hspa2;Dnajb6
prerank,Assembly Of HIV Virion R-HSA-175474,-0.8821891776200781,-1.4177936462824081,0.014473684210526316,0.11893341537623749,0.986,5/17,6.88%,Ubb;Ppia;Rps27a;Uba52;Vps28
prerank,Aggrephagy R-HSA-9646399,-0.8603804469034139,-1.4174647311123867,0.02454780361757106,0.11837574242622569,0.987,6/22,3.03%,Ubb;Dynll2;Dynll1;Rps27a;Park7;Hsp90aa1
prerank,Nuclear Events Mediated By NFE2L2 R-HSA-9759194,-0.7954010673687908,-1.4169807354243602,0.004524886877828055,0.11833972877008428,0.987,27/63,14.37%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Phgdh;Psmc2;Srxn1;Psma5;Sem1;Psma4;Uba52;Sqstm1;Psmd2;Psmc5;Psmd4;Psmd7;Gclm;Rbx1;Psmb3;Psmb1;Psma3;Psmd6;Prdx1;Psme3;Psma1;Psmc4
prerank,Fc Epsilon Receptor (FCERI) Signaling R-HSA-2454202,-0.7651464769452044,-1.416578134035935,0.004314994606256742,0.11812119611481371,0.988,31/98,14.78%,Calm1;Ubb;Rps27a;Jun;Psmc3;Rasgrp1;Psmb5;Psma7;Psmc2;Psma5;Sem1;Psma4;Uba52;Ppp3ca;Psmd2;Psmc5;Psmd4;Psmd7;Psmb3;Ppp3r1;Lyn;Psmb1;Psma3;Psmd6;Hras;Psme3;Ube2n;Psma1;Psmc4;Ppp3cb;Ube2v1
prerank,Programmed Cell Death R-HSA-5357801,-0.7498968115538532,-1.4157179282727426,0.0020898641588296763,0.11884803278545131,0.989,40/139,13.26%,Ubb;Hmgb1;Dynll2;Dynll1;Rps27a;Ywhag;Psmc3;Psmb5;Ywhah;Ywhab;Psma7;Hsp90aa1;Psmc2;Bax;Il18;Psma5;Maged1;Ndufa2;Sem1;Psma4;Uba52;Cycs;Cdc37;Bad;Ywhae;Psmd2;Psmc5;Psmd4;Psmd7;Chmp4b;C1qbp;Psmb3;Ywhaq;Gsdme;Ppp3r1;Psmb1;Psma3;Psmd6;Psme3;Chmp2a
prerank,SCF(Skp2)-mediated Degradation Of P27/P21 R-HSA-187577,-0.8025415075046012,-1.4154625558008225,0.011350737797956867,0.11832595423312676,0.989,23/48,14.44%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Psma5;Sem1;Psma4;Uba52;Psmd2;Psmc5;Cdk4;Psmd4;Psmd7;Psmb3;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4;Cdkn1b
prerank,RHOBTB GTPase Cycle R-HSA-9706574,-0.8264967994823701,-1.4125801248586365,0.020987654320987655,0.12418491695842951,0.99,6/32,7.76%,Hsp90ab1;Actg1;Hsp90aa1;Cct2;Cdc37;Cct6a
prerank,Sensory Perception R-HSA-9709957,-0.7676032142060798,-1.4120819894586045,0.01560758082497213,0.12405792096806269,0.99,6/83,3.02%,Calm1;Ttr;Apoe;Rab3a;Vamp2;Kcnj2
prerank,G1/S DNA Damage Checkpoints R-HSA-69615,-0.7943396525461379,-1.4111084307628317,0.014623172103487065,0.12379010261524107,0.99,22/49,14.44%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Psma5;Sem1;Psma4;Uba52;Psmd2;Psmc5;Psmd4;Psmd7;Psmb3;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4;Cdkn1b
prerank,p53-Dependent G1 DNA Damage Response R-HSA-69563,-0.7943396525461379,-1.4111084307628317,0.014623172103487065,0.12379010261524107,0.99,22/49,14.44%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Psma5;Sem1;Psma4;Uba52;Psmd2;Psmc5;Psmd4;Psmd7;Psmb3;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4;Cdkn1b
prerank,KEAP1-NFE2L2 Pathway R-HSA-9755511,-0.7772218767619692,-1.4110021974117881,0.006600660066006601,0.12275462633308523,0.99,31/80,14.37%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Phgdh;Psmc2;Sesn1;Srxn1;Psma5;Sem1;Map1lc3b;Psma4;Uba52;Sqstm1;Psmd2;Psmc5;Psmd4;Psmd7;Csnk2b;Gclm;Rbx1;Psmb3;Psmb1;Psma3;Psmd6;Prdx1;Psme3;Mul1;Psma1;Psmc4
prerank,Negative Regulation Of MAPK Pathway R-HSA-5675221,-0.8255992201908102,-1.4105395814911572,0.018315018315018316,0.12259407893320882,0.992,6/33,6.60%,Ubb;Pebp1;Rps27a;Ywhab;Dusp7;Uba52
prerank,Apoptosis R-HSA-109581,-0.7522391812118402,-1.4101925319227342,0.0021119324181626186,0.12220688879050624,0.992,35/123,13.08%,Ubb;Hmgb1;Dynll2;Dynll1;Rps27a;Ywhag;Psmc3;Psmb5;Ywhah;Ywhab;Psma7;Psmc2;Bax;Psma5;Maged1;Ndufa2;Sem1;Psma4;Uba52;Cycs;Bad;Ywhae;Psmd2;Psmc5;Psmd4;Psmd7;C1qbp;Psmb3;Ywhaq;Gsdme;Ppp3r1;Psmb1;Psma3;Psmd6;Psme3
prerank,Hedgehog Ligand Biogenesis R-HSA-5358346,-0.7895882651122383,-1.4090570416839552,0.01598173515981735,0.12334772979863272,0.992,22/52,14.37%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Psma5;Sem1;Psma4;Uba52;Psmd2;Psmc5;Psmd4;Psmd7;Psmb3;P4hb;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4
prerank,Regulation Of Apoptosis R-HSA-169911,-0.7995928567852336,-1.4082260403410518,0.013793103448275862,0.12400564403231916,0.993,21/46,14.37%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Psma5;Sem1;Psma4;Uba52;Psmd2;Psmc5;Psmd4;Psmd7;Psmb3;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4
prerank,Vif-mediated Degradation Of APOBEC3G R-HSA-180585,-0.7988985353175102,-1.408127269829591,0.011454753722794959,0.12312903600995109,0.993,23/46,14.37%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Elob;Psma5;Sem1;Psma4;Uba52;Psmd2;Psmc5;Psmd4;Psmd7;Rbx1;Psmb3;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4
prerank,Translesion Synthesis By Y Family DNA Polymerases Bypasses Lesions On DNA Template R-HSA-110313,-0.8656513576964806,-1.4078131045157243,0.018158236057068743,0.12263079947876358,0.993,5/21,8.11%,Ubb;Rps27a;Uba52;Pcna;Rpa3
prerank,FBXL7 Down-Regulates AURKA During Mitotic Entry And In Early Mitosis R-HSA-8854050,-0.7998150847212985,-1.4075887223237697,0.006936416184971098,0.12188299514324456,0.995,22/47,14.37%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Psma5;Sem1;Psma4;Uba52;Psmd2;Psmc5;Psmd4;Psmd7;Rbx1;Psmb3;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4
prerank,AUF1 (hnRNP D0) Binds And Destabilizes mRNA R-HSA-450408,-0.7966787840873858,-1.4071950504922088,0.014925373134328358,0.1216225472092525,0.996,22/46,14.37%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Hspa8;Psmc2;Psma5;Sem1;Psma4;Uba52;Psmd2;Psmc5;Psmd4;Psmd7;Psmb3;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4
prerank,Neutrophil Degranulation R-HSA-6798695,-0.7355745342861862,-1.4059360353038415,0.0,0.12346834216150776,0.997,52/231,11.33%,Fth1;Ttr;Hsp90ab1;Hmgb1;Eef1a1;Atp6v0c;Ppia;Rab3a;Atp6v1d;Pdap1;Dynll1;Cst3;Psmc3;Srp14;Prdx5;Aldoc;Lamtor2;Hsp90aa1;Nme2;Rap2b;Hspa8;Pgrmc1;Arl8a;Psmc2;Pkm;Gstp1;Cct2;Psma5;Ndufa2;Fuca1;Eef2;Arpc5;Commd3;Lamtor3;Pdxk;Ddost;Aprt;Rab24;Psmd2;Cstb;Ctsb;Tubb4b;Psmd7;Csnk2b;Vapa;Alad;Itgav;Lamp1;Rab31;Actr1b;Trappc1;Cd63
prerank,Negative Regulation Of NOTCH4 Signaling R-HSA-9604323,-0.7966254092766551,-1.4052495325772487,0.011337868480725623,0.12383745343255022,0.997,23/47,14.57%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Psma5;Sem1;Psma4;Uba52;Psmd2;Psmc5;Psmd4;Psmd7;Rbx1;Psmb3;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4;Ywhaz
prerank,DNA Replication Pre-Initiation R-HSA-69002,-0.7719898112309707,-1.4052169952974096,0.008733624454148471,0.12278898766942985,0.997,27/76,14.37%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;H2az1;Psmc2;H2bc4;Psma5;Sem1;Psma4;Ube2s;Uba52;Rpa3;Psmd2;Psmc5;Psmd4;Psmd7;Psmb3;Anapc11;Psmb1;Psma3;Psmd6;Psme3;H2aj;Psma1;Psmc4
prerank,Ubiquitin-dependent Degradation Of Cyclin D R-HSA-75815,-0.7981889698708995,-1.4051328977083033,0.01722158438576349,0.12191144356485886,0.997,22/45,14.37%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Psma5;Sem1;Psma4;Uba52;Psmd2;Psmc5;Cdk4;Psmd4;Psmd7;Psmb3;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4
prerank,Interleukin-1 Family Signaling R-HSA-446652,-0.7616212533941493,-1.4048022692238764,0.004310344827586207,0.12161512681937182,0.997,30/98,14.78%,Ubb;Hmgb1;Rps27a;Psmc3;Psmb5;Nfkb2;Psma7;Psmc2;Il18;Psma5;Nfkbib;Sem1;Psma4;Uba52;Sqstm1;Psmd2;Psmc5;Psmd4;Psmd7;Usp14;Rbx1;Psmb3;Psmb1;Psma3;Psmd6;Psme3;Ube2n;Psma1;Psmc4;Ube2v1
prerank,DNA Replication R-HSA-69306,-0.7667221552575533,-1.4045873733406595,0.0054288816503800215,0.12115578860441788,0.997,30/87,14.37%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;H2az1;Psmc2;H2bc4;Psma5;Sem1;Psma4;Ube2s;Uba52;Pcna;Rpa3;Psmd2;Psmc5;Psmd4;Psmd7;Rbx1;Psmb3;Gins2;Anapc11;Psmb1;Psma3;Psmd6;Psme3;H2aj;Psma1;Psmc4
prerank,Glycogen Metabolism R-HSA-8982491,-0.8990777302805665,-1.4044247065409141,0.016,0.12034313155677812,0.997,3/16,1.62%,Calm1;Ubb;Rps27a
prerank,Stabilization Of P53 R-HSA-69541,-0.794612310446004,-1.4041312577381402,0.017006802721088437,0.11994860057147745,0.997,21/46,14.37%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Psma5;Sem1;Psma4;Uba52;Psmd2;Psmc5;Psmd4;Psmd7;Psmb3;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4
prerank,Autodegradation Of E3 Ubiquitin Ligase COP1 R-HSA-349425,-0.8000487233299939,-1.402582537533288,0.014994232987312572,0.12213779087836961,1.0,21/43,14.37%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Psma5;Sem1;Psma4;Uba52;Psmd2;Psmc5;Psmd4;Psmd7;Psmb3;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4
prerank,Asymmetric Localization Of PCP Proteins R-HSA-4608870,-0.7892440784826394,-1.4024581788326995,0.017977528089887642,0.12137358758010944,1.0,21/49,14.37%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Psma5;Sem1;Psma4;Uba52;Psmd2;Psmc5;Psmd4;Psmd7;Psmb3;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4
prerank,GSK3B And BTRC:CUL1-mediated-degradation Of NFE2L2 R-HSA-9762114,-0.7984205366825333,-1.4022102533539924,0.013888888888888888,0.12091767326040859,1.0,22/46,14.37%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Psma5;Sem1;Psma4;Uba52;Psmd2;Psmc5;Psmd4;Psmd7;Rbx1;Psmb3;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4
prerank,Regulation Of Activated PAK-2p34 By Proteasome Mediated Degradation R-HSA-211733,-0.7999018066541722,-1.4017051868015487,0.017361111111111112,0.12092214970322143,1.0,21/43,14.37%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Psma5;Sem1;Psma4;Uba52;Psmd2;Psmc5;Psmd4;Psmd7;Psmb3;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4
prerank,NOTCH3 Activation And Transmission Of Signal To Nucleus R-HSA-9013507,-0.8604730155584169,-1.4013365442443486,0.02681992337164751,0.12055674618535026,1.0,5/20,8.39%,Ubb;Rps27a;Psenen;Uba52;Aph1a
prerank,Ubiquitin Mediated Degradation Of Phosphorylated Cdc25A R-HSA-69601,-0.8003758495461083,-1.401293985942058,0.019675925925925927,0.11964717072895478,1.0,21/42,14.37%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Psma5;Sem1;Psma4;Uba52;Psmd2;Psmc5;Psmd4;Psmd7;Psmb3;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4
prerank,Hh Mutants Are Degraded By ERAD R-HSA-5362768,-0.7913484008404167,-1.4011628554595505,0.020689655172413793,0.11807823670394857,1.0,21/48,14.37%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Psma5;Sem1;Psma4;Uba52;Psmd2;Psmc5;Psmd4;Psmd7;Psmb3;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4
prerank,Hh Mutants Abrogate Ligand Secretion R-HSA-5387390,-0.7913484008404167,-1.4011628554595505,0.020689655172413793,0.11807823670394857,1.0,21/48,14.37%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Psma5;Sem1;Psma4;Uba52;Psmd2;Psmc5;Psmd4;Psmd7;Psmb3;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4
prerank,Macroautophagy R-HSA-1632852,-0.7566995995190262,-1.4010574349071874,0.014192139737991267,0.11738930522378635,1.0,24/100,10.60%,Ubb;Gabarapl1;Dynll2;Dynll1;Rps27a;Park7;Tomm5;Lamtor2;Hsp90aa1;Hspa8;Vdac1;Rraga;Gabarapl2;Tomm7;Gabarap;Map1lc3b;Rheb;Uba52;Sqstm1;Lamtor3;Pink1;Atg12;Csnk2b;Chmp4b
prerank,FCGR3A-mediated IL10 Synthesis R-HSA-9664323,-0.8511571080095593,-1.4009440765038685,0.020151133501259445,0.11677049768558058,1.0,1/24,0.04%,Calm1
prerank,Regulation Of TP53 Activity Thru Methylation R-HSA-6804760,-0.87701413941798,-1.4009029605647845,0.0310391363022942,0.11596848988846878,1.0,3/16,6.60%,Ubb;Rps27a;Uba52
prerank,SCF-beta-TrCP Mediated Degradation Of Emi1 R-HSA-174113,-0.7978165293203245,-1.3999814891197493,0.013872832369942197,0.11684369063421135,1.0,21/46,14.37%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Psma5;Sem1;Psma4;Uba52;Psmd2;Psmc5;Psmd4;Psmd7;Psmb3;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4
prerank,Regulation Of RUNX3 Expression And Activity R-HSA-8941858,-0.7956940780567657,-1.3999782557211253,0.01834862385321101,0.11594618445401945,1.0,21/47,14.37%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Psma5;Sem1;Psma4;Uba52;Psmd2;Psmc5;Psmd4;Psmd7;Psmb3;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4
prerank,Host Interactions Of HIV Factors R-HSA-162909,-0.7555495635933274,-1.3994343585188989,0.005470459518599562,0.11622622345585133,1.0,35/104,14.96%,Ubb;Slc25a4;Ppia;Ran;Rps27a;Psmc3;Banf1;Psmb5;Psma7;Slc25a5;Psmc2;Elob;Psma5;Ap2m1;Sem1;Psma4;Uba52;Psip1;Psmd2;Psmc5;Psmd4;Psmd7;Rbx1;Psmb3;Ranbp1;Nup37;Psmb1;Psma3;Psmd6;Psme3;Nup50;Psma1;Psmc4;Sec13;Npm1
prerank,Regulation Of TNFR1 Signaling R-HSA-5357905,-0.8261406719703541,-1.3982940133433337,0.02832512315270936,0.11759177876442672,1.0,3/27,1.62%,Ubb;Rack1;Rps27a
prerank,"Respiratory Electron Transport, ATP Synthesis By Chemiosmotic Coupling, Heat Production By Uncoupling Proteins R-HSA-163200",-0.7558766927635001,-1.3973915428462425,0.009698275862068966,0.11852501457694613,1.0,41/92,14.18%,Ndufa3;Ndufa1;Uqcrq;Cox6c;Ndufs8;Ndufs5;Cox8a;Atp5pb;Cox5b;Uqcrb;Ndufs2;Cox7a2l;Cox4i1;Cox6b1;Ndufb1;Cox6a1;Cox7c;Ndufa2;Uqcr10;Ndufs7;Ndufb3;Uqcrc1;Ndufb11;Ndufb10;Cox5a;Cycs;Uqcrh;Ndufa13;Cox7b;Cox20;Sco2;Ndufb8;Uqcr11;Ndufa8;Ndufa7;Ndufv1;Uqcrc2;Cox14;Ndufc2;Sdhd;Ndufv2
prerank,Basigin Interactions R-HSA-210991,-0.8857174607479428,-1.3971247020148414,0.031207598371777476,0.11812248812717056,1.0,4/16,6.86%,Atp1b1;Ppia;Bsg;Atp1b2
prerank,Vpu Mediated Degradation Of CD4 R-HSA-180534,-0.7979646818706999,-1.3969815663016727,0.018604651162790697,0.1176067090808108,1.0,21/44,14.37%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Psma5;Sem1;Psma4;Uba52;Psmd2;Psmc5;Psmd4;Psmd7;Psmb3;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4
prerank,Degradation Of GLI1 By Proteasome R-HSA-5610780,-0.7887004076010395,-1.3967565957887444,0.021714285714285714,0.11725640726320537,1.0,22/51,14.37%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Psma5;Sem1;Psma4;Uba52;Psmd2;Psmc5;Psmd4;Psmd7;Rbx1;Psmb3;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4
prerank,E3 Ubiquitin Ligases Ubiquitinate Target Proteins R-HSA-8866654,-0.8081711516542243,-1.3966389281730887,0.024330900243309004,0.1166214072707863,1.0,6/38,7.23%,Ubb;Rps27a;Rraga;H2bc4;Uba52;Pcna
prerank,APC/C:Cdh1 Mediated Degradation Of Cdc20 And APC/C:Cdh1 Targets In Late Mitosis/Early G1 R-HSA-174178,-0.7732116635151159,-1.3964240106322727,0.02097130242825607,0.11625230495600872,1.0,23/60,14.37%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Psma5;Sem1;Psma4;Ube2s;Uba52;Psmd2;Psmc5;Psmd4;Psmd7;Psmb3;Anapc11;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4
prerank,Assembly Of Pre-Replicative Complex R-HSA-68867,-0.7733073186609151,-1.3963212207397522,0.007700770077007701,0.11566466493351615,1.0,26/70,14.37%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;H2az1;Psmc2;H2bc4;Psma5;Sem1;Psma4;Ube2s;Uba52;Psmd2;Psmc5;Psmd4;Psmd7;Psmb3;Anapc11;Psmb1;Psma3;Psmd6;Psme3;H2aj;Psma1;Psmc4
prerank,EGFR Downregulation R-HSA-182971,-0.8461845228614073,-1.3950600740834869,0.022222222222222223,0.11749986086586914,1.0,5/25,6.70%,Ubb;Rps27a;Spry2;Uba52;Cdc42
prerank,Respiratory Electron Transport R-HSA-611105,-0.7565230152953136,-1.3948030408939351,0.01079913606911447,0.117170442981781,1.0,54/88,20.09%,Ndufa3;Ndufa1;Uqcrq;Cox6c;Ndufs8;Ndufs5;Cox8a;Cox5b;Uqcrb;Ndufs2;Cox7a2l;Cox4i1;Cox6b1;Ndufb1;Cox6a1;Cox7c;Ndufa2;Uqcr10;Ndufs7;Ndufb3;Uqcrc1;Ndufb11;Ndufb10;Cox5a;Cycs;Uqcrh;Ndufa13;Cox7b;Cox20;Sco2;Ndufb8;Uqcr11;Ndufa8;Ndufa7;Ndufv1;Uqcrc2;Cox14;Ndufc2;Sdhd;Ndufv2;Ndufb6;Cox19;Ndufc1;Ndufb4;Surf1;Ndufaf3;Ndufa5;Sdhb;Ndufs6;Ndufa12;Ndufb5;Tmem186;Ndufaf2;Ndufb9
prerank,APC/C:Cdc20 Mediated Degradation Of Securin R-HSA-174154,-0.773433949108785,-1.3945350699797476,0.022099447513812154,0.11680791778436593,1.0,23/57,14.37%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Psma5;Sem1;Psma4;Ube2s;Uba52;Psmd2;Psmc5;Psmd4;Psmd7;Psmb3;Anapc11;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4
prerank,CDK-mediated Phosphorylation And Removal Of Cdc6 R-HSA-69017,-0.7731969629018026,-1.3942611176600466,0.016611295681063124,0.11658554844191586,1.0,23/59,14.37%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Psma5;Sem1;Psma4;Ube2s;Uba52;Psmd2;Psmc5;Psmd4;Psmd7;Psmb3;Anapc11;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4
prerank,Orc1 Removal From Chromatin R-HSA-68949,-0.7951963924229537,-1.3941783931588023,0.011507479861910242,0.11589692004456502,1.0,22/51,14.37%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Psma5;Sem1;Psma4;Uba52;Psmd2;Psmc5;Psmd4;Psmd7;Rbx1;Psmb3;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4
prerank,"GABA Synthesis, Release, Reuptake And Degradation R-HSA-888590",-0.8797686301197737,-1.3940112262595894,0.04980340760157274,0.11546940714746554,1.0,3/16,3.21%,Rab3a;Vamp2;Hspa8
prerank,APC:Cdc20 Mediated Degradation Of Cell Cycle Proteins Before Cycle Checkpoint Satisfied R-HSA-179419,-0.7719565036370017,-1.393426962680588,0.02207505518763797,0.11342840295711754,1.0,23/58,14.37%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Psma5;Sem1;Psma4;Ube2s;Uba52;Psmd2;Psmc5;Psmd4;Psmd7;Psmb3;Anapc11;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4
prerank,APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176409,-0.7719565036370017,-1.393426962680588,0.02207505518763797,0.11342840295711754,1.0,23/58,14.37%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Psma5;Sem1;Psma4;Ube2s;Uba52;Psmd2;Psmc5;Psmd4;Psmd7;Psmb3;Anapc11;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4
prerank,Activation Of APC/C And APC/C:Cdc20 Mediated Degradation Of Mitotic Proteins R-HSA-176814,-0.7719565036370017,-1.393426962680588,0.02207505518763797,0.11342840295711754,1.0,23/58,14.37%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Psma5;Sem1;Psma4;Ube2s;Uba52;Psmd2;Psmc5;Psmd4;Psmd7;Psmb3;Anapc11;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4
prerank,Cdc20:Phospho-APC/C Mediated Degradation Of Cyclin A R-HSA-174184,-0.7719565036370017,-1.393426962680588,0.02207505518763797,0.11342840295711754,1.0,23/58,14.37%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Psma5;Sem1;Psma4;Ube2s;Uba52;Psmd2;Psmc5;Psmd4;Psmd7;Psmb3;Anapc11;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4
prerank,Synthesis Of DNA R-HSA-69239,-0.7649762353364322,-1.3933393371011311,0.012008733624454149,0.11285304607905532,1.0,27/78,14.37%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Psma5;Sem1;Psma4;Ube2s;Uba52;Pcna;Rpa3;Psmd2;Psmc5;Psmd4;Psmd7;Rbx1;Psmb3;Gins2;Anapc11;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4
prerank,Cyclin E Associated Events During G1/S Transition R-HSA-69202,-0.7711933538820072,-1.3932001688534694,0.01,0.11231377111641941,1.0,23/68,14.44%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Psma5;Sem1;Psma4;Uba52;Psmd2;Psmc5;Cdk4;Psmd4;Psmd7;Psmb3;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4;Cdkn1b
prerank,TNF Signaling R-HSA-75893,-0.797520624336401,-1.3921711473705338,0.03333333333333333,0.11348203494043314,1.0,3/35,1.62%,Ubb;Rack1;Rps27a
prerank,Selective Autophagy R-HSA-9663891,-0.7844839493084024,-1.3918023971264963,0.02288329519450801,0.1133382309703855,1.0,16/53,10.15%,Ubb;Dynll2;Dynll1;Rps27a;Park7;Tomm5;Hsp90aa1;Hspa8;Vdac1;Tomm7;Map1lc3b;Uba52;Sqstm1;Pink1;Atg12;Csnk2b
prerank,Oncogenic MAPK Signaling R-HSA-6802957,-0.7835960441899376,-1.3914708413803156,0.0192090395480226,0.11337039067796195,1.0,4/57,4.66%,Calm1;Pebp1;Ywhab;Dusp7
prerank,Degradation Of Beta-Catenin By Destruction Complex R-HSA-195253,-0.7740176373594336,-1.3913282588425413,0.010123734533183352,0.11288327231005574,1.0,26/69,14.37%,Ubb;Rps27a;Psmc3;Psmb5;Tle5;Psma7;Psmc2;Psma5;Sem1;Psma4;Uba52;Tle4;Ppp2r1a;Psmd2;Psmc5;Psmd4;Psmd7;Rbx1;Psmb3;Ppp2ca;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4
prerank,Autodegradation Of Cdh1 By Cdh1:APC/C R-HSA-174084,-0.77584132555048,-1.3912824754783704,0.017877094972067038,0.11222372819124607,1.0,23/57,14.37%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Psma5;Sem1;Psma4;Ube2s;Uba52;Psmd2;Psmc5;Psmd4;Psmd7;Psmb3;Anapc11;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4
prerank,ER-Phagosome Pathway R-HSA-1236974,-0.7814778342956703,-1.390003932954407,0.015819209039548022,0.11402441045097624,1.0,27/59,14.37%,Ubb;Hmgb1;Rps27a;Psmc3;Psmb5;Psma7;Calr;Psmc2;Psma5;Ndufa2;Sem1;Psma4;Uba52;Pdia3;Psmd2;Psmc5;Psmd4;Psmd7;Psmb3;Sec61g;Psmb1;Psma3;Psmd6;Psme3;Vamp3;Psma1;Psmc4
prerank,Listeria Monocytogenes Entry Into Host Cells R-HSA-8876384,-0.8599808967819461,-1.389921138725752,0.0266497461928934,0.11347457489476523,1.0,3/19,6.60%,Ubb;Rps27a;Uba52
prerank,Cyclin A:Cdk2-associated Events At S Phase Entry R-HSA-69656,-0.7696518411090781,-1.3897053239767054,0.0077777777777777776,0.11320141912773554,1.0,23/70,14.44%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Psma5;Sem1;Psma4;Uba52;Psmd2;Psmc5;Cdk4;Psmd4;Psmd7;Psmb3;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4;Cdkn1b
prerank,Regulation Of mRNA Stability By Proteins That Bind AU-rich Elements R-HSA-450531,-0.7661993402764438,-1.3894718969821573,0.010976948408342482,0.11283789105933278,1.0,28/72,14.57%,Ubb;Rps27a;Psmc3;Set;Psmb5;Anp32a;Ywhab;Psma7;Hspa8;Psmc2;Psma5;Sem1;Psma4;Uba52;Psmd2;Psmc5;Psmd4;Psmd7;Exosc3;Psmb3;Exosc4;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4;Ywhaz
prerank,Defective CFTR Causes Cystic Fibrosis R-HSA-5678895,-0.7827374163647584,-1.3889197920711547,0.024,0.11325131729914044,1.0,22/52,14.37%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Psma5;Sem1;Psma4;Uba52;Psmd2;Psmc5;Psmd4;Rnf5;Psmd7;Psmb3;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4
prerank,Degradation Of GLI2 By Proteasome R-HSA-5610783,-0.7847059886161799,-1.3884961444162836,0.018244013683010263,0.1125962976596973,1.0,22/51,14.37%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Psma5;Sem1;Psma4;Uba52;Psmd2;Psmc5;Psmd4;Psmd7;Rbx1;Psmb3;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4
prerank,GLI3 Is Processed To GLI3R By Proteasome R-HSA-5610785,-0.7847059886161799,-1.3884961444162836,0.018244013683010263,0.1125962976596973,1.0,22/51,14.37%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Psma5;Sem1;Psma4;Uba52;Psmd2;Psmc5;Psmd4;Psmd7;Rbx1;Psmb3;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4
prerank,Regulation Of IGF Transport And Uptake By IGFBPs R-HSA-381426,-0.7788352412103928,-1.38837545237932,0.02235294117647059,0.11142455741429322,1.0,8/47,8.70%,Scg2;Apoe;Sparcl1;Cst3;Aplp2;Chgb;Ppp3ca;Pdia6
prerank,Post-translational Protein Phosphorylation R-HSA-8957275,-0.7788352412103928,-1.38837545237932,0.02235294117647059,0.11142455741429322,1.0,8/47,8.70%,Scg2;Apoe;Sparcl1;Cst3;Aplp2;Chgb;Ppp3ca;Pdia6
prerank,Degradation Of AXIN R-HSA-4641257,-0.791970062869014,-1.3883249616711946,0.018626309662398137,0.11091713723678749,1.0,21/48,14.37%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Psma5;Sem1;Psma4;Uba52;Psmd2;Psmc5;Psmd4;Psmd7;Psmb3;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4
prerank,Switching Of Origins To A Post-Replicative State R-HSA-69052,-0.7688821753130268,-1.388296792792568,0.015384615384615385,0.11028746990606429,1.0,24/68,14.37%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Psma5;Sem1;Psma4;Ube2s;Uba52;Psmd2;Psmc5;Psmd4;Psmd7;Rbx1;Psmb3;Anapc11;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4
prerank,Transcriptional Activation Of Mitochondrial Biogenesis R-HSA-2151201,-0.8037782889139236,-1.3882361883434724,0.020190023752969122,0.10975465791734003,1.0,1/42,0.04%,Calm1
prerank,Innate Immune System R-HSA-168249,-0.7150689074982961,-1.3882155734838437,0.0,0.10916477265529966,1.0,123/491,14.83%,Fth1;Calm1;Ttr;Hsp90ab1;Ubb;Hmgb1;Eef1a1;Atp6v0c;Ppia;Rab3a;Atp6v1d;Pdap1;Dynll1;Rps27a;Cst3;Jun;Actg1;Psmc3;Rasgrp1;Srp14;Atp6v1a;Psmb5;Nfkb2;Prdx5;Aldoc;Psma7;Lamtor2;Hsp90aa1;Nme2;Rap2b;Atp6v1g2;Hspa8;Pgrmc1;Arl8a;Dusp3;Atp6v0e2;Psmc2;Pkm;Brk1;Dusp7;Polr2f;Gstp1;Nck1;Cct2;Psma5;Ndufa2;Fuca1;Cd81;Eef2;Arpc5;Capza2;Nfkbib;Sem1;Psma4;Uba52;Cdc42;Atp6v1f;Commd3;Ppp3ca;Wasl;Lamtor3;Pdxk;Ddost;Aprt;Rab24;Ppp2r1a;Psmd2;Psmc5;Cstb;Ctsb;Tubb4b;Psmd4;Psmd7;Arpc3;Atg12;Csnk2b;Atp6v0b;Usp14;Polr2e;Vapa;Alad;Itgav;Lamp1;Rab31;Psmb3;Actr1b;Trappc1;Cd63;Ppp2ca;Gsdme;Cd47;Arpc2;Clu;Ppp3r1;Arpc1a;Lyn;Polr3h;Psmb1;Psma3;Polr3d;Psmd6;Hras;Psme3;Cotl1;Ube2n;Surf4;Ndufc2;Actr2;Rab14;Mef2c;Rab6a;Psma1;Hmox2;Atp6v1e1;Psmc4;Actr10;Ppp3cb;Rab18;C1qb;Ypel5;Atp6ap2;Ube2v1;Chga
prerank,Biological Oxidations R-HSA-211859,-0.7719195133871848,-1.3879906122803403,0.013422818791946308,0.1089475062519132,1.0,11/64,10.29%,Hsp90ab1;Prnp;Gstm5;Aurkaip1;Gstm1;Trmt112;Gstp1;Hpgds;Mat2b;Ptges3;Gclm
prerank,G1/S Transition R-HSA-69206,-0.7633483534467259,-1.3878145342109252,0.00547645125958379,0.10868892678429487,1.0,27/86,14.44%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Psma5;Sem1;Psma4;Uba52;Pcna;Rpa3;Ppp2r1a;Psmd2;Psmc5;Cdk4;Psmd4;Psmd7;Psmb3;Ppp2ca;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4;Cdkn1b
prerank,Intrinsic Pathway For Apoptosis R-HSA-109606,-0.8125692395013087,-1.3871054981703281,0.01566265060240964,0.10938038798411806,1.0,13/36,12.17%,Dynll2;Dynll1;Ywhag;Ywhah;Ywhab;Bax;Cycs;Bad;Ywhae;C1qbp;Ywhaq;Gsdme;Ppp3r1
prerank,APC/C-mediated Degradation Of Cell Cycle Proteins R-HSA-174143,-0.769532700889281,-1.3868667971496256,0.018909899888765295,0.10923379315727436,1.0,23/64,14.37%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Psma5;Sem1;Psma4;Ube2s;Uba52;Psmd2;Psmc5;Psmd4;Psmd7;Psmb3;Anapc11;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4
prerank,Signaling By RAF1 Mutants R-HSA-9656223,-0.8252303546924565,-1.3867742168076596,0.02689486552567237,0.10883640099335554,1.0,2/28,2.63%,Calm1;Ywhab
prerank,RHO GTPases Activate PAKs R-HSA-5627123,-0.8861028406681681,-1.386548422039965,0.030183727034120734,0.1085599126152269,1.0,2/15,1.60%,Calm1;Myl6
prerank,Ion Transport By P-type ATPases R-HSA-936837,-0.8143517882397333,-1.385505134897083,0.04353083434099154,0.10993642186737684,1.0,2/31,0.12%,Calm1;Atp1b1
prerank,Late Endosomal Microautophagy R-HSA-9615710,-0.8363608856670278,-1.3854618157286787,0.03939008894536213,0.10942679716585572,1.0,6/23,6.88%,Ubb;Rps27a;Park7;Hspa8;Uba52;Vps28
prerank,G2/M Checkpoints R-HSA-69481,-0.7615650575448674,-1.3853908395888204,0.008830022075055188,0.10892293093553823,1.0,30/83,14.57%,Ubb;Rps27a;Ywhag;Psmc3;Psmb5;Ywhah;Ywhab;Psma7;Psmc2;H2bc4;Psma5;Sem1;Psma4;Uba52;Ywhae;Rpa3;Psmd2;Psmc5;Psmd4;Psmd7;Psmb3;Ywhaq;Psmb1;Psma3;Psmd6;Psme3;Ube2n;Psma1;Psmc4;Ywhaz
prerank,Termination Of Translesion DNA Synthesis R-HSA-5656169,-0.885151869772182,-1.3852891590340917,0.03247631935047361,0.10846063826026213,1.0,5/15,8.11%,Ubb;Rps27a;Uba52;Pcna;Rpa3
prerank,Mitotic G1 Phase And G1/S Transition R-HSA-453279,-0.7528607787891555,-1.3852711630339642,0.005411255411255411,0.10790232825386761,1.0,29/97,14.58%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Psma5;Sem1;Psma4;Uba52;Pcna;Rpa3;Ppp2r1a;Psmd2;Psmc5;Cdk4;Psmd4;Psmd7;Psmb3;Ppp2ca;Lyn;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4;Cdkn1b;Ccnd3
prerank,Neurexins And Neuroligins R-HSA-6794361,0.6104102027085294,1.3845091024697267,0.07518796992481203,0.6593353093632315,0.996,12/50,8.23%,Dlgap2;Shank2;Grin2a;Dlgap1;Nlgn1;Shank3;Epb41l1;Mpp3;Dlgap3;Shank1;Cask;Stx1a
prerank,SMAD2/SMAD3:SMAD4 Heterotrimer Regulates Transcription R-HSA-2173796,-0.8182548628132703,-1.3844985288319456,0.03300733496332518,0.10867604457664458,1.0,2/28,1.62%,Ubb;Rps27a
prerank,Antigen processing-Cross Presentation R-HSA-1236975,-0.7790829280446282,-1.3831940107222083,0.016910935738444193,0.11056546645047394,1.0,28/64,14.37%,Ubb;Hmgb1;Rps27a;Psmc3;Psmb5;Psma7;Calr;Psmc2;Psma5;Ndufa2;Sem1;Psma4;Uba52;Pdia3;Psmd2;Psmc5;Psmd4;Psmd7;Itgav;Psmb3;Sec61g;Psmb1;Psma3;Psmd6;Psme3;Vamp3;Psma1;Psmc4
prerank,Regulation Of APC/C Activators Between G1/S And Early Anaphase R-HSA-176408,-0.7696388064531846,-1.383052001807562,0.015625,0.11026236199883231,1.0,23/62,14.37%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Psma5;Sem1;Psma4;Ube2s;Uba52;Psmd2;Psmc5;Psmd4;Psmd7;Psmb3;Anapc11;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4
prerank,Diseases Of Carbohydrate Metabolism R-HSA-5663084,-0.8794928476470503,-1.3830067480847077,0.02759526938239159,0.10975298457933753,1.0,4/18,7.22%,Ubb;Rps27a;Uba52;G6pc3
prerank,Synthesis Of Active Ubiquitin: Roles Of E1 And E2 Enzymes R-HSA-8866652,-0.830816375848394,-1.3829971971133062,0.03217821782178218,0.10917387151188664,1.0,4/27,6.60%,Ubb;Rps27a;Ube2s;Uba52
prerank,FCERI Mediated Ca+2 Mobilization R-HSA-2871809,-0.8824978636167965,-1.3828844053936766,0.03038309114927345,0.10881985668732336,1.0,1/15,0.04%,Calm1
prerank,Negative Regulation Of NMDA Receptor-Mediated Neuronal Transmission R-HSA-9617324,-0.861658793393859,-1.3800637856933446,0.025380710659898477,0.11358468232745399,1.0,2/20,0.67%,Calm1;Nefl
prerank,Signaling By NOTCH4 R-HSA-9013694,-0.7625811864905675,-1.3790293171794972,0.013201320132013201,0.11487447546307589,1.0,28/68,14.65%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Snw1;Psenen;Psma5;Sem1;Psma4;Uba52;Aph1a;Psmd2;Psmc5;Psmd4;Psmd7;Rbx1;Psmb3;Psmb1;Psma3;Psmd6;Psme3;Jag1;Psma1;Psmc4;Ywhaz;Hey1
prerank,Cellular Response To Heat Stress R-HSA-3371556,-0.755580421580651,-1.378768863399608,0.019036954087346025,0.1147338008665958,1.0,16/76,10.71%,Hsp90ab1;Ubb;Eef1a1;Hsbp1;Hsp90aa1;Hspa8;Mrpl18;Hspa2;Dnajb6;Ywhae;Rpa3;Bag5;Bag1;Ptges3;St13;Hikeshi
prerank,ABC Transporter Disorders R-HSA-5619084,-0.7667758148013396,-1.3765150468607654,0.02593010146561443,0.1186307083655826,1.0,22/61,14.37%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Psma5;Sem1;Psma4;Uba52;Psmd2;Psmc5;Psmd4;Rnf5;Psmd7;Psmb3;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4
prerank,"Platelet Activation, Signaling And Aggregation R-HSA-76002",-0.730927000660999,-1.3746498702702348,0.005257623554153523,0.12143802439706314,1.0,27/143,12.28%,Calm1;Ttr;Tuba4a;Ppia;Tmsb4x;Rasgrp1;Gnb2;Timp3;Vegfc;Aplp2;P2ry12;Fam3c;Manf;Cdc42;Sod1;Pdgfa;Gng2;Gng13;Adra2c;Sccpdh;Vegfb;Gng10;Sparc;Cd63;Pfn1;Clu;Lyn
prerank,CREB1 Phosphorylation Thru NMDA Receptor-Mediated Activation Of RAS Signaling R-HSA-442742,-0.8242990615978831,-1.3738983315741518,0.03663003663003663,0.12216882730816044,1.0,2/25,0.67%,Calm1;Nefl
prerank,Cell Surface Interactions At Vascular Wall R-HSA-202733,-0.7783307925056261,-1.373684257661176,0.029137529137529136,0.1218987603102225,1.0,12/51,13.36%,Atp1b1;Ppia;Tspan7;Bsg;Atp1b2;Angpt2;Tek;Itgav;Cd47;Lyn;Hras;Slc16a1
prerank,Antigen Activates B Cell Receptor Leading To Second Messenger Generation R-HSA-983695,-0.8643140914740236,-1.373661243563716,0.04935064935064935,0.12132788241889497,1.0,3/16,5.95%,Calm1;Nck1;Orai2
prerank,Hedgehog On State R-HSA-5632684,-0.763672746072285,-1.3736287953633983,0.021134593993325918,0.12076838158515567,1.0,22/66,14.37%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Psma5;Sem1;Psma4;Uba52;Psmd2;Psmc5;Psmd4;Psmd7;Rbx1;Psmb3;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4
prerank,Budding And Maturation Of HIV Virion R-HSA-162588,-0.8272348092479687,-1.3736023963711421,0.0403530895334174,0.12018730144228917,1.0,5/25,6.88%,Ubb;Ppia;Rps27a;Uba52;Vps28
prerank,Amino Acids Regulate mTORC1 R-HSA-9639288,-0.7830892596940082,-1.3733982268612477,0.03286384976525822,0.12001439104996071,1.0,13/45,10.19%,Atp6v0c;Atp6v1d;Atp6v1a;Lamtor2;Atp6v1g2;Atp6v0e2;Sesn1;Rraga;Rheb;Atp6v1f;Lamtor3;Itfg2;Atp6v0b
prerank,Transcriptional Activity Of SMAD2/SMAD3:SMAD4 Heterotrimer R-HSA-2173793,-0.7810437755856854,-1.3727845682028983,0.03686635944700461,0.1205462875683627,1.0,4/42,6.60%,Ubb;Rps27a;Snw1;Uba52
prerank,rRNA Modification In Nucleus And Cytosol R-HSA-6790901,-0.7804628836592172,-1.3723789796860915,0.022300469483568074,0.12063158786973352,1.0,18/54,15.27%,Rps2;Rps7;Rps6;Thumpd1;Trmt112;Rps14;Pdcd11;Rps9;Emg1;Nop10;Snu13;Gar1;Utp3;Pno1;Fcf1;Dkc1;Nhp2;Utp11
prerank,PCP/CE Pathway R-HSA-4086400,-0.7606052712550935,-1.3717267456691358,0.021300448430493273,0.12122463576605684,1.0,24/69,14.37%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Clta;Psmc2;Psma5;Ap2m1;Sem1;Psma4;Uba52;Psmd2;Psmc5;Psmd4;Psmd7;Psmb3;Pfn1;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4
prerank,Leishmania Infection R-HSA-9658195,-0.7431688992012466,-1.3710547876949535,0.004310344827586207,0.12180642621646966,1.0,24/111,12.28%,Calm1;Hsp90ab1;Glp2r;Gnas;Jun;Actg1;Nfkb2;Gnb2;Ramp2;Brk1;Plk2;Nck1;Il18;Arpc5;Cdc42;Wasl;Gng2;Gng13;Arpc3;Gng10;Adrb1;Arpc2;Arpc1a;Lyn
prerank,Cyclin D Associated Events In G1 R-HSA-69231,-0.8045333926711331,-1.370467479363538,0.037575757575757575,0.12217570958683474,1.0,9/34,14.58%,Ubb;Rps27a;Uba52;Ppp2r1a;Cdk4;Ppp2ca;Lyn;Cdkn1b;Ccnd3
prerank,Membrane Binding And Targetting Of GAG Proteins R-HSA-174490,-0.8659116726963771,-1.3703294380056177,0.04155495978552279,0.12182404212696857,1.0,4/15,6.88%,Ubb;Rps27a;Uba52;Vps28
prerank,"Plasma Lipoprotein Assembly, Remodeling, And Clearance R-HSA-174824",-0.804166992375141,-1.3695203456336082,0.0425273390036452,0.12264619762655245,1.0,7/34,6.60%,Ubb;Apoe;Rps27a;Clta;Nceh1;Ap2m1;Uba52
prerank,Transcriptional Regulation By RUNX3 R-HSA-8878159,-0.7577505829284333,-1.368468830641966,0.013303769401330377,0.12408177225528368,1.0,23/71,14.37%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Snw1;Psma5;Sem1;Psma4;Uba52;Psmd2;Psmc5;Psmd4;Psmd7;Psmb3;Psmb1;Psma3;Psmd6;Psme3;Jag1;Psma1;Psmc4
prerank,Negative Regulation Of FGFR3 Signaling R-HSA-5654732,-0.8402716142595639,-1.3673086502400105,0.05612244897959184,0.12565925250560614,1.0,7/20,11.40%,Ubb;Rps27a;Spry2;Uba52;Ppp2r1a;Fgf13;Ppp2ca
prerank,S Phase R-HSA-69242,-0.733376139980366,-1.3671820143098876,0.01592356687898089,0.1253026749501582,1.0,31/112,14.44%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Psma5;Sem1;Psma4;Ube2s;Uba52;Pcna;Smc1a;Rpa3;Psmd2;Psmc5;Cdk4;Psmd4;Psmd7;Rbx1;Psmb3;Gins2;Anapc11;Psmb1;Rad21;Psma3;Psmd6;Psme3;Psma1;Psmc4;Cdkn1b
prerank,Non-integrin membrane-ECM Interactions R-HSA-3000171,-0.8382789375655324,-1.3669292263347308,0.03156565656565657,0.12517600301909165,1.0,1/23,0.05%,Ttr
prerank,Downregulation Of SMAD2/3:SMAD4 Transcriptional Activity R-HSA-2173795,-0.8230773627056591,-1.366596232993085,0.03803680981595092,0.125311775351123,1.0,4/26,6.60%,Ubb;Rps27a;Snw1;Uba52
prerank,Mitotic Anaphase R-HSA-68882,-0.7214763367538376,-1.3658191789069656,0.0020898641588296763,0.12547290146675363,1.0,40/159,13.26%,Ubb;Tuba4a;Dynll2;Tubb2a;Dynll1;Ran;Rps27a;Tuba1a;Psmc3;Banf1;Rps27;Psmb5;Psma7;Psmc2;Psma5;Tubb2b;Sem1;Psma4;Ube2s;Uba52;Smc1a;Emd;Ppp2r1a;Psmd2;Psmc5;Tubb4b;Tubb4a;Psmd4;Psmd7;Chmp4b;Psmb3;Ppp2ca;Anapc11;Nup37;Psmb1;Rad21;Psma3;Psmd6;Psme3;Chmp2a
prerank,Mitotic Metaphase And Anaphase R-HSA-2555396,-0.7214763367538376,-1.3658191789069656,0.0020898641588296763,0.12547290146675363,1.0,40/159,13.26%,Ubb;Tuba4a;Dynll2;Tubb2a;Dynll1;Ran;Rps27a;Tuba1a;Psmc3;Banf1;Rps27;Psmb5;Psma7;Psmc2;Psma5;Tubb2b;Sem1;Psma4;Ube2s;Uba52;Smc1a;Emd;Ppp2r1a;Psmd2;Psmc5;Tubb4b;Tubb4a;Psmd4;Psmd7;Chmp4b;Psmb3;Ppp2ca;Anapc11;Nup37;Psmb1;Rad21;Psma3;Psmd6;Psme3;Chmp2a
prerank,InlB-mediated Entry Of Listeria Monocytogenes Into Host Cell R-HSA-8875360,-0.8658719114752387,-1.3651805627943097,0.0494148244473342,0.12614055760844636,1.0,3/15,6.60%,Ubb;Rps27a;Uba52
prerank,Inositol Phosphate Metabolism R-HSA-1483249,-0.8000394722567716,-1.3650277313814825,0.04062126642771804,0.1258119033255818,1.0,1/33,0.04%,Calm1
prerank,APC/C:Cdc20 Mediated Degradation Of Cyclin B R-HSA-174048,-0.8436508298667061,-1.3648236324502945,0.056921086675291076,0.12556636454880646,1.0,4/19,6.60%,Ubb;Rps27a;Ube2s;Uba52
prerank,FCERI Mediated NF-kB Activation R-HSA-2871837,-0.7612476704279258,-1.364440939188653,0.019101123595505618,0.12566165674416455,1.0,25/64,14.78%,Ubb;Rps27a;Psmc3;Rasgrp1;Psmb5;Psma7;Psmc2;Psma5;Sem1;Psma4;Uba52;Psmd2;Psmc5;Psmd4;Psmd7;Psmb3;Lyn;Psmb1;Psma3;Psmd6;Psme3;Ube2n;Psma1;Psmc4;Ube2v1
prerank,"Nucleotide-binding Domain, Leucine Rich Repeat Containing NLR Signaling Pathways R-HSA-168643",-0.8071211933648318,-1.364297908207765,0.033816425120772944,0.12525557537335635,1.0,2/32,2.53%,Hsp90ab1;Nfkb2
prerank,Centrosome Maturation R-HSA-380287,-0.763512599523664,-1.3641011613899225,0.03229398663697105,0.12499629294252887,1.0,13/62,9.62%,Tuba4a;Dynll1;Tuba1a;Ywhag;Hsp90aa1;Cetn2;Nme7;Csnk1e;Ywhae;Ppp2r1a;Tubb4b;Tubb4a;Dctn3
prerank,APC-Cdc20 Mediated Degradation Of Nek2A R-HSA-179409,-0.8407612494720336,-1.363865104537799,0.054474708171206226,0.12487687032629316,1.0,4/20,6.60%,Ubb;Rps27a;Ube2s;Uba52
prerank,UCH Proteinases R-HSA-5689603,-0.7475040998734358,-1.3635538049627156,0.024336283185840708,0.12484651159190459,1.0,27/72,14.37%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;H2ac25;Psma5;Senp8;Sem1;Psma4;Uba52;Adrm1;Kdm1b;Psmd2;Psmc5;Nedd8;Psmd4;Psmd7;Ruvbl1;Psmb3;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4
prerank,Negative Regulators Of DDX58/IFIH1 Signaling R-HSA-936440,-0.8421899995787371,-1.3633959273354177,0.04365079365079365,0.12451967669638347,1.0,3/19,6.60%,Ubb;Rps27a;Uba52
prerank,Potential Therapeutics For SARS R-HSA-9679191,-0.7573900597421297,-1.3633120624382318,0.026018099547511313,0.12412317256881333,1.0,14/67,11.73%,Hsp90ab1;Atp1b1;Fkbp1a;Hsp90aa1;Sap18;Nck1;Ap2m1;Atp1b2;Atp1a3;Hmg20b;Ifngr2;Ptges3;Rbx1;Atp1a2
prerank,NIK To Noncanonical NF-kB Signaling R-HSA-5676590,-0.7731849796672229,-1.3624938344023712,0.02991944764096663,0.12523916228357246,1.0,22/51,14.37%,Ubb;Rps27a;Psmc3;Psmb5;Nfkb2;Psma7;Psmc2;Psma5;Sem1;Psma4;Uba52;Psmd2;Psmc5;Psmd4;Psmd7;Psmb3;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4
prerank,Synthesis Of Very Long-Chain Fatty acyl-CoAs R-HSA-75876,-0.8519626256436214,-1.362333579041168,0.04062909567496723,0.12493417165630684,1.0,3/18,8.75%,Tecr;Acsl3;Hacd4
prerank,Glutathione Conjugation R-HSA-156590,-0.847312406530554,-1.3621280329301066,0.04666666666666667,0.12483257342191868,1.0,6/18,10.29%,Prnp;Gstm5;Gstm1;Gstp1;Hpgds;Gclm
prerank,Negative Regulation Of FGFR4 Signaling R-HSA-5654733,-0.8429565507103203,-1.3621211575564072,0.06103896103896104,0.12428004136820232,1.0,7/19,11.40%,Ubb;Rps27a;Spry2;Uba52;Ppp2r1a;Fgf13;Ppp2ca
prerank,Insulin Receptor Recycling R-HSA-77387,-0.8445782270630682,-1.3618924523962137,0.055412371134020616,0.1240922869220685,1.0,6/18,6.78%,Atp6v0c;Atp6v1d;Atp6v1a;Atp6v1g2;Atp6v0e2;Atp6v1f
prerank,Recruitment Of NuMA To Mitotic Centrosomes R-HSA-380320,-0.762538787662274,-1.361591836980911,0.03662597114317425,0.12416075704196508,1.0,13/62,9.62%,Tuba4a;Dynll1;Tuba1a;Ywhag;Hsp90aa1;Cetn2;Nme7;Csnk1e;Ywhae;Ppp2r1a;Tubb4b;Tubb4a;Dctn3
prerank,NOTCH2 Activation And Transmission Of Signal To Nucleus R-HSA-2979096,-0.843729830615369,-1.3614935135232509,0.043758043758043756,0.123792141146623,1.0,5/18,8.39%,Ubb;Rps27a;Psenen;Uba52;Aph1a
prerank,N-glycan Trimming In ER And Calnexin/Calreticulin Cycle R-HSA-532668,-0.7951555606875983,-1.3609003491772063,0.05048076923076923,0.12428654988044996,1.0,8/33,10.22%,Ubb;Rps27a;Calr;Uba52;Pdia3;Rnf5;Canx;Ubxn1
prerank,Inactivation Of CSF3 (G-CSF) Signaling R-HSA-9705462,-0.8550709588838243,-1.3595930802514269,0.053475935828877004,0.12617700487086428,1.0,4/16,6.60%,Ubb;Rps27a;Elob;Uba52
prerank,Mitochondrial Translation Initiation R-HSA-5368286,-0.7356335759307209,-1.3592169127696232,0.030133928571428572,0.12626301308601456,1.0,31/81,16.20%,Aurkaip1;Mrpl36;Mrps26;Mrpl52;Mrpl18;Mrps24;Mrpl54;Mrpl44;Mrpl14;Mrpl23;Mrpl41;Mrps21;Mrpl9;Mrpl39;Chchd1;Mrps14;Mrps36;Mrpl30;Mrpl17;Mrps16;Mrpl11;Mrpl57;Mrpl33;Mtif3;Mrps33;Mrpl19;Mrps5;Mrpl12;Mrpl43;Mrpl16;Mrpl20
prerank,Infection With Mycobacterium Tuberculosis R-HSA-9635486,-0.836176898139035,-1.3590548020847182,0.05216284987277354,0.12598392132628475,1.0,3/19,6.60%,Ubb;Rps27a;Uba52
prerank,Response Of Mtb To Phagocytosis R-HSA-9637690,-0.8414602330173119,-1.3587012976940707,0.05791505791505792,0.1260700203479621,1.0,3/18,6.60%,Ubb;Rps27a;Uba52
prerank,DNA Double Strand Break Response R-HSA-5693606,-0.7909576081527949,-1.3583358168825848,0.04028436018957346,0.12565267847093284,1.0,5/34,6.60%,Ubb;Rps27a;H2bc4;Eya1;Uba52
prerank,Recruitment And ATM-mediated Phosphorylation Of Repair And Signal Proteins At DNA Double Strand Breaks R-HSA-5693565,-0.7909576081527949,-1.3583358168825848,0.04028436018957346,0.12565267847093284,1.0,5/34,6.60%,Ubb;Rps27a;H2bc4;Eya1;Uba52
prerank,Dectin-1 Mediated Noncanonical NF-kB Signaling R-HSA-5607761,-0.770004657561314,-1.3582551810320025,0.03218390804597701,0.12526306106664198,1.0,22/52,14.37%,Ubb;Rps27a;Psmc3;Psmb5;Nfkb2;Psma7;Psmc2;Psma5;Sem1;Psma4;Uba52;Psmd2;Psmc5;Psmd4;Psmd7;Psmb3;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4
prerank,Signaling By CSF3 (G-CSF) R-HSA-9674555,-0.8351863283962211,-1.3581873938659963,0.05304010349288486,0.12483160171707158,1.0,4/20,6.60%,Ubb;Rps27a;Elob;Uba52
prerank,Activation Of BH3-only Proteins R-HSA-114452,-0.8396573536025106,-1.357617333348449,0.04314720812182741,0.12534330750292472,1.0,9/20,12.17%,Dynll2;Dynll1;Ywhag;Ywhah;Ywhab;Bad;Ywhae;Ywhaq;Ppp3r1
prerank,Calnexin/calreticulin Cycle R-HSA-901042,-0.8144775793475167,-1.3574159403028425,0.05309734513274336,0.12521953480354692,1.0,7/25,10.17%,Ubb;Rps27a;Calr;Uba52;Pdia3;Rnf5;Canx
prerank,Transferrin Endocytosis And Recycling R-HSA-917977,-0.8367293774818493,-1.3567159347231443,0.04325032765399738,0.1260730369898995,1.0,6/20,6.78%,Atp6v0c;Atp6v1d;Atp6v1a;Atp6v1g2;Atp6v0e2;Atp6v1f
prerank,Degradation Of DVL R-HSA-4641258,-0.7663128127701289,-1.356250986135338,0.027522935779816515,0.12638672996330463,1.0,22/48,14.37%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Psma5;Sem1;Psma4;Uba52;Psmd2;Psmc5;Psmd4;Psmd7;Rbx1;Psmb3;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4
prerank,HIV Infection R-HSA-162906,-0.7124586365954854,-1.3561304998522028,0.004197271773347324,0.12618501621835423,1.0,60/183,18.45%,Ubb;Slc25a4;Ppia;Ran;Rps27a;Psmc3;Banf1;Psmb5;Psma7;Slc25a5;Psmc2;Elob;Polr2f;Psma5;Ap2m1;Sem1;Psma4;Uba52;Polr2i;Vps28;Psip1;Psmd2;Psmc5;Psmd4;Taf10;Psmd7;Polr2e;Chmp4b;Taf11;Polr2c;Polr2g;Rbx1;Psmb3;Ranbp1;Nup37;Psmb1;Psma3;Psmd6;Psme3;Nup50;Chmp2a;Psma1;Psmc4;Sec13;Npm1;Tsg101;Psmc6;Vps4a;Tcea1;Nup107;Gtf2b;Seh1l;Lrig1;Taf5;Chmp7;Nup205;Psmc1;Gtf2h5;Psmb6;Psmb10
prerank,Toll Like Receptor 7/8 (TLR7/8) Cascade R-HSA-168181,-0.7476893179567192,-1.3556338262745475,0.03662597114317425,0.12560726079701634,1.0,10/68,6.60%,Ubb;Hmgb1;Rps27a;Jun;Nfkb2;Dusp3;Dusp7;Ndufa2;Nfkbib;Uba52
prerank,TRAF6 Mediated Induction Of NFkB And MAP Kinases Upon TLR7/8 Or 9 Activation R-HSA-975138,-0.7476893179567192,-1.3556338262745475,0.03662597114317425,0.12560726079701634,1.0,10/68,6.60%,Ubb;Hmgb1;Rps27a;Jun;Nfkb2;Dusp3;Dusp7;Ndufa2;Nfkbib;Uba52
prerank,MyD88 Dependent Cascade Initiated On Endosome R-HSA-975155,-0.7476893179567192,-1.3556338262745475,0.03662597114317425,0.12560726079701634,1.0,10/68,6.60%,Ubb;Hmgb1;Rps27a;Jun;Nfkb2;Dusp3;Dusp7;Ndufa2;Nfkbib;Uba52
prerank,Toll Like Receptor 9 (TLR9) Cascade R-HSA-168138,-0.7441141563106028,-1.35558359591253,0.03402854006586169,0.12515980626658704,1.0,10/72,6.60%,Ubb;Hmgb1;Rps27a;Jun;Nfkb2;Dusp3;Dusp7;Ndufa2;Nfkbib;Uba52
prerank,RHO GTPases Activate PKNs R-HSA-5625740,-0.7981226468389377,-1.3537411470612852,0.0496969696969697,0.12784287586724666,1.0,11/28,14.57%,Myl6;Ywhag;Ywhah;Ywhab;H2az1;H2bc4;Ywhae;Myl12b;Ywhaq;H2aj;Ywhaz
prerank,MyD88:MAL(TIRAP) Cascade Initiated On Plasma Membrane R-HSA-166058,-0.7448838198478813,-1.353353731676208,0.036464088397790057,0.12799386007574212,1.0,10/69,6.60%,Ubb;Hmgb1;Rps27a;Jun;Nfkb2;Dusp3;Dusp7;Ndufa2;Nfkbib;Uba52
prerank,Activation Of NF-kappaB In B Cells R-HSA-1169091,-0.7597323775458698,-1.353352385269841,0.03824521934758155,0.12748205174232968,1.0,22/55,14.37%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Psma5;Nfkbib;Sem1;Psma4;Uba52;Psmd2;Psmc5;Psmd4;Psmd7;Psmb3;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4
prerank,Formation Of Incision Complex In GG-NER R-HSA-5696395,-0.7752900618106746,-1.3533253879505736,0.060240963855421686,0.1270385346438918,1.0,6/40,8.11%,Ubb;Rps27a;Cetn2;Sumo2;Uba52;Rpa3
prerank,Phase I - Functionalization Of Compounds R-HSA-211945,-0.827293246240689,-1.3524106019849367,0.05172413793103448,0.12806880855969024,1.0,2/24,2.13%,Hsp90ab1;Aurkaip1
prerank,Mitochondrial Translation Termination R-HSA-5419276,-0.7335666230262122,-1.3524098364814316,0.036748329621380846,0.1275585742626397,1.0,30/81,16.20%,Aurkaip1;Mrpl36;Mrps26;Mrpl52;Mrpl18;Mrps24;Mrpl54;Mrpl44;Mrpl14;Mrpl23;Mrpl41;Mrps21;Mrpl9;Mrpl39;Chchd1;Mrps14;Mrps36;Mrpl30;Mrpl17;Mrps16;Mrpl11;Mrpl57;Mrpl33;Mrps33;Mrpl19;Mrps5;Mrpl12;Mrpl43;Mrpl16;Mrpl20
prerank,Transcriptional Regulation By RUNX2 R-HSA-8878166,-0.7453802235283641,-1.351906260043077,0.01978021978021978,0.1279233062625017,1.0,28/80,15.99%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Bax;Psma5;Sem1;Psma4;Uba52;Ppm1d;Psmd2;Psmc5;Cdk4;Psmd4;Psmd7;Rbx1;Psmb3;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4;Hey1;Stub1;Psmc6
prerank,Signaling By NOTCH3 R-HSA-9012852,-0.7868623264137673,-1.3506717836752684,0.04132231404958678,0.12976744146034275,1.0,6/35,8.39%,Ubb;Rps27a;Snw1;Psenen;Uba52;Aph1a
prerank,AURKA Activation By TPX2 R-HSA-8854518,-0.7651348130415064,-1.3485164920417279,0.042382588774341354,0.1327563723527636,1.0,12/53,9.62%,Tuba4a;Dynll1;Tuba1a;Ywhag;Hsp90aa1;Cetn2;Csnk1e;Ywhae;Ppp2r1a;Tubb4b;Tubb4a;Dctn3
prerank,Loss Of Nlp From Mitotic Centrosomes R-HSA-380259,-0.7651348130415064,-1.3485164920417279,0.042382588774341354,0.1327563723527636,1.0,12/53,9.62%,Tuba4a;Dynll1;Tuba1a;Ywhag;Hsp90aa1;Cetn2;Csnk1e;Ywhae;Ppp2r1a;Tubb4b;Tubb4a;Dctn3
prerank,ECM Proteoglycans R-HSA-3000178,0.664745084525579,1.3481730376417138,0.12077294685990338,0.7324448358320088,0.998,4/23,8.81%,Ptprs;Lamb1;Tnr;Lamc1
prerank,Regulation Of RUNX2 Expression And Activity R-HSA-8939902,-0.7581114021426725,-1.3480451648157796,0.03615819209039548,0.13300354427193192,1.0,22/59,14.37%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Psma5;Sem1;Psma4;Uba52;Psmd2;Psmc5;Psmd4;Psmd7;Rbx1;Psmb3;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4
prerank,MyD88 Cascade Initiated On Plasma Membrane R-HSA-975871,-0.7429613861586043,-1.3476172630055698,0.038802660753880266,0.13322391967680036,1.0,9/67,6.60%,Ubb;Hmgb1;Rps27a;Jun;Nfkb2;Dusp3;Dusp7;Nfkbib;Uba52
prerank,Complex I Biogenesis R-HSA-6799198,-0.7558043287952882,-1.3470548546715615,0.043173862310385065,0.1337068703766898,1.0,29/50,20.09%,Ndufa3;Ndufa1;Ndufs8;Ndufs5;Ndufs2;Ndufb1;Ndufa2;Ndufs7;Ndufb3;Ndufb11;Ndufb10;Ndufa13;Ndufb8;Ndufa8;Ndufa7;Ndufv1;Ndufc2;Ndufv2;Ndufb6;Ndufc1;Ndufb4;Ndufaf3;Ndufa5;Ndufs6;Ndufa12;Ndufb5;Tmem186;Ndufaf2;Ndufb9
prerank,Receptor-type Tyrosine-Protein Phosphatases R-HSA-388844,0.6936482124533372,1.3469758602334758,0.14901960784313725,0.687003069051267,0.998,4/18,6.09%,Ptprs;Il1rapl2;Ptprf;Ntrk3
prerank,Sensory Processing Of Sound By Outer Hair Cells Of Cochlea R-HSA-9662361,0.718131434338497,1.3464606041260008,0.1322314049586777,0.6456534501768403,0.998,11/17,15.56%,Atp2b4;Ripor2;Pls1;Epb41l1;Pcdh15;Cask;Sptan1;Kcnma1;Epb41l3;Eps8;Myh9
prerank,Mitochondrial Protein Import R-HSA-1268020,-0.7576201041331627,-1.346239822468036,0.04971098265895954,0.13479077446210128,1.0,23/51,17.13%,Slc25a4;Dnajc19;Cox17;Tomm5;Timm8b;Vdac1;Chchd10;Chchd2;Tomm7;Timm13;Timm22;Pam16;Ndufb8;Timm10;Bcs1l;Timm23;Hscb;Chchd4;Cox19;Tomm20;Grpel1;Samm50;Fxn
prerank,Downregulation Of ERBB2 Signaling R-HSA-8863795,-0.8163113147010572,-1.3459233842768965,0.06683168316831684,0.1348869984388561,1.0,6/23,7.28%,Ubb;Rps27a;Nrg4;Hsp90aa1;Uba52;Cdc37
prerank,TNFR2 Non-Canonical NF-kB Pathway R-HSA-5668541,-0.7538959754684454,-1.3454347394975898,0.04067796610169491,0.1352559768567604,1.0,22/56,14.37%,Ubb;Rps27a;Psmc3;Psmb5;Nfkb2;Psma7;Psmc2;Psma5;Sem1;Psma4;Uba52;Psmd2;Psmc5;Psmd4;Psmd7;Psmb3;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4
prerank,Negative Regulation Of MET Activity R-HSA-6807004,-0.8266080855605008,-1.3451023310715837,0.06524466750313676,0.13539848736147442,1.0,3/21,6.60%,Ubb;Rps27a;Uba52
prerank,Signaling By EGFR In Cancer R-HSA-1643713,-0.8469575292749683,-1.344958254240116,0.058666666666666666,0.1351955854741231,1.0,5/18,7.28%,Ubb;Rps27a;Hsp90aa1;Uba52;Cdc37
prerank,ROS And RNS Production In Phagocytes R-HSA-1222556,-0.8455656464903754,-1.3440573209371718,0.06542056074766354,0.13639456733645303,1.0,6/17,6.78%,Atp6v0c;Atp6v1d;Atp6v1a;Atp6v1g2;Atp6v0e2;Atp6v1f
prerank,Mitochondrial Translation Elongation R-HSA-5389840,-0.7286021863083435,-1.3411979325705405,0.03910614525139665,0.14117065463149922,1.0,30/81,16.20%,Aurkaip1;Mrpl36;Mrps26;Mrpl52;Mrpl18;Mrps24;Mrpl54;Mrpl44;Mrpl14;Mrpl23;Mrpl41;Mrps21;Mrpl9;Mrpl39;Chchd1;Mrps14;Mrps36;Mrpl30;Mrpl17;Mrps16;Mrpl11;Mrpl57;Mrpl33;Mrps33;Mrpl19;Mrps5;Mrpl12;Mrpl43;Mrpl16;Mrpl20
prerank,Extra-nuclear Estrogen Signaling R-HSA-9009391,-0.7742270271644176,-1.3401921904018763,0.04373522458628842,0.14262653608465153,1.0,10/46,14.44%,Calm1;Gnb2;Hsp90aa1;Gng2;Gng13;Gng10;Hras;Gng3;Gnai2;Cdkn1b
prerank,Nuclear Envelope (NE) Reassembly R-HSA-2995410,-0.7542204940827363,-1.3400010523554247,0.042725173210161664,0.1425073389925869,1.0,21/54,17.78%,Tuba4a;Tubb2a;Ran;Tuba1a;Banf1;Tubb2b;Emd;Ppp2r1a;Tubb4b;Tubb4a;Chmp4b;Ppp2ca;Nup37;Chmp2a;Sec13;Vps4a;Tuba1b;Nup107;Seh1l;Chmp7;Nup205
prerank,Mitochondrial Translation R-HSA-5368287,-0.7243493598650913,-1.3399044685081187,0.039779005524861875,0.1421544858714411,1.0,29/87,14.41%,Aurkaip1;Mrpl36;Mrps26;Mrpl52;Mrpl18;Mrps24;Mrpl54;Mrpl44;Mrpl14;Mrpl23;Mrpl41;Mrps21;Mrpl9;Mrpl39;Chchd1;Mrps14;Mrps36;Mrpl30;Mrpl17;Mrps16;Mrpl11;Mrpl57;Mrpl33;Mtif3;Mrps33;Mrpl19;Mrps5;Mrpl12;Mrpl43
prerank,Collagen Biosynthesis And Modifying Enzymes R-HSA-1650814,0.6972508568795414,1.3383733070801818,0.1440329218106996,0.6311284512086548,0.998,6/20,5.39%,Col23a1;P3h2;Col11a1;Col19a1;Colgalt2;Adamts3
prerank,Downstream TCR Signaling R-HSA-202424,-0.7431762769711735,-1.337505400076028,0.042175360710321866,0.14615296229626049,1.0,23/66,14.78%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Psma5;Sem1;Psma4;Uba52;Psmd2;Psmc5;Psmd4;Psmd7;Psmb3;Psmb1;Psma3;Psmd6;Psme3;Ube2n;Psma1;Psmc4;Ube2v1
prerank,ABC-family Proteins Mediated Transport R-HSA-382556,-0.7387303150537721,-1.3368446837187273,0.027442371020856202,0.14692169430738283,1.0,23/75,14.37%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Psma5;Sem1;Psma4;Uba52;Psmd2;Psmc5;Psmd4;Rnf5;Psmd7;Psmb3;Eif2s2;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4
prerank,Formation Of Tubulin Folding Intermediates By CCT/TriC R-HSA-389960,-0.8525015797499306,-1.3367530055206638,0.06002728512960437,0.14661542828915392,1.0,8/16,9.60%,Tuba4a;Tubb2a;Tuba1a;Cct2;Tubb2b;Cct6a;Tubb4b;Tubb4a
prerank,Class B/2 (Secretin Family Receptors) R-HSA-373080,-0.8090815732023605,-1.3364831006370994,0.08290816326530612,0.1467540225100608,1.0,7/24,10.10%,Glp2r;Gnas;Gnb2;Ramp2;Gng2;Gng13;Gng10
prerank,Constitutive Signaling By Ligand-Responsive EGFR Cancer Variants R-HSA-1236382,-0.8470383966445674,-1.3359601710954643,0.06064690026954178,0.14718819442018685,1.0,5/17,7.28%,Ubb;Rps27a;Hsp90aa1;Uba52;Cdc37
prerank,Protein Ubiquitination R-HSA-8852135,-0.7503007854698402,-1.3353869386469555,0.037122969837587005,0.1477591758857879,1.0,7/56,7.23%,Ubb;Rps27a;Rraga;H2bc4;Ube2s;Uba52;Pcna
prerank,Signaling By EGFR R-HSA-177929,-0.7729957814869092,-1.3343215986579557,0.05587892898719441,0.14921318689049495,1.0,5/41,6.70%,Ubb;Rps27a;Spry2;Uba52;Cdc42
prerank,DARPP-32 Events R-HSA-180024,-0.83005129350728,-1.333797106492991,0.05150753768844221,0.14968777121852522,1.0,6/21,12.17%,Calm1;Ppp1ca;Ppp3ca;Ppp2r1a;Ppp2ca;Ppp3r1
prerank,MyD88-independent TLR4 Cascade R-HSA-166166,-0.7364938524181646,-1.3337166662552509,0.04888888888888889,0.1492704600894424,1.0,10/73,6.60%,Ubb;Hmgb1;Rps27a;Jun;Nfkb2;Dusp3;Dusp7;Ndufa2;Nfkbib;Uba52
prerank,"Transport Of Vitamins, Nucleosides, And Related Molecules R-HSA-425397",-0.8086742912940074,-1.3336262532079137,0.06982543640897755,0.14894429525609928,1.0,2/22,3.38%,Slc25a4;Slc25a5
prerank,ER Quality Control Compartment (ERQC) R-HSA-901032,-0.8056787756301931,-1.3331382192701555,0.08097686375321336,0.1492390840383781,1.0,4/20,9.69%,Ubb;Rps27a;Uba52;Rnf5
prerank,Regulation Of Ornithine Decarboxylase (ODC) R-HSA-350562,-0.7659807360970279,-1.3331123939515446,0.054245283018867926,0.1487593569791424,1.0,23/41,18.45%,Psmc3;Psmb5;Psma7;Psmc2;Psma5;Oaz1;Sem1;Psma4;Psmd2;Psmc5;Psmd4;Psmd7;Psmb3;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4;Psmc6;Psmc1;Psmb6;Psmb10
prerank,Prefoldin Mediated Transfer Of Substrate To CCT/TriC R-HSA-389957,-0.8226119171960288,-1.3323542948020801,0.06490066225165562,0.14970104124294903,1.0,10/21,9.60%,Tuba4a;Tubb2a;Tuba1a;Cct2;Tubb2b;Cct6a;Pfdn6;Pfdn4;Tubb4b;Tubb4a
prerank,DNA Damage Recognition In GG-NER R-HSA-5696394,-0.778762555495189,-1.3322712449297498,0.061893203883495146,0.1492986381720219,1.0,7/34,10.97%,Ubb;Rps27a;Cetn2;Cops6;Uba52;Ruvbl1;Rbx1
prerank,PKA-mediated Phosphorylation Of CREB R-HSA-111931,-0.8392542009145648,-1.3318793226552266,0.07770700636942675,0.1496896535390013,1.0,1/16,0.04%,Calm1
prerank,Metabolism Of Polyamines R-HSA-351202,-0.7580770509732004,-1.3304809068528534,0.056778679026651215,0.15188983431574526,1.0,23/45,18.45%,Psmc3;Psmb5;Psma7;Psmc2;Psma5;Oaz1;Sem1;Psma4;Psmd2;Psmc5;Psmd4;Psmd7;Psmb3;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4;Psmc6;Psmc1;Psmb6;Psmb10
prerank,Regulation Of TP53 Expression And Degradation R-HSA-6806003,-0.8022870174482426,-1.3303564199506421,0.08024691358024691,0.15103627613804607,1.0,6/27,11.40%,Ubb;Rps27a;Uba52;Usp2;Ppp2r1a;Ppp2ca
prerank,Regulation Of TP53 Degradation R-HSA-6804757,-0.8022870174482426,-1.3303564199506421,0.08024691358024691,0.15103627613804607,1.0,6/27,11.40%,Ubb;Rps27a;Uba52;Usp2;Ppp2r1a;Ppp2ca
prerank,ESR-mediated Signaling R-HSA-8939211,-0.712278182991491,-1.3292957687221132,0.031149301825993556,0.15254428764077665,1.0,19/121,10.90%,Calm1;Hsp90ab1;Ddx5;Jun;Gnb2;Hsp90aa1;H2az1;Jund;Polr2f;H2bc4;Polr2i;Smc1a;Gng2;Gng13;Ptges3;Gng10;Polr2e;Polr2c;Polr2g
prerank,Dual Incision In TC-NER R-HSA-6782135,-0.7540980888042738,-1.3292380509198958,0.06190476190476191,0.15212559845342555,1.0,12/50,10.97%,Ubb;Rps27a;Polr2f;Uba52;Polr2i;Pcna;Hmgn1;Rpa3;Polr2e;Polr2c;Polr2g;Rbx1
prerank,Signaling By NOTCH2 R-HSA-1980145,-0.7977392630777077,-1.3285552999272114,0.07338308457711443,0.15296321075669608,1.0,5/25,8.39%,Ubb;Rps27a;Psenen;Uba52;Aph1a
prerank,Signaling By FGFR4 R-HSA-5654743,-0.7993480536274216,-1.328319278333059,0.07196029776674938,0.15285456122442456,1.0,8/26,12.78%,Ubb;Rps27a;Spry2;Uba52;Ppp2r1a;Fgf13;Ppp2ca;Hras
prerank,Spry Regulation Of FGF Signaling R-HSA-1295596,-0.8441155875675205,-1.3280067296690083,0.08388814913448735,0.15297731060143221,1.0,6/16,11.40%,Ubb;Rps27a;Spry2;Uba52;Ppp2r1a;Ppp2ca
prerank,Phase II - Conjugation Of Compounds R-HSA-156580,-0.7644812111442532,-1.327991390677735,0.05569007263922518,0.1524789559545992,1.0,8/40,10.29%,Prnp;Gstm5;Gstm1;Trmt112;Gstp1;Hpgds;Mat2b;Gclm
prerank,TCR Signaling R-HSA-202403,-0.7339398540963387,-1.3273661431776556,0.03322259136212625,0.15311484722385627,1.0,24/77,14.78%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Nck1;Psma5;Sem1;Psma4;Uba52;Psmd2;Psmc5;Psmd4;Psmd7;Psmb3;Psmb1;Psma3;Psmd6;Psme3;Ube2n;Psma1;Psmc4;Ube2v1
prerank,MAP3K8 (TPL2)-dependent MAPK1/3 Activation R-HSA-5684264,-0.8557472402251378,-1.327196920610896,0.07972972972972973,0.15290931789616505,1.0,3/15,6.60%,Ubb;Rps27a;Uba52
prerank,Toll Like Receptor 3 (TLR3) Cascade R-HSA-168164,-0.7326450729604698,-1.326960161543638,0.051054384017758046,0.1528315845931733,1.0,9/71,6.60%,Ubb;Hmgb1;Rps27a;Jun;Nfkb2;Dusp3;Dusp7;Nfkbib;Uba52
prerank,Signaling By Interleukins R-HSA-449147,-0.6951091437992005,-1.3268353910211559,0.007186858316221766,0.15257441141563155,1.0,62/222,16.92%,Ubb;Hmgb1;Ppia;Vamp2;Rps27a;Jun;Psmc3;Aurkaip1;Cebpd;Psmb5;Nfkb2;Psma7;Hsp90aa1;Hspa8;Dusp3;Ndn;Psmc2;Dusp7;Il18;Psma5;Nfkbib;Sem1;Psma4;Uba52;Cdc42;Sqstm1;Sod1;Ppp2r1a;Psmd2;Psmc5;Psmd4;Psmd7;Irs2;Canx;Usp14;Fgf13;Hnrnpa2b1;Rbx1;Psmb3;Clstn1;Ppp2ca;Lyn;P4hb;Psmb1;Psma3;Psmd6;Psme3;Ube2n;Mef2c;Hnrnpf;Psma1;Psmc4;Ywhaz;Ube2v1;Csf1r;Rplp0;Psmc6;Rala;Ppp2r5d;Pik3r1;Gsto1;Oprm1
prerank,Glucagon-type Ligand Receptors R-HSA-420092,-0.8421187430713688,-1.3262116027518343,0.08243243243243244,0.15331979413712418,1.0,6/15,10.10%,Glp2r;Gnas;Gnb2;Gng2;Gng13;Gng10
prerank,HDR Thru Homologous Recombination (HRR) Or Single Strand Annealing (SSA) R-HSA-5693567,-0.7445139774148419,-1.326119188955357,0.05835240274599542,0.1529518791533341,1.0,8/54,8.11%,Ubb;Rps27a;Sumo2;H2bc4;Sem1;Uba52;Pcna;Rpa3
prerank,Signaling By FGFR3 R-HSA-5654741,-0.7930784406809024,-1.3259072625248578,0.07512315270935961,0.15289285935837604,1.0,8/28,12.78%,Ubb;Rps27a;Spry2;Uba52;Ppp2r1a;Fgf13;Ppp2ca;Hras
prerank,Signaling By Nuclear Receptors R-HSA-9006931,-0.7014954284412339,-1.325504674922413,0.01689545934530095,0.1530792735082925,1.0,31/150,14.44%,Calm1;Hsp90ab1;Apoe;Ddx5;Jun;Gnb2;Hsp90aa1;H2az1;Jund;Polr2f;H2bc4;Polr2i;Gps2;Smc1a;Gng2;Gng13;Kdm1b;Ptges3;Gng10;Polr2e;Polr2c;Polr2g;Dlat;Rad21;Hras;Rdh14;H2aj;Gng3;Gnai2;Tbl1xr1;Cdkn1b
prerank,Cross-presentation Of Soluble Exogenous Antigens (Endosomes) R-HSA-1236978,-0.7654744695738668,-1.3253167330530948,0.05778301886792453,0.1529388138371799,1.0,22/38,18.45%,Psmc3;Psmb5;Psma7;Psmc2;Psma5;Sem1;Psma4;Psmd2;Psmc5;Psmd4;Psmd7;Psmb3;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4;Psmc6;Psmc1;Psmb6;Psmb10
prerank,COPI-independent Golgi-to-ER Retrograde Traffic R-HSA-6811436,-0.7795278027642639,-1.3240605101985277,0.06884057971014493,0.15474309812941928,1.0,11/30,17.37%,Dynll2;Dynll1;Capza2;Dctn6;Rab6b;Dctn3;Rab6a;Actr10;Rab18;Pafah1b2;Pafah1b1
prerank,Downregulation Of TGF-beta Receptor Signaling R-HSA-2173788,-0.80138874031913,-1.3228108551574786,0.08114856429463171,0.15655656985318428,1.0,4/23,6.60%,Ubb;Rps27a;Ppp1ca;Uba52
prerank,Dual Incision In GG-NER R-HSA-5696400,-0.7776810552873307,-1.3226206807848213,0.08121827411167512,0.15638503032132073,1.0,5/30,8.11%,Ubb;Rps27a;Uba52;Pcna;Rpa3
prerank,Gap-filling DNA Repair Synthesis And Ligation In TC-NER R-HSA-6782210,-0.7537017921539622,-1.322352398348741,0.06339712918660287,0.15634735317589335,1.0,12/48,10.97%,Ubb;Rps27a;Polr2f;Uba52;Polr2i;Pcna;Hmgn1;Rpa3;Polr2e;Polr2c;Polr2g;Rbx1
prerank,"Cell Cycle, Mitotic R-HSA-69278",-0.6886758001320938,-1.322222822526879,0.00202020202020202,0.15618110020981565,1.0,68/329,14.59%,Hsp90ab1;Ubb;Tuba4a;Dynll2;Tubb2a;Dynll1;Ran;Rps27a;Tuba1a;Ywhag;Psmc3;Set;Banf1;Rps27;Psmb5;Psma7;Hsp90aa1;H2az1;Cetn2;Psmc2;Rab2a;Nme7;Csnk1e;H2bc4;Psma5;Tubb2b;Sem1;Psma4;Ube2s;Uba52;Pcna;Smc1a;Ywhae;Rpa3;Rab1b;Emd;Ppp2r1a;Psmd2;Psmc5;Cdk4;Tubb4b;Tubb4a;Dctn3;Psmd4;Psmd7;Csnk2b;Chmp4b;Rbx1;Psmb3;Ppp2ca;Gins2;Ensa;Anapc11;Nup37;Lyn;Psmb1;Rad21;Psma3;Psmd6;Psme3;Nup50;Chmp2a;H2aj;Psma1;Psmc4;Cdkn1b;Ccnd3;Ncaph2
prerank,Regulation Of RAS By GAPs R-HSA-5658442,-0.7387870454271696,-1.3220595822022732,0.047619047619047616,0.15599163796753587,1.0,24/56,14.37%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Psma5;Sem1;Psma4;Uba52;Rasal2;Psmd2;Psmc5;Psmd4;Psmd7;Rbx1;Psmb3;Psmb1;Psma3;Psmd6;Hras;Psme3;Psma1;Psmc4
prerank,Mitophagy R-HSA-5205647,-0.8052270533355702,-1.322031910249332,0.05674653215636822,0.15553705765219267,1.0,11/27,10.15%,Ubb;Rps27a;Tomm5;Vdac1;Tomm7;Map1lc3b;Uba52;Sqstm1;Pink1;Atg12;Csnk2b
prerank,Collagen Formation R-HSA-1474290,0.656007890072819,1.321188373414362,0.13636363636363635,0.6444590021526316,1.0,7/27,5.39%,Col23a1;P3h2;Col11a1;Dst;Col19a1;Colgalt2;Adamts3
prerank,Cooperation Of Prefoldin And TriC/CCT In Actin And Tubulin Folding R-HSA-389958,-0.8117200375907698,-1.3211489364467446,0.06842105263157895,0.15679901350251346,1.0,10/22,9.60%,Tuba4a;Tubb2a;Tuba1a;Cct2;Tubb2b;Cct6a;Pfdn6;Pfdn4;Tubb4b;Tubb4a
prerank,Homology Directed Repair R-HSA-5693538,-0.7373194367103169,-1.3209054171769024,0.06621004566210045,0.15669874707171755,1.0,13/57,15.21%,Ubb;Rps27a;Sumo2;H2bc4;Sem1;Uba52;Pcna;Rpa3;Ppp4c;Ube2n;Sirt6;Parp1;Rnf168
prerank,Ub-specific Processing Proteases R-HSA-5689880,-0.7038207279738162,-1.319872973536918,0.030687830687830688,0.15817494846089333,1.0,46/130,18.58%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Vdac1;H2ac25;H2bc4;Psma5;Sem1;Psma4;Uba52;Usp2;Adrm1;Mat2b;Psmd2;Psmc5;Psmd4;Taf10;Psmd7;Ruvbl1;Usp14;Psmb3;Tada2b;Usp22;Psmb1;Psma3;Psmd6;Psme3;Mul1;Otub1;Psma1;Psmc4;Snx3;Psmc6;Tomm20;Ptrh2;Smad7;Ddb2;Smad2;Stam2;Psmc1;Psmb6;Psmb10;Vdac2
prerank,M Phase R-HSA-68886,-0.6917869030377339,-1.3196719853662833,0.0040650406504065045,0.15806408527088042,1.0,67/256,16.36%,Ubb;Tuba4a;Dynll2;Tubb2a;Dynll1;Ran;Rps27a;Tuba1a;Ywhag;Psmc3;Set;Banf1;Rps27;Psmb5;Psma7;Hsp90aa1;H2az1;Cetn2;Psmc2;Rab2a;Nme7;Csnk1e;H2bc4;Psma5;Tubb2b;Sem1;Psma4;Ube2s;Uba52;Smc1a;Ywhae;Rab1b;Emd;Ppp2r1a;Psmd2;Psmc5;Tubb4b;Tubb4a;Dctn3;Psmd4;Psmd7;Csnk2b;Chmp4b;Psmb3;Ppp2ca;Ensa;Anapc11;Nup37;Psmb1;Rad21;Psma3;Psmd6;Psme3;Nup50;Chmp2a;H2aj;Psma1;Psmc4;Ncaph2;Sec13;Ctdnep1;Psmc6;Vps4a;Haus2;Tuba1b;Nup107;Ppp2r5d
prerank,Interleukin-12 Family Signaling R-HSA-447115,-0.7804677662702422,-1.3184813232351649,0.07769423558897243,0.15979879698011673,1.0,11/31,16.72%,Ppia;Aurkaip1;Cdc42;Sod1;Canx;Hnrnpa2b1;P4hb;Hnrnpf;Rplp0;Rala;Gsto1
prerank,Regulation Of Actin Dynamics For Phagocytic Cup Formation R-HSA-2029482,-0.7587871158713855,-1.3178083696466742,0.07270560190703218,0.16063350075478022,1.0,12/43,13.51%,Hsp90ab1;Actg1;Hsp90aa1;Brk1;Nck1;Arpc5;Cdc42;Wasl;Arpc3;Arpc2;Arpc1a;Actr2
prerank,PINK1-PRKN Mediated Mitophagy R-HSA-5205685,-0.8177844795250919,-1.314088153591366,0.07672301690507152,0.1674832230236717,1.0,10/21,10.14%,Ubb;Rps27a;Tomm5;Vdac1;Tomm7;Map1lc3b;Uba52;Sqstm1;Pink1;Atg12
prerank,Pyruvate Metabolism R-HSA-70268,-0.7933195716207051,-1.3133617392919754,0.09383033419023136,0.16827484006684562,1.0,8/21,14.85%,Vdac1;Bsg;Glo1;Ldha;Hagh;Dlat;Slc16a1;Ldhb
prerank,"Cell Death Signaling Via NRAGE, NRIF And NADE R-HSA-204998",-0.7339378865944626,-1.312243807279256,0.06941176470588235,0.1698781522505602,1.0,10/53,8.39%,Ubb;Bex3;Rps27a;Psenen;Maged1;Uba52;Sqstm1;Bad;Ywhae;Aph1a
prerank,Gene And Protein Expression By JAK-STAT Signaling After Interleukin-12 Stimulation R-HSA-8950505,-0.7992120004460163,-1.3103774079780084,0.08430609597924774,0.17298906374577167,1.0,9/22,16.72%,Ppia;Aurkaip1;Cdc42;Sod1;Hnrnpa2b1;Hnrnpf;Rplp0;Rala;Gsto1
prerank,Signaling By ERBB2 R-HSA-1227986,-0.7597872647394626,-1.309865783504393,0.0881316098707403,0.17335520148303238,1.0,6/39,7.28%,Ubb;Rps27a;Nrg4;Hsp90aa1;Uba52;Cdc37
prerank,Signaling By ERBB4 R-HSA-1236394,-0.750443137139696,-1.3090884595663814,0.07577497129735936,0.17435495753876662,1.0,8/48,8.39%,Ubb;Apoe;Rps27a;Nrg4;Psenen;Uba52;Gabrg2;Aph1a
prerank,Netrin-1 Signaling R-HSA-373752,0.6148913425338349,1.3086721288237262,0.1588235294117647,0.6452762560639322,1.0,7/35,4.55%,Dscaml1;Ablim3;Trio;Slit3;Ablim2;Mapk14;Trpc5
prerank,TGF-beta Receptor Signaling Activates SMADs R-HSA-2173789,-0.7626119591374249,-1.3074223019796174,0.08462455303933254,0.17712414023390063,1.0,8/36,10.80%,Ubb;Rps27a;Fkbp1a;Ppp1ca;Uba52;Nedd8;Bambi;Itgav
prerank,IKK Complex Recruitment Mediated By RIP1 R-HSA-937041,-0.8314832786068382,-1.3071765951678846,0.09554973821989529,0.1771100706340805,1.0,4/16,6.60%,Ubb;Rps27a;Ndufa2;Uba52
prerank,Separation Of Sister Chromatids R-HSA-2467813,-0.6995285615136566,-1.3062755705464189,0.03727369542066028,0.17831320939311113,1.0,29/117,13.08%,Ubb;Dynll2;Dynll1;Rps27a;Psmc3;Rps27;Psmb5;Psma7;Psmc2;Psma5;Sem1;Psma4;Ube2s;Uba52;Smc1a;Ppp2r1a;Psmd2;Psmc5;Psmd4;Psmd7;Psmb3;Ppp2ca;Anapc11;Nup37;Psmb1;Rad21;Psma3;Psmd6;Psme3
prerank,Axon Guidance R-HSA-422475,-0.6730758148600033,-1.3059431482565447,0.0,0.17842051022180877,1.0,94/396,7.66%,Rpl6;Hsp90ab1;Ubb;Rps29;Epha5;Rps2;Rpl23;Rps7;Rpl37;Rpl5;Rpl3;Rpl19;Rplp2;Rpsa;Rpl21;Rps5;Pfn2;Rpl18a;Rpl7;Rpl22;Rps11;Rps28;Prnp;Rpl14;Rpl11;Rps25;Rps23;Rps24;Rpl27;Rpl29;Rpl28;Fau;Myl6;Rps27a;Rps8;Rps6;Rpl4;Rpl27a;Actg1;Psmc3;Rps4x;Rps15;Rpl7a;Rps17;Rpl8;Rps27;Rpl38;Psmb5;Rps21;Rpl12;Rpl23a;Rplp1;Rpl9;Rpl37a;Rps3;Rps20;Psma7;Rpl41;Hsp90aa1;Rps10;Epha7;Hspa8;Rpl13a;Rps15a;Clta;Psmc2;Rps16;Elob;Rpl39;Rps14;Rpl22l1;Rps12;Rpl15;Psenen;Nck1;Rpl30;Psma5;Ap2m1;Rpl18;Rpl31;Rps9;Arpc5;Rpl26;Rpl36;Sem1;Psma4;Uba52;Cdc42;Rpl34;Magoh;Rpl36a;Wasl;Rbm8a;Rpl35a
prerank,Endosomal Sorting Complex Required For Transport (ESCRT) R-HSA-917729,-0.7853765208749212,-1.3059337289364232,0.08489388264669163,0.17789447097105301,1.0,4/26,6.88%,Ubb;Rps27a;Uba52;Vps28
prerank,Chaperonin-mediated Protein Folding R-HSA-390466,-0.727542531039206,-1.3054070321602873,0.06356413166855845,0.17843705234442014,1.0,18/62,12.02%,Tuba4a;Tubb2a;Tuba1a;Gnb2;Cct2;Tubb2b;Pdcl;Cct6a;Gng2;Gng13;Pfdn6;Pfdn4;Tubb4b;Tubb4a;Gng10;Csnk2b;Fbxw2;Pfdn2
prerank,P75 NTR Receptor-Mediated Signaling R-HSA-193704,-0.7228251471370195,-1.3053506564393131,0.06327683615819209,0.17800214813309623,1.0,11/71,8.39%,Ubb;Bex3;Arhgdia;Rps27a;Psenen;Maged1;Uba52;Sqstm1;Bad;Ywhae;Aph1a
prerank,Cell Cycle Checkpoints R-HSA-69620,-0.6925872604328971,-1.3051123327027436,0.01973001038421599,0.17792719234025636,1.0,44/155,16.36%,Ubb;Dynll2;Dynll1;Rps27a;Ywhag;Psmc3;Rps27;Psmb5;Ywhah;Ywhab;Psma7;Psmc2;H2bc4;Psma5;Sem1;Psma4;Ube2s;Uba52;Ywhae;Rpa3;Ppp2r1a;Psmd2;Psmc5;Psmd4;Psmd7;Psmb3;Ppp2ca;Ywhaq;Anapc11;Nup37;Psmb1;Psma3;Psmd6;Psme3;Ube2n;Psma1;Psmc4;Cdkn1b;Ywhaz;Sec13;Rnf168;Psmc6;Nup107;Ppp2r5d
prerank,Death Receptor Signaling R-HSA-73887,-0.7005520542991334,-1.3039626170103666,0.04777415852334419,0.17965317465113395,1.0,13/101,8.39%,Ubb;Rack1;Bex3;Arhgdia;Rps27a;Psenen;Maged1;Uba52;Sqstm1;Bad;Ywhae;Usp2;Aph1a
prerank,Toll Like Receptor 4 (TLR4) Cascade R-HSA-166016,-0.7127831311416994,-1.3036751858392817,0.05786026200873363,0.17969312322337744,1.0,10/83,6.60%,Ubb;Hmgb1;Rps27a;Jun;Nfkb2;Dusp3;Dusp7;Ndufa2;Nfkbib;Uba52
prerank,Serotonin Neurotransmitter Release Cycle R-HSA-181429,-0.8095535143843995,-1.3036720691996442,0.1077762619372442,0.17915989983046202,1.0,2/17,1.14%,Rab3a;Vamp2
prerank,Nervous System Development R-HSA-9675108,-0.6715309655575511,-1.3035216919337902,0.0,0.17896362631492377,1.0,94/409,7.66%,Rpl6;Hsp90ab1;Ubb;Rps29;Epha5;Rps2;Rpl23;Rps7;Rpl37;Rpl5;Rpl3;Rpl19;Rplp2;Rpsa;Rpl21;Rps5;Pfn2;Rpl18a;Rpl7;Rpl22;Rps11;Rps28;Prnp;Rpl14;Rpl11;Rps25;Rps23;Rps24;Rpl27;Rpl29;Rpl28;Fau;Myl6;Rps27a;Rps8;Rps6;Rpl4;Rpl27a;Actg1;Psmc3;Rps4x;Rps15;Rpl7a;Rps17;Rpl8;Rps27;Rpl38;Psmb5;Rps21;Rpl12;Rpl23a;Rplp1;Rpl9;Rpl37a;Rps3;Rps20;Psma7;Rpl41;Hsp90aa1;Rps10;Epha7;Hspa8;Rpl13a;Rps15a;Clta;Psmc2;Rps16;Elob;Rpl39;Rps14;Rpl22l1;Rps12;Rpl15;Psenen;Nck1;Rpl30;Psma5;Ap2m1;Rpl18;Rpl31;Rps9;Arpc5;Rpl26;Rpl36;Sem1;Psma4;Uba52;Cdc42;Rpl34;Magoh;Rpl36a;Wasl;Rbm8a;Rpl35a
prerank,Processing Of DNA Double-Strand Break Ends R-HSA-5693607,-0.7495753052720654,-1.3033097666731241,0.09004739336492891,0.17882292107161316,1.0,6/38,8.11%,Ubb;Rps27a;Sumo2;H2bc4;Uba52;Rpa3
prerank,Norepinephrine Neurotransmitter Release Cycle R-HSA-181430,-0.8174840985448524,-1.3016477774972823,0.12258953168044077,0.18165914230389776,1.0,2/15,1.14%,Rab3a;Vamp2
prerank,Cell Cycle R-HSA-1640170,-0.6761207230952035,-1.301611040666069,0.0,0.18118048178295812,1.0,97/407,16.39%,Hsp90ab1;Ubb;Tuba4a;Dynll2;Tubb2a;Dynll1;Ran;Rps27a;Tuba1a;Ywhag;Psmc3;Set;Banf1;Rps27;Psmb5;Ywhah;Ywhab;Psma7;Hsp90aa1;H2az1;Cetn2;Psmc2;Rab2a;Nme7;Hspa2;Polr2f;Csnk1e;H2bc4;Psma5;Tubb2b;Sem1;Psma4;Ube2s;Uba52;Polr2i;Nop10;Pcna;Smc1a;Ywhae;Gar1;Rpa3;Rab1b;Emd;Hjurp;Ppp2r1a;Psmd2;Psmc5;Cdk4;Tubb4b;Tubb4a;Dctn3;Psmd4;Psmd7;Ruvbl1;Csnk2b;Polr2e;Chmp4b;Polr2c;Polr2g;Rbx1;Psmb3;Ppp2ca;Gins2;Ensa;Ywhaq;Anapc11;Nup37;Lyn;Psmb1;Rad21;Psma3;Psmd6;Psme3;Ube2n;Nup50;Chmp2a;H2aj;Dkc1;Psma1;Psmc4;Nhp2;Cdkn1b;Ywhaz;Ccnd3;Ncaph2;Sec13;Npm1;Rnf168;Rbbp7;Ctdnep1;Psmc6;Vps4a;Haus2;Tuba1b;Nup107;Ppp2r5d;Terf1
prerank,mTORC1-mediated Signaling R-HSA-166208,-0.7958231401571132,-1.300796742927736,0.10955414012738854,0.182353493534515,1.0,7/23,7.69%,Rps6;Fkbp1a;Ywhab;Lamtor2;Rraga;Rheb;Lamtor3
prerank,Anti-inflammatory Response Favoring Leishmania Infection R-HSA-9662851,-0.7288022970915589,-1.3005398400116177,0.06492027334851937,0.18238143809406254,1.0,10/60,10.72%,Calm1;Glp2r;Gnas;Gnb2;Ramp2;Plk2;Gng2;Gng13;Gng10;Adrb1
prerank,Constitutive Signaling By NOTCH1 HD+PEST Domain Mutants R-HSA-2894862,-0.7494563574836318,-1.2992682529160322,0.06478209658421673,0.1843319686845239,1.0,10/48,14.65%,Ubb;Rps27a;Snw1;Psenen;Uba52;Aph1a;Rbx1;Jag1;Tbl1xr1;Hey1
prerank,SARS-CoV-1 Infection R-HSA-9678108,-0.755439145279507,-1.2982608225991032,0.08716707021791767,0.18606671275139955,1.0,8/38,10.60%,Ubb;Ddx5;Rps27a;Map1lc3b;Uba52;Zcrb1;Canx;Chmp4b
prerank,Transcription-Coupled Nucleotide Excision Repair (TC-NER) R-HSA-6781827,-0.7271481931635053,-1.2979730695319323,0.07017543859649122,0.18613989268775494,1.0,13/61,10.97%,Ubb;Rps27a;Polr2f;Cops6;Uba52;Polr2i;Pcna;Hmgn1;Rpa3;Polr2e;Polr2c;Polr2g;Rbx1
prerank,Pyruvate Metabolism And Citric Acid (TCA) Cycle R-HSA-71406,-0.7453267284866397,-1.2977765024962828,0.08353221957040573,0.18596269775305704,1.0,17/39,18.09%,Mdh2;Idh3b;Vdac1;Bsg;Glo1;Ldlr;Ldha;Hagh;Dlat;Slc16a1;Sdhd;Fahd1;Ldhb;Idh3a;Suclg1;Sdhb;Idh2
prerank,Gluconeogenesis R-HSA-70263,-0.8170761636083237,-1.297772676571393,0.11558441558441558,0.18542206236018102,1.0,8/15,13.25%,Mdh2;Aldoc;Mdh1;G6pc3;Tpi1;Pgk1;Eno2;Got2
prerank,VEGFA-VEGFR2 Pathway R-HSA-4420097,-0.7268192631261575,-1.2964130892765446,0.07587768969422423,0.18756514640137503,1.0,5/63,6.70%,Calm1;Hsp90aa1;Brk1;Nck1;Cdc42
prerank,Disorders Of Transmembrane Transporters R-HSA-5619115,-0.698153171415613,-1.295859038677267,0.038002171552660155,0.1882339518149368,1.0,38/110,18.76%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Psma5;Bsg;Sem1;Psma4;Uba52;Psmd2;Psmc5;Psmd4;Rnf5;Psmd7;Slc24a5;Psmb3;Nup37;Psmb1;Psma3;Psmd6;Psme3;Nup50;Slc16a1;Psma1;Psmc4;Sec13;Psmc6;Nup107;Slc35a1;Seh1l;Abcb6;Nup205;Psmc1;Psmb6;Psmb10;Rnf185
prerank,Regulation Of PTEN Stability And Activity R-HSA-8948751,-0.7280267007288878,-1.2916729943928589,0.06892655367231638,0.1965820648868715,1.0,22/60,14.37%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Psma5;Sem1;Psma4;Uba52;Psmd2;Psmc5;Psmd4;Psmd7;Csnk2b;Psmb3;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4
prerank,Insertion Of Tail-Anchored Proteins Into Endoplasmic Reticulum Membrane R-HSA-9609523,-0.8050187058414283,-1.2904529613014428,0.11378002528445007,0.19862812535727906,1.0,5/19,12.03%,Vamp2;Prnp;Emd;Vapa;Sec61g
prerank,Interleukin-12 Signaling R-HSA-9020591,-0.780724420151472,-1.2899177657930119,0.11182519280205655,0.1992040014445965,1.0,10/26,16.72%,Ppia;Aurkaip1;Cdc42;Sod1;Hnrnpa2b1;P4hb;Hnrnpf;Rplp0;Rala;Gsto1
prerank,Activation Of NMDA Receptors And Postsynaptic Events R-HSA-442755,-0.7175328495784793,-1.2895429815712183,0.07599118942731277,0.19940612939312433,1.0,4/65,2.09%,Nrgn;Calm1;Nefl;Lin7c
prerank,Dopamine Neurotransmitter Release Cycle R-HSA-212676,-0.7872027176624706,-1.288524299577053,0.11717709720372836,0.20110292354490789,1.0,3/22,2.09%,Rab3a;Vamp2;Lin7c
prerank,Sealing Of Nuclear Envelope (NE) By ESCRT-III R-HSA-9668328,-0.8096550877685436,-1.28763827346138,0.11290322580645161,0.2023608203932148,1.0,7/17,10.60%,Tuba4a;Tubb2a;Tuba1a;Tubb2b;Tubb4b;Tubb4a;Chmp4b
prerank,Formation Of TC-NER Pre-Incision Complex R-HSA-6781823,-0.7374950947449448,-1.2861310797400687,0.08353221957040573,0.2048165673324542,1.0,11/48,10.97%,Ubb;Rps27a;Polr2f;Cops6;Uba52;Polr2i;Hmgn1;Polr2e;Polr2c;Polr2g;Rbx1
prerank,HS-GAG Biosynthesis R-HSA-2022928,-0.7946619933583382,-1.2845451653931828,0.10981912144702842,0.20767604379972313,1.0,1/19,1.00%,Ndst4
prerank,RHO GTPase Effectors R-HSA-195258,-0.6849291702733067,-1.2831945253995036,0.032563025210084036,0.21012394664956083,1.0,29/158,12.25%,Calm1;Dynll2;Pfn2;Dynll1;Myl6;Ywhag;Actg1;Rps27;Ywhah;Ywhab;H2az1;Brk1;H2bc4;Nck1;Arpc5;Cdc42;Wasl;Ywhae;Myl12b;Ppp2r1a;Arpc3;Lin7b;Ppp2ca;Pfn1;Ctnna1;Ywhaq;Arpc2;Nup37;Arpc1a
prerank,HIV Life Cycle R-HSA-162587,-0.6886765373560594,-1.2830528129762029,0.04422869471413161,0.209846382692621,1.0,32/120,17.78%,Ubb;Ppia;Ran;Rps27a;Banf1;Elob;Polr2f;Uba52;Polr2i;Vps28;Psip1;Taf10;Polr2e;Chmp4b;Taf11;Polr2c;Polr2g;Ranbp1;Nup37;Nup50;Chmp2a;Sec13;Tsg101;Vps4a;Tcea1;Nup107;Gtf2b;Seh1l;Lrig1;Taf5;Chmp7;Nup205
prerank,Global Genome Nucleotide Excision Repair (GG-NER) R-HSA-5696399,-0.7111328892171931,-1.2824453641581885,0.08418657565415244,0.21065978473085376,1.0,10/66,10.97%,Ubb;Rps27a;Cetn2;Sumo2;Cops6;Uba52;Pcna;Rpa3;Ruvbl1;Rbx1
prerank,Ion Channel Transport R-HSA-983712,-0.6891208218229815,-1.2808175850094994,0.07717391304347826,0.21357845512720397,1.0,14/96,7.53%,Calm1;Ubb;Atp1b1;Atp6v0c;Atp6v1d;Rps27a;Atp6v1a;Atp6v1g2;Atp6v0e2;Uba52;Atp6v1f;Cutc;Atp1b2;Atp1a3
prerank,Signaling By Non-Receptor Tyrosine Kinases R-HSA-9006927,-0.741973136064784,-1.27934895618766,0.10545023696682465,0.21617637631762374,1.0,4/37,6.60%,Ubb;Rps27a;Nrg4;Uba52
prerank,SUMOylation Of Transcription Cofactors R-HSA-3899300,-0.7399672507359487,-1.2791979858297873,0.12259615384615384,0.21587310356906897,1.0,3/36,4.56%,Ddx5;Park7;Sumo2
prerank,Regulation Of HSF1-mediated Heat Shock Response R-HSA-3371453,-0.7180514242270926,-1.2782027247219112,0.10300925925925926,0.21752127929508108,1.0,23/59,19.11%,Ubb;Hsbp1;Hspa8;Mrpl18;Hspa2;Dnajb6;Ywhae;Rpa3;Bag5;Bag1;St13;Hikeshi;Nup37;Nup50;Rps19bp1;Sec13;Nup107;Bag4;Seh1l;Nup205;Mapk3;Fkbp4;Hsph1
prerank,Cytoprotection By HMOX1 R-HSA-9707564,-0.7445387781746632,-1.2779952644019763,0.10011641443538999,0.21729586005773457,1.0,20/40,17.69%,Cox6c;Cox8a;Cox5b;Cox7a2l;Cox4i1;Cox6b1;Cox6a1;Cox7c;Cox5a;Cycs;Sin3b;Cox7b;Cox20;Sco2;Cox14;Hmox2;Tbl1xr1;Cox19;Surf1;Tbl1x
prerank,Neurotransmitter Release Cycle R-HSA-112310,-0.7311468577747566,-1.2747460314035668,0.12953995157384987,0.22383000231714212,1.0,5/39,5.22%,Rab3a;Vamp2;Lin7c;Hspa8;Arl6ip5
prerank,SLC-mediated Transmembrane Transport R-HSA-425407,-0.6814363557821217,-1.2731233683808583,0.05561497326203209,0.2268463858355417,1.0,5/112,5.52%,Calm1;Slc25a4;Slc15a2;Slc25a5;Bsg
prerank,Drug ADME R-HSA-9748784,-0.772136451729941,-1.2721403713078832,0.1450980392156863,0.22844617041783338,1.0,4/20,5.52%,Gstm1;Nme2;Gstp1;Bsg
prerank,Signaling By TGF-beta Receptor Complex R-HSA-170834,-0.7046668223309653,-1.271977599410379,0.0814081408140814,0.2281610189237358,1.0,10/72,10.80%,Ubb;Rps27a;Fkbp1a;Snw1;Ppp1ca;Uba52;Nedd8;Bambi;Skil;Itgav
prerank,Diseases Of Programmed Cell Death R-HSA-9645723,-0.7531539454708854,-1.271956844857226,0.11220715166461159,0.22759721684772163,1.0,10/33,15.30%,Jun;H2az1;H2bc4;Ywhae;C1qbp;Gsdme;Prdx1;H2aj;Cdk5r1;Rbbp7
prerank,Protein Folding R-HSA-391251,-0.7043852983602945,-1.2715173346401214,0.08680947012401354,0.22793305621461563,1.0,19/68,12.02%,Tuba4a;Tubb2a;Tuba1a;Gnb2;Cct2;Tbcc;Tubb2b;Pdcl;Cct6a;Gng2;Gng13;Pfdn6;Pfdn4;Tubb4b;Tubb4a;Gng10;Csnk2b;Fbxw2;Pfdn2
prerank,Deactivation Of Beta-Catenin Transactivating Complex R-HSA-3769402,-0.7593940072399612,-1.2711803880405264,0.12409638554216867,0.22814223728592276,1.0,4/30,7.87%,Ubb;Rps27a;Uba52;Tle4
prerank,COPII-mediated Vesicle Transport R-HSA-204005,-0.7210336880794611,-1.270221242798154,0.09887640449438202,0.22959227542770239,1.0,12/53,14.89%,Cnih2;Trappc6b;Cnih1;Tmed2;Trappc2;Rab1b;Trappc2l;Trappc1;Lman2;Mcfd2;Napg;Sec13
prerank,Nucleotide Excision Repair R-HSA-5696398,-0.6931609625976011,-1.270084966603475,0.09080717488789238,0.22928478383968873,1.0,16/88,10.97%,Ubb;Rps27a;Cetn2;Sumo2;Polr2f;Cops6;Uba52;Polr2i;Pcna;Hmgn1;Rpa3;Ruvbl1;Polr2e;Polr2c;Polr2g;Rbx1
prerank,Fatty acyl-CoA Biosynthesis R-HSA-75105,-0.7634727916422719,-1.2681628323538754,0.12706480304955528,0.23301305204033307,1.0,4/25,8.75%,Tecr;Acsl3;Hsd17b8;Hacd4
prerank,Anchoring Of Basal Body To Plasma Membrane R-HSA-5620912,-0.6963885962416748,-1.267527846968011,0.08546059933407325,0.23381508130154227,1.0,14/79,11.25%,Tuba4a;Dynll1;Tuba1a;Ywhag;Hsp90aa1;Cetn2;Csnk1e;Ywhae;Ppp2r1a;Tubb4b;Tubb4a;Dctn3;Tmem216;Rab11a
prerank,Regulation Of MECP2 Expression And Activity R-HSA-9022692,-0.7570607613651239,-1.2674830697055532,0.1135005973715651,0.23329824060500257,1.0,1/29,0.04%,Calm1
prerank,Detoxification Of Reactive Oxygen Species R-HSA-3299685,-0.7992580897024588,-1.2671202205550287,0.14690026954177898,0.23346111013552473,1.0,6/18,12.86%,Prdx5;Gstp1;Sod1;Cycs;P4hb;Prdx1
prerank,Mitochondrial Biogenesis R-HSA-1592230,-0.7062366208354998,-1.2670934129251297,0.09688581314878893,0.23291664464025533,1.0,2/62,2.92%,Calm1;Atp5pb
prerank,Toll-like Receptor Cascades R-HSA-168898,-0.6907989517267759,-1.2668117466764202,0.07516339869281045,0.2329347696215547,1.0,15/94,11.90%,Ubb;Hmgb1;Rps27a;Jun;Nfkb2;Dusp3;Dusp7;Ndufa2;Nfkbib;Uba52;Ppp2r1a;Ctsb;Usp14;Ppp2ca;Gsdme
prerank,Late Phase Of HIV Life Cycle R-HSA-162599,-0.6815921800719479,-1.266783977135064,0.05856832971800434,0.23236343163751,1.0,29/113,17.78%,Ubb;Ppia;Ran;Rps27a;Elob;Polr2f;Uba52;Polr2i;Vps28;Taf10;Polr2e;Chmp4b;Taf11;Polr2c;Polr2g;Ranbp1;Nup37;Nup50;Chmp2a;Sec13;Tsg101;Vps4a;Tcea1;Nup107;Gtf2b;Seh1l;Taf5;Chmp7;Nup205
prerank,FLT3 Signaling R-HSA-9607240,-0.7651606825624121,-1.2666585071033656,0.14267834793491865,0.23200424693406957,1.0,2/25,1.62%,Ubb;Rps27a
prerank,Smooth Muscle Contraction R-HSA-445355,-0.7885874246711464,-1.2652264611362662,0.15822784810126583,0.2346148442637078,1.0,2/20,1.60%,Calm1;Myl6
prerank,Neddylation R-HSA-8951664,-0.6652127950056966,-1.2642198479708864,0.05735140771637122,0.23628401411793795,1.0,51/176,18.61%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Elob;Cops6;Psma5;Senp8;Sem1;Psma4;Uba52;Klhl9;Sqstm1;Commd3;Commd4;Fbxl16;Asb13;Psmd2;Psmc5;Nedd8;Psmd4;Psmd7;Asb5;Fbxo32;Rbx1;Psmb3;Rnf7;Fbxw2;Fbxo9;Commd6;Psmb1;Psma3;Psmd6;Psme3;Mul1;Psma1;Psmc4;Rbbp7;Gps1;Psmc6;Dda1;Commd7;Ddb2;Psmc1;Cops8;Psmb6;Psmb10;Commd2;Wsb2
prerank,HCMV Infection R-HSA-9609646,-0.6884912240233599,-1.2636618443137428,0.0957683741648107,0.23686218347733032,1.0,23/78,17.78%,Dynll2;Dynll1;Cebpd;H2ac25;H2bc4;Pml;Vps28;Gps2;Chmp4b;Nup37;Nup50;Chmp2a;Dut;Tbl1xr1;Sec13;Tsg101;Rbbp7;Vps4a;Nup107;Seh1l;Chmp7;Tbl1x;Nup205
prerank,TP53 Regulates Transcription Of Cell Cycle Genes R-HSA-6791312,-0.744819738340884,-1.2633526431637274,0.15873015873015872,0.23696474175657362,1.0,8/29,18.49%,Bax;Plk2;Btg2;Pcna;Cdkn1b;Npm1;Cnot8;E2f4
prerank,Signaling By TGFB Family Members R-HSA-9006936,-0.69221777545798,-1.2627495806092348,0.07608695652173914,0.23772496423307624,1.0,12/87,10.80%,Ubb;Rps27a;Fkbp1a;Snw1;Drap1;Ppp1ca;Uba52;Nedd8;Bambi;Skil;Inhba;Itgav
prerank,PLC Beta Mediated Events R-HSA-112043,-0.7326101697325783,-1.2624879449301538,0.13333333333333333,0.23766061361599544,1.0,1/36,0.04%,Calm1
prerank,Metabolism Of Carbohydrates R-HSA-71387,-0.6644531958138419,-1.2609555477954948,0.039832285115303984,0.24050423428376813,1.0,21/176,13.25%,Calm1;Ubb;Ndst4;Rps27a;Mdh2;Aldoc;Phgdh;Pkm;Uba52;Mdh1;G6pc3;B3galt2;Tpi1;Ppp2r1a;Pgk1;Ppp2ca;Nup37;Eno2;Ogn;Nup50;Got2
prerank,Golgi-to-ER Retrograde Transport R-HSA-8856688,-0.6937590309677092,-1.2605945170702813,0.09550561797752809,0.24064884500580688,1.0,24/82,18.98%,Dynll2;Dynll1;Tmed9;Arf4;Capza2;Dctn6;Tmed2;Rab1b;Rab6b;Dctn3;Arf3;Surf4;Rab6a;Arfgap2;Actr10;Rab18;Napg;Tmed7;Arf5;Ube2z;Pafah1b2;Pafah1b1;Copb2;Copg1
prerank,Cargo Concentration In ER R-HSA-5694530,-0.768167572348779,-1.2602739664016256,0.15796019900497513,0.24076510558448125,1.0,3/21,7.12%,Cnih2;Cnih1;Tmed2
prerank,Chondroitin Sulfate Biosynthesis R-HSA-2022870,0.6939723335264494,1.258656842296416,0.2159090909090909,0.7629916806277475,1.0,1/15,1.68%,Chst11
prerank,Regulation Of TP53 Activity Thru Phosphorylation R-HSA-6804756,-0.7123090351033718,-1.2579128740595171,0.12055109070034443,0.2454671875214912,1.0,7/49,10.63%,Ubb;Rps27a;Uba52;Rpa3;Taf10;Csnk2b;Taf11
prerank,Trafficking Of GluR2-containing AMPA Receptors R-HSA-416993,0.6686425256756388,1.2576290830769592,0.18548387096774194,0.7299783782235777,1.0,4/15,3.63%,Gria3;Gria4;Gria1;Prkcg
prerank,Platelet Calcium Homeostasis R-HSA-418360,-0.7960127328539538,-1.2569984309234123,0.16731016731016732,0.24703397339116265,1.0,1/15,0.04%,Calm1
prerank,MAPK6/MAPK4 Signaling R-HSA-5687128,-0.6974695509755798,-1.2568069038046858,0.09572072072072071,0.24677687908358864,1.0,25/67,14.58%,Ubb;Rps27a;Jun;Psmc3;Psmb5;Psma7;Psmc2;Psma5;Sem1;Psma4;Uba52;Cdc42;Psmd2;Psmc5;Psmd4;Mapk6;Psmd7;Psmb3;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4;Ccnd3
prerank,Fcgamma Receptor (FCGR) Dependent Phagocytosis R-HSA-2029480,-0.7021268286166656,-1.2564201360239184,0.1252821670428894,0.24697457834336028,1.0,13/61,13.51%,Hsp90ab1;Actg1;Hsp90aa1;Brk1;Nck1;Arpc5;Cdc42;Wasl;Arpc3;Arpc2;Arpc1a;Lyn;Actr2
prerank,DNA Double-Strand Break Repair R-HSA-5693532,-0.6873290135190466,-1.2544908113976776,0.11037527593818984,0.25086063374329426,1.0,15/77,15.21%,Ubb;Rps27a;Sumo2;H2bc4;Eya1;Sem1;Uba52;Pcna;Rpa3;Ubxn1;Ppp4c;Ube2n;Sirt6;Parp1;Rnf168
prerank,ADP Signaling Thru P2Y Purinoceptor 12 R-HSA-392170,-0.8104713962814827,-1.2536636276255197,0.13360323886639677,0.2522237314327982,1.0,8/15,16.48%,Gnb2;P2ry12;Gng2;Gng13;Gng10;Gng3;Gnai2;Gnai1
prerank,Adaptive Immune System R-HSA-1280218,-0.6484301696714051,-1.253649294468243,0.008040201005025126,0.2516361592606769,1.0,76/418,13.32%,Calm1;Ubb;Hmgb1;Ppia;Dynll2;Dynll1;Rps27a;Pianp;Psmc3;Rasgrp1;Psmb5;Fkbp1a;Ywhab;Psma7;Icam5;Calr;Pja1;Clta;Psmc2;Elob;Rnf220;Nck1;Anapc13;Psma5;Ndufa2;Ube3a;Ap2m1;Cd81;Orai2;Capza2;Nfkbib;Sem1;Dctn6;Psma4;Ube2s;Uba52;Ube2j1;Cdc42;Klhl9;Ppp3ca;Fbxl16;Ctso;Pdia3;Rnf6;Asb13;Ppp2r1a;Psmd2;Psmc5;Ctsb;Dctn3;Psmd4;Psmd7;Canx;Asb5;Fbxo32;Itgav;Rbx1;Psmb3;Clstn1;Actr1b;Ppp2ca;Rnf7;Fbxw2;Sec61g;Anapc11;Fbxo9;Ppp3r1;Lyn;Uba1;Psmb1;Psma3;Psmd6;Hras;Psme3;Ube2n;Vamp3
prerank,Signaling By VEGF R-HSA-194138,-0.6975341386477023,-1.2536310841943707,0.11896745230078563,0.2510461616001427,1.0,6/68,6.70%,Calm1;Hsp90aa1;Vegfc;Brk1;Nck1;Cdc42
prerank,Transport Of Small Molecules R-HSA-382551,-0.6454600121665822,-1.2529977683462818,0.021169354838709676,0.2519695824039535,1.0,49/386,10.27%,Fth1;Calm1;Ubb;Atp1b1;Slc25a4;Atp6v0c;Apoe;Atp6v1d;Slc15a2;Gnas;Rps27a;Psmc3;Atp6v1a;Psmb5;Psma7;Gnb2;Atp6v1g2;Slc25a5;Smdt1;Atp6v0e2;Clta;Psmc2;Nceh1;Vdac1;Psma5;Bsg;Ap2m1;Slc22a17;Sem1;Psma4;Uba52;Atp6v1f;Cutc;Atp1b2;Aqp4;Atp1a3;Slc39a3;Gng2;Gng13;Psmd2;Psmc5;Nedd8;Psmd4;Rnf5;Ldlr;Psmd7;Gng10;Atp6v0b;Slc24a5
prerank,FLT3 Signaling In Disease R-HSA-9682385,-0.764504709131216,-1.2510677330714701,0.16603295310519645,0.25550070558037496,1.0,2/22,1.62%,Ubb;Rps27a
prerank,"Glutamate Binding, Activation Of AMPA Receptors And Synaptic Plasticity R-HSA-399721",0.6020528945881399,1.2502673649134945,0.1511627906976744,0.7185937514237699,1.0,5/28,6.01%,Gria3;Gria4;Gria1;Prkcg;Epb41l1
prerank,Beta-catenin Independent WNT Signaling R-HSA-3858494,-0.6732293027013009,-1.249863698473424,0.09580193756727665,0.25759440974073883,1.0,33/105,14.45%,Calm1;Ubb;Rps27a;Psmc3;Psmb5;Psma7;Gnb2;Clta;Psmc2;Psma5;Ap2m1;Sem1;Psma4;Uba52;Ppp3ca;Gng2;Gng13;Psmd2;Psmc5;Psmd4;Psmd7;Gng10;Psmb3;Pfn1;Ppp3r1;Psmb1;Psma3;Psmd6;Psme3;Gng3;Psma1;Psmc4;Ppp3cb
prerank,Cargo Recognition For Clathrin-Mediated Endocytosis R-HSA-8856825,-0.6984134955064983,-1.2498225247176633,0.10276243093922652,0.2570515854504072,1.0,11/68,10.65%,Ubb;Vamp2;Rps27a;Clta;Necap1;Cops6;Ap2m1;Uba52;Nedd8;Ldlr;Ubqln2
prerank,Ca-dependent Events R-HSA-111996,-0.7411165813481231,-1.249453907313337,0.1630952380952381,0.257277817679761,1.0,1/29,0.04%,Calm1
prerank,Apoptotic Execution Phase R-HSA-75153,-0.7299717351917567,-1.2493261600152739,0.1674698795180723,0.25688232709861,1.0,1/31,0.16%,Hmgb1
prerank,Senescence-Associated Secretory Phenotype (SASP) R-HSA-2559582,-0.7203302437328485,-1.2491337067351782,0.14469078179696615,0.2567810615897843,1.0,7/40,6.60%,Ubb;Rps27a;Jun;H2az1;H2bc4;Ube2s;Uba52
prerank,Nuclear Signaling By ERBB4 R-HSA-1251985,-0.7505957556341915,-1.2482592277901654,0.15337423312883436,0.25808757324717413,1.0,6/26,12.21%,Apoe;Nrg4;Psenen;Aph1a;Sparc;Stmn1
prerank,Signaling By NOTCH1 R-HSA-1980143,-0.7013514891270954,-1.2470626907868028,0.112,0.26019127241592804,1.0,7/60,8.39%,Ubb;Rps27a;Snw1;Psenen;Uba52;Tle4;Aph1a
prerank,Negative Regulation Of FGFR2 Signaling R-HSA-5654727,-0.7615518266181391,-1.2470414409065218,0.1830808080808081,0.25957624284876984,1.0,8/22,11.40%,Ubb;Rps27a;Spry2;Fgfr2;Uba52;Ppp2r1a;Fgf13;Ppp2ca
prerank,TNFR1-induced NFkappaB Signaling Pathway R-HSA-5357956,-0.7565451543493084,-1.2467066085199348,0.16687898089171974,0.2597244941425672,1.0,1/20,0.23%,Rack1
prerank,Estrogen-dependent Gene Expression R-HSA-9018519,-0.6845874458596792,-1.2461973097025612,0.12611607142857142,0.26026300926011164,1.0,14/77,10.90%,Hsp90ab1;Ddx5;Jun;Hsp90aa1;H2az1;Jund;Polr2f;H2bc4;Polr2i;Smc1a;Ptges3;Polr2e;Polr2c;Polr2g
prerank,DAG And IP3 Signaling R-HSA-1489509,-0.7297999225167965,-1.2460407341511852,0.15393518518518517,0.2599926344656476,1.0,1/33,0.04%,Calm1
prerank,Lysosome Vesicle Biogenesis R-HSA-432720,-0.7494934860577096,-1.2453842447204209,0.14687100893997446,0.2608150910103537,1.0,3/27,3.89%,Vamp2;Hspa8;Clta
prerank,CaM Pathway R-HSA-111997,-0.7424090255684686,-1.2449542077734626,0.17349397590361446,0.2610552437762124,1.0,1/28,0.04%,Calm1
prerank,TCF Dependent Signaling In Response To WNT R-HSA-201681,-0.66967511477042,-1.2447954029195725,0.09935897435897435,0.2607797180136713,1.0,32/122,14.57%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;H2az1;Psmc2;Csnk1e;H2bc4;Psma5;Sem1;Psma4;Uba52;Tle4;Ppp2r1a;Psmd2;Psmc5;Psmd4;Psmd7;Ruvbl1;Csnk2b;Rbx1;Psmb3;Ppp2ca;Psmb1;Psma3;Psmd6;Psme3;H2aj;Psma1;Psmc4;Ywhaz
prerank,Glutamate Neurotransmitter Release Cycle R-HSA-210500,-0.7454239032815511,-1.242961141276657,0.16732026143790849,0.26441975203118656,1.0,3/22,5.22%,Rab3a;Vamp2;Arl6ip5
prerank,MAPK1/MAPK3 Signaling R-HSA-5684996,-0.6516530654481986,-1.2421341681060394,0.05997931747673216,0.2657018707926522,1.0,40/188,13.08%,Calm1;Ubb;Nefl;Pebp1;Rps27a;Psmc3;Rasgrp1;Psmb5;Nrg4;Ywhab;Psma7;Lamtor2;Psmc2;Dusp7;Fgfr2;Psma5;Sem1;Psma4;Uba52;Lamtor3;Pdgfa;Rasal2;Abhd17a;Ppp2r1a;Psmd2;Psmc5;Tek;Psmd4;Psmd7;Irs2;Fgf13;Rbx1;Psmb3;Ppp2ca;Fgfr1;Psmb1;Psma3;Psmd6;Hras;Psme3
prerank,Transcriptional Regulation By AP-2 (TFAP2) Family Of Transcription Factors R-HSA-8864260,-0.7717282022119659,-1.2420203837052324,0.19712793733681463,0.2653293875846624,1.0,3/19,5.92%,Apoe;Dek;Cited2
prerank,RAF/MAP Kinase Cascade R-HSA-5673001,-0.6521564437257581,-1.2414999304875682,0.061139896373056994,0.2659546150243425,1.0,40/185,13.08%,Calm1;Ubb;Nefl;Pebp1;Rps27a;Psmc3;Rasgrp1;Psmb5;Nrg4;Ywhab;Psma7;Lamtor2;Psmc2;Dusp7;Fgfr2;Psma5;Sem1;Psma4;Uba52;Lamtor3;Pdgfa;Rasal2;Abhd17a;Ppp2r1a;Psmd2;Psmc5;Tek;Psmd4;Psmd7;Irs2;Fgf13;Rbx1;Psmb3;Ppp2ca;Fgfr1;Psmb1;Psma3;Psmd6;Hras;Psme3
prerank,Cytosolic Sensors Of Pathogen-Associated DNA R-HSA-1834949,-0.7014801389862216,-1.2394753574581647,0.15357561547479484,0.27001432750884613,1.0,6/45,6.60%,Ubb;Rps27a;Nfkb2;Polr2f;Nfkbib;Uba52
prerank,Signaling By FGFR R-HSA-190236,-0.6922161359271651,-1.2392287163448379,0.13439635535307518,0.2698288031722659,1.0,18/61,13.73%,Ubb;Rps27a;Spry2;Polr2f;Fgfr2;Flrt2;Uba52;Polr2i;Ppp2r1a;Polr2e;Hnrnpa1;Fgf13;Polr2c;Polr2g;Ppp2ca;Fgfr1;Hras;Hnrnpf
prerank,G-protein Mediated Events R-HSA-112040,-0.7163078848940221,-1.2381913672228861,0.156794425087108,0.2713738360858888,1.0,1/40,0.04%,Calm1
prerank,Base Excision Repair R-HSA-73884,-0.7290080718279263,-1.2371835537347011,0.20100502512562815,0.27306950135434177,1.0,11/27,17.35%,H2az1;H2bc4;Pcna;Mpg;Rpa3;Adprs;H2aj;Parp1;Apex1;Terf1;Lrig1
prerank,Negative Regulation Of FGFR1 Signaling R-HSA-5654726,-0.7481517429617787,-1.2366570036730602,0.18969849246231155,0.27355945870639725,1.0,8/23,11.74%,Ubb;Rps27a;Spry2;Uba52;Ppp2r1a;Fgf13;Ppp2ca;Fgfr1
prerank,mRNA Splicing R-HSA-72172,-0.6494474096388291,-1.2342673402297026,0.06230529595015576,0.2785978346917371,1.0,44/182,15.82%,Ddx5;Tfip11;Hspa8;Snrpg;Sf3b4;Snw1;Snrpf;Polr2f;Snrpd2;Rbm42;Cpsf2;Snrnp27;Wbp11;Polr2i;Magoh;Snu13;Bud31;Lsm2;Rbm8a;Wbp4;Sf3b2;Zcrb1;Zrsr2;Magohb;Pcbp1;Rbm22;Lsm4;Polr2e;Hnrnpa1;Polr2c;Polr2g;Hnrnpa2b1;Txnl4a;Lsm7;Puf60;Hnrnpf;Snrnp200;U2af1l4;Lsm8;Ctnnbl1;Syf2;Pdcd7;U2af1;Phf5a
prerank,Signaling By FGFR2 R-HSA-5654738,-0.6945895343017583,-1.2339867890982912,0.15005727376861397,0.2785687385223124,1.0,16/54,13.73%,Ubb;Rps27a;Spry2;Polr2f;Fgfr2;Uba52;Polr2i;Ppp2r1a;Polr2e;Hnrnpa1;Fgf13;Polr2c;Polr2g;Ppp2ca;Hras;Hnrnpf
prerank,MHC Class II Antigen Presentation R-HSA-2132295,-0.6863068201026713,-1.2333700893763284,0.12249443207126949,0.27940825258585356,1.0,11/65,11.28%,Dynll2;Dynll1;Clta;Ap2m1;Capza2;Dctn6;Ctso;Ctsb;Dctn3;Canx;Actr1b
prerank,Cytokine Signaling In Immune System R-HSA-1280215,-0.6394193864583528,-1.2321840483898145,0.024365482233502538,0.2813923065015571,1.0,78/327,17.04%,Ubb;Hmgb1;Ppia;Vamp2;Rps27a;Jun;Psmc3;Eif4a1;Aurkaip1;Cebpd;Psmb5;Nfkb2;Psma7;Hsp90aa1;Hspa8;Dusp3;Ndn;Egr1;Psmc2;Elob;Dusp7;Il18;Psma5;Nfkbib;Sem1;Psma4;Pml;Uba52;Cdc42;Sqstm1;Sod1;Eif4a2;Ifngr2;Ppp2r1a;Psmd2;Psmc5;Trim35;Psmd4;Psmd7;Irs2;Canx;Usp14;Fgf13;Hnrnpa2b1;Rbx1;Psmb3;Clstn1;Ppp2ca;Rnf7;Nup37;Lyn;P4hb;Psmb1;Psma3;Psmd6;Hras;Psme3;Ube2n;Nup50;Mef2c;Hnrnpf;Psma1;Psmc4;Cdkn1b;Ywhaz;Ube2v1;Sec13;Csf1r;Rplp0;Psmc6;Rala;Nup107;Ppp2r5d;Pik3r1;Gsto1;Seh1l;Oprm1;Smad7
prerank,Inwardly Rectifying K+ Channels R-HSA-1296065,-0.7688503595418369,-1.2313346025763667,0.17564102564102563,0.2826559018393188,1.0,7/19,10.26%,Kcnj3;Gnb2;Kcnj2;Gng2;Gng13;Gng10;Kcnj4
prerank,Signaling By NOTCH R-HSA-157118,-0.6561431960757399,-1.2305486068572398,0.09090909090909091,0.2837656491755431,1.0,38/142,14.65%,Ubb;Rps27a;Jun;Psmc3;Psmb5;Psma7;H2az1;Psmc2;Snw1;Psenen;H2bc4;Psma5;Sem1;Psma4;Uba52;Tmed2;Tle4;Aph1a;Psmd2;Psmc5;Psmd4;Psmd7;Rbx1;Psmb3;Psmb1;Psma3;Psmd6;Fabp7;Psme3;Jag1;Sirt6;H2aj;Rab6a;Psma1;Tbl1xr1;Psmc4;Ywhaz;Hey1
prerank,Vesicle-mediated Transport R-HSA-5653656,-0.6363189854808124,-1.23049110318237,0.01609657947686117,0.2832470871116988,1.0,89/457,16.25%,Fth1;Calm1;Ubb;Cnih2;Apoe;Rab3a;Dynll2;Vamp2;Dynll1;Rps27a;Ywhag;Trappc6b;Ywhah;Tmed9;Ywhab;Hsp90aa1;Calr;Hspa8;Cnih1;Clta;Necap1;Cops6;Arf4;Bet1l;Gabarapl2;Ap2m1;Arpc5;Capza2;Gabarap;Map1lc3b;Dctn6;Uba52;Cyth2;Vps28;Tmed2;Trappc2;Wasl;Ywhae;Rab1b;Trappc2l;Rab6b;C1d;Gja1;Nedd8;Dctn3;Ldlr;Arpc3;Chmp4b;Hip1r;Ubqln2;Naa38;Sparc;Rab31;Rab11a;Trappc1;Stx16;Ywhaq;Lman2;Arpc2;Bloc1s4;Arpc1a;Arf3;Surf4;Chmp2a;Vamp3;Actr2;Rab14;Mcfd2;Rab6a;Arfgap2;Cyth4;Actr10;Rab18;Ywhaz;Napg;Tbc1d7;Epn1;Sec13;Tmed7;Arf5;Tsg101;Snap29;Gps1;Ube2z;Sbf1;Vps4a;Scoc;Pafah1b2;Rala
prerank,Translation Of Structural Proteins R-HSA-9683701,-0.7539160247899367,-1.2302417308964495,0.18041237113402062,0.28315262014608805,1.0,2/22,1.62%,Ubb;Rps27a
prerank,Signaling By FGFR1 R-HSA-5654736,-0.7168884372281878,-1.2268849191501237,0.19121140142517815,0.29029978473154705,1.0,10/34,12.78%,Ubb;Rps27a;Spry2;Flrt2;Uba52;Ppp2r1a;Fgf13;Ppp2ca;Fgfr1;Hras
prerank,NGF-stimulated Transcription R-HSA-9031628,-0.7610966445173754,-1.2259199980563726,0.1976127320954907,0.29181348446294175,1.0,7/19,18.37%,Cdk5r2;Egr1;Jund;Vgf;Cdk5r1;Id2;Egr3
prerank,MTOR Signaling R-HSA-165159,-0.7103696996479651,-1.2253281376549143,0.17695961995249407,0.2926115332435294,1.0,7/38,7.69%,Rps6;Fkbp1a;Ywhab;Lamtor2;Rraga;Rheb;Lamtor3
prerank,HCMV Early Events R-HSA-9609690,-0.6858827137248376,-1.2220121362528125,0.15825688073394495,0.3002407110827801,1.0,16/57,17.78%,Dynll2;Dynll1;H2ac25;H2bc4;Pml;Gps2;Nup37;Nup50;Dut;Tbl1xr1;Sec13;Rbbp7;Nup107;Seh1l;Tbl1x;Nup205
prerank,mRNA Splicing - Major Pathway R-HSA-72163,-0.6452664748842045,-1.2214629260403764,0.07651991614255765,0.3008799173619763,1.0,43/176,16.94%,Ddx5;Tfip11;Hspa8;Snrpg;Sf3b4;Snw1;Snrpf;Polr2f;Snrpd2;Rbm42;Cpsf2;Snrnp27;Wbp11;Polr2i;Magoh;Snu13;Bud31;Lsm2;Rbm8a;Wbp4;Sf3b2;Magohb;Pcbp1;Rbm22;Lsm4;Polr2e;Hnrnpa1;Polr2c;Polr2g;Hnrnpa2b1;Txnl4a;Lsm7;Puf60;Hnrnpf;Snrnp200;U2af1l4;Lsm8;Ctnnbl1;Syf2;U2af1;Phf5a;Ybx1;Snrpe
prerank,Hedgehog Off State R-HSA-5610787,-0.6675645944258805,-1.2213508885960012,0.14,0.3004704617403017,1.0,24/83,14.37%,Ubb;Gnas;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Psma5;Sem1;Psma4;Uba52;Psmd2;Psmc5;Psmd4;Psmd7;Rbx1;Psmb3;Adcy10;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4
prerank,mRNA Splicing - Minor Pathway R-HSA-72165,-0.6971472029448819,-1.221329824455722,0.16859122401847576,0.2998419588978721,1.0,17/47,16.94%,Snrpg;Sf3b4;Snrpf;Polr2f;Snrpd2;Polr2i;Sf3b2;Zcrb1;Zrsr2;Polr2e;Polr2c;Polr2g;Txnl4a;Snrnp200;Pdcd7;Ybx1;Snrpe
prerank,Ion Homeostasis R-HSA-5578775,-0.7191710149984553,-1.2212419803222896,0.18610129564193167,0.2993412539141714,1.0,2/32,0.12%,Calm1;Atp1b1
prerank,Activation Of G Protein Gated Potassium Channels R-HSA-1296041,-0.7709835330339948,-1.2202618212101457,0.20680628272251309,0.3010444958430097,1.0,7/17,10.26%,Kcnj3;Gnb2;Kcnj2;Gng2;Gng13;Gng10;Kcnj4
prerank,Mitotic Prometaphase R-HSA-68877,-0.6519192816502213,-1.2187970700252806,0.11192468619246862,0.3037468246963046,1.0,20/123,12.52%,Tuba4a;Dynll2;Dynll1;Tuba1a;Ywhag;Rps27;Hsp90aa1;Cetn2;Nme7;Csnk1e;Smc1a;Ywhae;Ppp2r1a;Tubb4b;Tubb4a;Dctn3;Csnk2b;Ppp2ca;Nup37;Rad21
prerank,Diseases Of Signal Transduction By Growth Factor Receptors And Second Messengers R-HSA-5663202,-0.6318625938208716,-1.218746523850118,0.04356636271529889,0.303167661830113,1.0,59/308,14.65%,Calm1;Ubb;Pebp1;Rps27a;Rps6;Psmc3;Psmb5;Fkbp1a;Nrg4;Ywhab;Psma7;Hsp90aa1;Psmc2;Snw1;Eef1g;Dusp7;Psenen;Polr2f;Fgfr2;Psma5;Sem1;Psma4;Uba52;Polr2i;Sqstm1;Cdc37;Bad;Pdgfa;Aph1a;Ppp2r1a;Psmd2;Psmc5;Psmd4;Psmd7;Irs2;Polr2e;Fgf13;Polr2c;Polr2g;Rbx1;Psmb3;Clstn1;Ppp2ca;Fgfr1;Lyn;Fam131b;Psmb1;Psma3;Atic;Psmd6;Hras;Psme3;Jag1;Cebpb;Psma1;Tbl1xr1;Psmc4;Cdkn1b;Hey1
prerank,G-protein Activation R-HSA-202040,-0.779409410961229,-1.2178228469154224,0.1986842105263158,0.3044962259262339,1.0,7/15,16.97%,Gnb2;Gng2;Gng13;Gng10;Gng3;Oprm1;Gna11
prerank,RMTs Methylate Histone Arginines R-HSA-3214858,-0.7124625434778074,-1.2170141004593125,0.20432692307692307,0.305734003893211,1.0,3/34,4.63%,Rps2;H2az1;H2ac25
prerank,NOTCH1 Intracellular Domain Regulates Transcription R-HSA-2122947,-0.7149148289131698,-1.2166810143023863,0.18601895734597157,0.3058403785145639,1.0,5/39,7.87%,Ubb;Rps27a;Snw1;Uba52;Tle4
prerank,Stimuli-sensing Channels R-HSA-2672351,-0.6753118894342686,-1.2150012279531663,0.2023121387283237,0.30914004157887176,1.0,3/50,1.62%,Calm1;Ubb;Rps27a
prerank,Resolution Of Abasic Sites (AP Sites) R-HSA-73933,-0.7537603911246327,-1.2146101528905977,0.22654155495978553,0.30936811474673087,1.0,7/18,17.35%,Pcna;Mpg;Rpa3;Adprs;Parp1;Apex1;Lrig1
prerank,Meiotic Recombination R-HSA-912446,-0.7745762004390603,-1.2127155056259504,0.20239680426098536,0.31323765417327915,1.0,5/15,13.76%,H2az1;H2bc4;Rpa3;Cdk4;H2aj
prerank,Membrane Trafficking R-HSA-199991,-0.6276927995096255,-1.2126137917674762,0.02620967741935484,0.3127683752923654,1.0,84/445,16.25%,Fth1;Calm1;Ubb;Cnih2;Rab3a;Dynll2;Vamp2;Dynll1;Rps27a;Ywhag;Trappc6b;Ywhah;Tmed9;Ywhab;Hspa8;Cnih1;Clta;Necap1;Cops6;Arf4;Bet1l;Gabarapl2;Ap2m1;Arpc5;Capza2;Gabarap;Map1lc3b;Dctn6;Uba52;Cyth2;Vps28;Tmed2;Trappc2;Wasl;Ywhae;Rab1b;Trappc2l;Rab6b;Gja1;Nedd8;Dctn3;Ldlr;Arpc3;Chmp4b;Hip1r;Ubqln2;Naa38;Rab31;Rab11a;Trappc1;Stx16;Ywhaq;Lman2;Arpc2;Bloc1s4;Arpc1a;Arf3;Surf4;Chmp2a;Vamp3;Actr2;Rab14;Mcfd2;Rab6a;Arfgap2;Cyth4;Actr10;Rab18;Ywhaz;Napg;Tbc1d7;Epn1;Sec13;Tmed7;Arf5;Tsg101;Snap29;Gps1;Ube2z;Sbf1;Vps4a;Scoc;Pafah1b2;Rala
prerank,Interactions Of Vpr With Host Cellular Proteins R-HSA-176033,-0.7125040594686362,-1.2087401655939107,0.20752427184466019,0.3213331568672674,1.0,3/30,3.38%,Slc25a4;Banf1;Slc25a5
prerank,Signaling By MET R-HSA-6806834,-0.6895020846672162,-1.2080990424921225,0.19610091743119265,0.322218339404709,1.0,2/47,1.62%,Ubb;Rps27a
prerank,G-protein Beta:Gamma Signaling R-HSA-397795,-0.7507374400235666,-1.206749665324367,0.21568627450980393,0.32449314283756614,1.0,6/20,14.05%,Gnb2;Cdc42;Gng2;Gng13;Gng10;Gng3
prerank,Initiation Of Nuclear Envelope (NE) Reformation R-HSA-2995383,-0.7569441686185299,-1.205833913193543,0.2579787234042553,0.32595105682881836,1.0,4/16,11.40%,Banf1;Emd;Ppp2r1a;Ppp2ca
prerank,Interleukin-17 Signaling R-HSA-448424,-0.6856000960496398,-1.2056973766343,0.18045977011494252,0.32481269546955355,1.0,6/51,6.60%,Ubb;Rps27a;Jun;Dusp3;Dusp7;Uba52
prerank,MAP Kinase Activation R-HSA-450294,-0.6856000960496398,-1.2056973766343,0.18045977011494252,0.32481269546955355,1.0,6/51,6.60%,Ubb;Rps27a;Jun;Dusp3;Dusp7;Uba52
prerank,Thromboxane Signaling Thru TP Receptor R-HSA-428930,-0.7677079656936499,-1.2035244832125296,0.22280471821756226,0.32935505243812785,1.0,6/15,16.97%,Gnb2;Gng2;Gng13;Gng10;Gng3;Gna11
prerank,Signaling By Cytosolic FGFR1 Fusion Mutants R-HSA-1839117,0.6469487624889151,1.2031229181370122,0.24100719424460432,0.8313074980186783,1.0,3/15,7.67%,Lrrfip1;Zmym2;Gab2
prerank,Transcriptional Regulation By RUNX1 R-HSA-8878171,-0.643385290154892,-1.202374066889061,0.13291139240506328,0.3315090300311634,1.0,29/134,14.58%,Ubb;Lmo1;Rps27a;Psmc3;Psmb5;Psma7;H2az1;Psmc2;H2bc4;Psma5;Sem1;Psma4;Pml;Uba52;Sin3b;Psmd2;Psmc5;Psmd4;Psmd7;Csnk2b;Psmb3;Psmb1;Psma3;Psmd6;Psme3;H2aj;Psma1;Psmc4;Ccnd3
prerank,TP53 Regulates Metabolic Genes R-HSA-5628897,-0.6625309490001419,-1.194895502373225,0.185589519650655,0.34943729833409526,1.0,27/74,13.31%,Ywhag;Cox6c;Ywhah;Prdx5;Ywhab;Cox8a;Lamtor2;Cox5b;Sesn1;Rraga;Cox7a2l;Cox4i1;Cox6b1;Cox6a1;Cox7c;Cox5a;Rheb;Cycs;Lamtor3;Ywhae;Cox7b;Cox20;Sco2;Ywhaq;Rragd;Prdx1;Cox14
prerank,Defective Intrinsic Pathway For Apoptosis R-HSA-9734009,-0.7594614981799568,-1.1946973557188572,0.2327127659574468,0.34921722087211404,1.0,5/16,14.74%,Jun;Ywhae;C1qbp;Prdx1;Cdk5r1
prerank,G2/M DNA Damage Checkpoint R-HSA-69473,-0.6946844125928998,-1.1945859149387197,0.234375,0.348736433092819,1.0,10/35,15.21%,Ywhag;Ywhah;Ywhab;H2bc4;Ywhae;Rpa3;Ywhaq;Ube2n;Ywhaz;Rnf168
prerank,Signaling By Hedgehog R-HSA-5358351,-0.6453039836208092,-1.1938401697656822,0.15065502183406113,0.3497474351415782,1.0,25/109,14.37%,Ubb;Gnas;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Psma5;Sem1;Psma4;Uba52;Psmd2;Psmc5;Psmd4;Psmd7;Rbx1;Psmb3;Adcy10;P4hb;Psmb1;Psma3;Psmd6;Psme3;Psma1;Psmc4
prerank,Transcriptional Regulation By TP53 R-HSA-3700989,-0.6271360890870429,-1.193747562938562,0.0931422722620266,0.3491931512330836,1.0,62/250,16.14%,Ubb;Rps27a;Ywhag;Jun;Cox6c;Ywhah;Prdx5;Ywhab;Cox8a;Lamtor2;Triap1;Cox5b;Elob;Sesn1;Rraga;Bax;Cox7a2l;Cox4i1;Bnip3l;Polr2f;Cox6b1;Plk2;Cox6a1;Cox7c;Btg2;Cox5a;Rheb;Pml;Uba52;Polr2i;Cycs;Pcna;Lamtor3;Ywhae;Usp2;Rpa3;Ppp2r1a;Cox7b;Cox20;Sco2;Taf10;Csnk2b;Polr2e;Taf11;Polr2c;Polr2g;Ppp2ca;Ywhaq;Rragd;Pip4k2a;Prdx1;Cox14;Brd7;Cdkn1b;Ywhaz;Cdk5r1;Npm1;Rbbp7;Pip4p1;Tcea1;Cox19;Prelid3a
prerank,L1CAM Interactions R-HSA-373760,0.5011992467693205,1.1931295384946232,0.15517241379310345,0.8282411186047511,1.0,18/72,9.57%,Sptbn4;Scn1a;Ank3;Rps6ka2;Nrp1;Lamb1;Sptb;Shtn1;Scn8a;Dnm1;Dnm3;Kcnq2;Mpp3;Rps6ka6;Cntn6;Lamc1;Csnk2a2;Nfasc
prerank,MAPK Family Signaling Cascades R-HSA-5683057,-0.6229479169516378,-1.1921315517768036,0.1026694045174538,0.3523945311123162,1.0,43/213,13.08%,Calm1;Ubb;Nefl;Pebp1;Rps27a;Jun;Psmc3;Rasgrp1;Psmb5;Nrg4;Ywhab;Psma7;Lamtor2;Psmc2;Dusp7;Fgfr2;Psma5;Sem1;Psma4;Uba52;Cdc42;Lamtor3;Pdgfa;Rasal2;Abhd17a;Ppp2r1a;Psmd2;Psmc5;Tek;Psmd4;Mapk6;Psmd7;Irs2;Fgf13;Rbx1;Psmb3;Ppp2ca;Fgfr1;Psmb1;Psma3;Psmd6;Hras;Psme3
prerank,CDC42 GTPase Cycle R-HSA-9013148,0.49891850460301496,1.1920848555917103,0.1643835616438356,0.798264816644472,1.0,16/104,5.97%,Shkbp1;Dock9;Dock11;Trio;Myo9b;Fgd4;Iqgap2;Sh3pxd2a;Fmnl2;Fmnl1;Dock10;Dlc1;Dock7;Srgap2;Itsn1;Abr
prerank,RAB Geranylgeranylation R-HSA-8873719,-0.6801250897530366,-1.1908952391566912,0.23329425556858147,0.3547551540354746,1.0,12/42,14.49%,Rab3a;Rab2a;Rab40b;Rab1b;Rab6b;Rab24;Rab31;Rab11a;Rab22a;Rab14;Rab6a;Rab18
prerank,ER To Golgi Anterograde Transport R-HSA-199977,-0.6420392217133427,-1.1908506873942497,0.1670235546038544,0.35409655041000476,1.0,25/111,15.01%,Cnih2;Dynll2;Dynll1;Trappc6b;Tmed9;Cnih1;Arf4;Bet1l;Capza2;Dctn6;Tmed2;Trappc2;Rab1b;Trappc2l;Dctn3;Trappc1;Lman2;Arf3;Mcfd2;Arfgap2;Actr10;Napg;Sec13;Tmed7;Arf5
prerank,Late SARS-CoV-2 Infection Events R-HSA-9772573,-0.6758931676336635,-1.1893861953857054,0.22505800464037123,0.35703131196772425,1.0,6/48,10.17%,Ubb;Rps27a;Uba52;Ddost;Dad1;Canx
prerank,RHO GTPases Activate WASPs And WAVEs R-HSA-5663213,-0.7047229713232781,-1.1890531103919142,0.22888616891064872,0.3571069781779877,1.0,10/29,13.51%,Actg1;Brk1;Nck1;Arpc5;Cdc42;Wasl;Arpc3;Arpc2;Arpc1a;Actr2
prerank,Factors Involved In Megakaryocyte Development And Platelet Production R-HSA-983231,0.5097224137920064,1.1880921800208224,0.16806722689075632,0.7806678408293598,1.0,17/67,12.56%,Dock9;Dock11;Kif26b;Dock3;Phf21a;Dock10;Dock7;Vps45;Jak2;Hdac1;Dock4;Cables1;Carmil1;Kif3c;Kif1c;Kif1b;Cables2
prerank,Signaling By WNT R-HSA-195721,-0.6278600803893599,-1.1880710692626206,0.12291666666666666,0.3588125538151758,1.0,46/190,14.57%,Calm1;Ubb;Rps27a;Psmc3;Psmb5;Tle5;Psma7;Gnb2;H2az1;Clta;Psmc2;Vps29;Csnk1e;H2bc4;Psma5;Ap2m1;Sem1;Psma4;Uba52;Ppp3ca;Tle4;Gng2;Gng13;Ppp2r1a;Psmd2;Psmc5;Psmd4;Psmd7;Ruvbl1;Gng10;Csnk2b;Rbx1;Psmb3;Ppp2ca;Pfn1;Ppp3r1;Psmb1;Psma3;Psmd6;Psme3;H2aj;Gng3;Psma1;Psmc4;Ppp3cb;Ywhaz
prerank,Organelle Biogenesis And Maintenance R-HSA-1852241,-0.6168170068070126,-1.1845835996710883,0.11740473738414006,0.3671345620064327,1.0,19/214,9.62%,Calm1;Tuba4a;Dynll2;Dynll1;Tuba1a;Ywhag;Atp5pb;Hsp90aa1;Cetn2;Csnk1e;Arf4;Cct2;Cycs;Ywhae;Ppp2r1a;Bbip1;Tubb4b;Tubb4a;Dctn3
prerank,EPH-ephrin Mediated Repulsion Of Cells R-HSA-3928665,-0.6866792665456652,-1.1834073631196278,0.23543990086741015,0.36934170959909474,1.0,6/36,8.39%,Epha5;Epha7;Clta;Psenen;Ap2m1;Aph1a
prerank,Processing Of Capped Intron-Containing Pre-mRNA R-HSA-72203,-0.6196283213855776,-1.1830482835558676,0.1171634121274409,0.3694428383050436,1.0,54/225,16.94%,Ddx5;Tfip11;Hspa8;Snrpg;Sf3b4;Snw1;Snrpf;Polr2f;Snrpd2;Rbm42;Cpsf2;Snrnp27;Wbp11;Polr2i;Magoh;Snu13;Bud31;Lsm2;Rbm8a;Wbp4;Sf3b2;Zcrb1;Zrsr2;Magohb;Pcbp1;Rbm22;Lsm4;Polr2e;Hnrnpa1;Polr2c;Polr2g;Hnrnpa2b1;Txnl4a;Nup37;Lsm7;Puf60;Nup50;Hnrnpf;Snrnp200;Chtop;U2af1l4;Lsm8;Ctnnbl1;Sec13;Syf2;Pdcd7;U2af1;Slbp;Poldip3;Phf5a;Nup107;Ybx1;Seh1l;Snrpe
prerank,Transcriptional Regulation Of Granulopoiesis R-HSA-9616222,-0.7535783808562465,-1.1823537131236521,0.2635761589403974,0.3704768922936097,1.0,7/16,13.76%,H2az1;H2bc4;Dek;Pml;Cdk4;Cebpb;H2aj
prerank,Citric Acid Cycle (TCA Cycle) R-HSA-71403,-0.7379270123275227,-1.1820311628288114,0.25620915032679736,0.3704456865362208,1.0,9/17,18.09%,Mdh2;Idh3b;Ldlr;Sdhd;Fahd1;Idh3a;Suclg1;Sdhb;Idh2
prerank,Deregulated CDK5 Triggers Neurodegenerative Pathways In Alzheimers Disease Models R-HSA-8862803,-0.7499434871410128,-1.1781481941585996,0.25891677675033026,0.3793956531629558,1.0,4/15,14.74%,Jun;Ywhae;Prdx1;Cdk5r1
prerank,Semaphorin Interactions R-HSA-373755,-0.673897426923074,-1.178042992727068,0.22829964328180738,0.37883217426594684,1.0,3/43,3.03%,Hsp90ab1;Myl6;Hsp90aa1
prerank,Chromosome Maintenance R-HSA-73886,-0.6630716796026559,-1.1776545996465213,0.21586931155192532,0.379020469867017,1.0,20/54,17.35%,H2az1;Polr2f;H2bc4;Polr2i;Nop10;Pcna;Gar1;Rpa3;Hjurp;Ruvbl1;Polr2e;Polr2c;Polr2g;H2aj;Dkc1;Nhp2;Npm1;Rbbp7;Terf1;Lrig1
prerank,Oncogene Induced Senescence R-HSA-2559585,-0.7112085728223372,-1.1776429821637673,0.23657289002557544,0.37824168226453825,1.0,4/25,6.60%,Ubb;Rps27a;Ets2;Uba52
prerank,Thrombin Signaling Thru Proteinase Activated Receptors (PARs) R-HSA-456926,-0.7324583636289378,-1.1742127489782275,0.26098191214470284,0.3859646034821796,1.0,7/20,17.95%,Gnb2;Gng2;Gng13;Gng10;Gng3;Gna11;Mapk3
prerank,Defective Pyroptosis R-HSA-9710421,-0.7522246516240394,-1.1734625193861399,0.2777777777777778,0.3870921838577522,1.0,5/15,15.30%,H2az1;H2bc4;Gsdme;H2aj;Rbbp7
prerank,Cooperation Of PDCL (PhLP1) And TRiC/CCT In G-protein Beta Folding R-HSA-6814122,-0.7045628501648252,-1.1727812811276184,0.26438188494492043,0.38792181949641336,1.0,13/27,19.50%,Gnb2;Cct2;Pdcl;Cct6a;Gng2;Gng13;Gng10;Csnk2b;Gng3;Gna11;Cct7;Cct8;Cct5
prerank,Phase 0 - Rapid Depolarisation R-HSA-5576892,-0.7144129251909193,-1.1717274429595792,0.28865979381443296,0.38973742997836924,1.0,1/21,0.04%,Calm1
prerank,Signaling By Receptor Tyrosine Kinases R-HSA-9006934,-0.6074008255629281,-1.1692932400718807,0.1065989847715736,0.3950291464158802,1.0,54/320,12.28%,Calm1;Ubb;Atp6v0c;Apoe;Atp6v1d;Rps27a;Cdk5r2;Atp6v1a;Nrg4;Ywhab;Hsp90aa1;Atp6v1g2;Vegfc;Spry2;Dusp3;Atp6v0e2;Egr1;Clta;Bax;Jund;Brk1;Dusp7;Psenen;Polr2f;Fgfr2;Nck1;Flrt2;Ap2m1;Uba52;Cdc42;Polr2i;Atp6v1f;Cdc37;Gabrg2;Pdgfa;Aph1a;Ppp2r1a;Vegfb;Irs2;Dnal4;Atp6v0b;Polr2e;Hnrnpa1;Fgf13;Itgav;Polr2c;Polr2g;Sparc;Ppp2ca;Ctnna1;Fgfr1;Vgf;Stmn1;Lyn
prerank,TP53 Regulates Transcription Of Cell Death Genes R-HSA-5633008,-0.7411431579571309,-1.1689851856878566,0.2743243243243243,0.3950451997661899,1.0,3/15,4.82%,Triap1;Bax;Bnip3l
prerank,Telomere Maintenance R-HSA-157579,-0.6649789653474415,-1.1663013029792477,0.24882075471698112,0.40096302169121234,1.0,17/46,17.35%,H2az1;Polr2f;H2bc4;Polr2i;Nop10;Pcna;Gar1;Rpa3;Ruvbl1;Polr2e;Polr2c;Polr2g;H2aj;Dkc1;Nhp2;Terf1;Lrig1
prerank,Nuclear Receptor Transcription Pathway R-HSA-383280,0.561113431363248,1.1661912471626144,0.23958333333333334,0.8164715827702497,1.0,9/28,13.17%,Rarb;Nr2f1;Nr3c2;Rora;Nr6a1;Esrrg;Ppard;Thrb;Pparg
prerank,Signaling By Insulin Receptor R-HSA-74752,-0.6591283879847895,-1.1658703050567607,0.23391812865497075,0.4012479710466883,1.0,12/49,12.78%,Atp6v0c;Atp6v1d;Atp6v1a;Atp6v1g2;Atp6v0e2;Fgfr2;Atp6v1f;Irs2;Atp6v0b;Fgf13;Fgfr1;Hras
prerank,Transcriptional Regulation By MECP2 R-HSA-8986944,-0.6583657776116631,-1.1649892063930496,0.2304147465437788,0.40253082063727413,1.0,1/51,0.04%,Calm1
prerank,Signaling By FGFR2 IIIa TM R-HSA-8851708,-0.7264988988662215,-1.163403438980355,0.2691292875989446,0.4058840004148097,1.0,7/18,10.90%,Polr2f;Fgfr2;Polr2i;Polr2e;Fgf13;Polr2c;Polr2g
prerank,GPCR Ligand Binding R-HSA-500792,-0.6342778920675834,-1.1611833152676774,0.21715526601520088,0.41077738964152005,1.0,15/77,10.72%,Plppr4;Glp2r;Gnas;Gnb2;Npy1r;Ramp2;Grm3;P2ry14;P2ry12;Gng2;Npy5r;Gng13;Adra2c;Gng10;Adrb1
prerank,Interleukin-4 And Interleukin-13 Signaling R-HSA-6785807,-0.6781986086996857,-1.1609881548410184,0.25206124852767964,0.4104664176773668,1.0,5/37,5.27%,Cebpd;Hsp90aa1;Hspa8;Ndn;Il18
prerank,Heparan Sulfate/Heparin (HS-GAG) Metabolism R-HSA-1638091,-0.6783125251993606,-1.1609775785111804,0.2749391727493917,0.40964595041318297,1.0,1/34,1.00%,Ndst4
prerank,Class I MHC Mediated Antigen Processing And Presentation R-HSA-983169,-0.6046398414430687,-1.1606471154321807,0.13524590163934427,0.4095967234246199,1.0,47/274,13.32%,Ubb;Hmgb1;Rps27a;Psmc3;Psmb5;Psma7;Calr;Pja1;Psmc2;Elob;Rnf220;Anapc13;Psma5;Ndufa2;Ube3a;Sem1;Psma4;Ube2s;Uba52;Ube2j1;Klhl9;Fbxl16;Pdia3;Rnf6;Asb13;Psmd2;Psmc5;Psmd4;Psmd7;Canx;Asb5;Fbxo32;Itgav;Rbx1;Psmb3;Rnf7;Fbxw2;Sec61g;Anapc11;Fbxo9;Uba1;Psmb1;Psma3;Psmd6;Psme3;Ube2n;Vamp3
prerank,"Unblocking Of NMDA Receptors, Glutamate Binding And Activation R-HSA-438066",-0.7186806770887205,-1.1583932732664228,0.2886334610472541,0.414503523993519,1.0,2/20,0.67%,Calm1;Nefl
prerank,EPH-Ephrin Signaling R-HSA-2682334,-0.6392618148897663,-1.1582064095845421,0.24688561721404303,0.4141874758606635,1.0,18/70,13.51%,Epha5;Myl6;Actg1;Epha7;Clta;Psenen;Ap2m1;Arpc5;Cdc42;Wasl;Aph1a;Myl12b;Arpc3;Arpc2;Arpc1a;Lyn;Hras;Actr2
prerank,G Beta:Gamma Signaling Thru PI3Kgamma R-HSA-392451,-0.7379132151879968,-1.1571493280761156,0.30294906166219837,0.41604916421578936,1.0,5/16,14.05%,Gnb2;Gng2;Gng13;Gng10;Gng3
prerank,ISG15 Antiviral Mechanism R-HSA-1169408,-0.6503633270726489,-1.1505095380981232,0.24398625429553264,0.4323001840624189,1.0,5/55,7.48%,Ubb;Rps27a;Eif4a1;Uba52;Eif4a2
prerank,Signal Amplification R-HSA-392518,-0.7139063125025259,-1.1502185764049746,0.2904040404040404,0.4321707652182914,1.0,9/21,16.97%,Gnb2;P2ry12;Gng2;Gng13;Gng10;Gng3;Gnai2;Gnai1;Gna11
prerank,Transcriptional Regulation By VENTX R-HSA-8853884,0.5548243482530874,1.1498724922389287,0.24064171122994651,0.8349424373899222,1.0,8/32,11.70%,Tnrc6c;Mov10;Cdc27;Ehmt1;Ago4;Ago1;Ehmt2;Anapc5
prerank,Asparagine N-linked Glycosylation R-HSA-446203,-0.6063454301500006,-1.1494612004575273,0.17080745341614906,0.4332066726918207,1.0,42/224,15.35%,Ubb;Cnih2;Dynll2;Dynll1;Rps27a;Trappc6b;Tmed9;Dpm3;Pmm1;Calr;Cnih1;Arf4;Bet1l;Fuca1;Capza2;Dctn6;Uba52;Tmed2;Trappc2;Rab1b;Trappc2l;Pdia3;Ddost;Dad1;Dctn3;Rnf5;Canx;Ubxn1;Trappc1;Lman2;Arf3;Mcfd2;Cmas;Arfgap2;Nanp;Actr10;Napg;Chga;Sec13;Tmed7;Arf5;Dpm2
prerank,DNA Repair R-HSA-73894,-0.6016914090611013,-1.1452630122242764,0.20292887029288703,0.4429168133317928,1.0,34/191,16.39%,Ubb;Rps27a;H2az1;Cetn2;Sumo2;Polr2f;Cops6;H2bc4;Eya1;Sem1;Uba52;Polr2i;Pcna;Hmgn1;Mpg;Alkbh5;Rpa3;Ruvbl1;Ubxn1;Polr2e;Ppp4c;Polr2c;Polr2g;Rbx1;Adprs;Ube2n;Sirt6;H2aj;Parp1;Apex1;Rnf168;Gps1;Tcea1;Terf1
prerank,Deadenylation Of mRNA R-HSA-429947,-0.7003664830394838,-1.1450880462143553,0.29404309252217997,0.44243958000698996,1.0,2/24,7.48%,Eif4a1;Eif4a2
prerank,TP53 Regulates Transcription Of Additional Cell Cycle Genes With Uncertain Roles In P53 Pathway R-HSA-6804115,-0.7245079409595749,-1.144779295330448,0.3253012048192771,0.4423552016489827,1.0,5/15,22.30%,Plk2;Btg2;Npm1;Cnot8;Cnot11
prerank,PTEN Regulation R-HSA-6807070,-0.6164957804514719,-1.1440077589512987,0.23109691160809373,0.44329153960907774,1.0,29/120,13.08%,Ubb;Rps27a;Jun;Psmc3;Psmb5;Psma7;Lamtor2;Egr1;Psmc2;Rraga;Psma5;Sem1;Rheb;Psma4;Pml;Uba52;Lamtor3;Psmd2;Psmc5;Psmd4;Psmd7;Csnk2b;Vapa;Psmb3;Rragd;Psmb1;Psma3;Psmd6;Psme3
prerank,Cholesterol Biosynthesis R-HSA-191273,-0.7012038981968571,-1.1427504601404634,0.31675392670157065,0.44568742857814375,1.0,4/19,7.85%,Sqle;Fdps;Msmo1;Hmgcs1
prerank,Clathrin-mediated Endocytosis R-HSA-8856828,-0.6270062924539764,-1.1408821953335073,0.2513601741022851,0.44953195864352263,1.0,20/101,13.51%,Ubb;Vamp2;Rps27a;Hspa8;Clta;Necap1;Cops6;Ap2m1;Arpc5;Uba52;Wasl;Nedd8;Ldlr;Arpc3;Hip1r;Ubqln2;Arpc2;Arpc1a;Vamp3;Actr2
prerank,Nuclear Events Stimulated By ALK Signaling In Cancer R-HSA-9725371,-0.7209267804043816,-1.1391938412576765,0.3288590604026846,0.45283906782780664,1.0,5/15,17.95%,Rps6;Rbx1;Cebpb;Npm1;Mapk3
prerank,Regulation Of RUNX1 Expression And Activity R-HSA-8934593,0.610356788853823,1.138905479524743,0.29957805907172996,0.8376712670341234,1.0,5/16,10.55%,Tnrc6c;Mov10;Ago4;Ago1;Ccnd2
prerank,G Alpha (I) Signaling Events R-HSA-418594,-0.6188904909434394,-1.1353161393636009,0.24219590958019377,0.46188312213528354,1.0,28/107,16.97%,Calm1;Gnas;Gnb2;Npy1r;Grm3;P2ry14;P2ry12;Rgs4;Ppp1ca;Ppp3ca;Gng2;Npy5r;Gng13;Adra2c;Ppp2r1a;Gng10;Ppp2ca;Ppp3r1;Sstr2;Gng3;Gnai2;Ppp3cb;Pde1c;Gpr37l1;Ppp2r5d;Gnai1;Oprm1;Gna11
prerank,Opioid Signaling R-HSA-111885,-0.6365775227283441,-1.134820397024099,0.28683035714285715,0.4621769904552704,1.0,19/67,17.55%,Calm1;Gnb2;Ppp1ca;Ppp3ca;Gng2;Gng13;Ppp2r1a;Gng10;Ppp2ca;Ppp3r1;Gng3;Gnai2;Ppp3cb;Pde1c;Ppp2r5d;Gnai1;Oprm1;Gna11;Prkar1b
prerank,B-WICH Complex Positively Regulates rRNA Expression R-HSA-5250924,-0.6650772143765501,-1.13246287121729,0.3287671232876712,0.46736033312836495,1.0,7/31,13.76%,H2az1;Polr2f;H2bc4;Dek;Polr1g;Polr2e;H2aj
prerank,PRC2 Methylates Histones And DNA R-HSA-212300,-0.7237111820746163,-1.1312446592229752,0.3575268817204301,0.46944107610468855,1.0,4/15,15.30%,H2az1;H2bc4;H2aj;Rbbp7
prerank,Antiviral Mechanism By IFN-stimulated Genes R-HSA-1169410,-0.6385245725968113,-1.1301598095943395,0.2876712328767123,0.47124564789999523,1.0,5/58,7.48%,Ubb;Rps27a;Eif4a1;Uba52;Eif4a2
prerank,SARS-CoV-2 Activates/Modulates Innate And Adaptive Immune Responses R-HSA-9705671,-0.6229224251247641,-1.1284193027779221,0.2948430493273543,0.4748348849736344,1.0,3/66,4.20%,Hsp90ab1;Hsp90aa1;Cnbp
prerank,Oxidative Stress Induced Senescence R-HSA-2559580,-0.6369515328869253,-1.1263020925323413,0.30296127562642367,0.4794123156816385,1.0,6/56,6.60%,Ubb;Rps27a;Jun;H2az1;H2bc4;Uba52
prerank,HIV Elongation Arrest And Recovery R-HSA-167287,-0.6708585994730331,-1.1262098140151406,0.3354350567465322,0.4786950916075826,1.0,6/27,10.90%,Elob;Polr2f;Polr2i;Polr2e;Polr2c;Polr2g
prerank,Mitotic Prophase R-HSA-68875,-0.6294829749356131,-1.1256276151820022,0.27524972253052166,0.47911096552656035,1.0,20/73,17.95%,Set;Banf1;H2az1;Rab2a;H2bc4;Rab1b;Emd;Ppp2r1a;Ppp2ca;Ensa;Nup37;Nup50;H2aj;Ncaph2;Sec13;Ctdnep1;Nup107;Seh1l;Nup205;Mapk3
prerank,"Gamma Carboxylation, Hypusine Formation And Arylsulfatase Activation R-HSA-163841",-0.672073463916561,-1.1227357574456984,0.3341645885286783,0.48555825976104816,1.0,4/26,15.05%,Dohh;Eef2;Arsj;Dhps
prerank,ADORA2B Mediated Anti-Inflammatory Cytokine Production R-HSA-9660821,-0.6403831777257277,-1.1223326751088532,0.30688448074679114,0.4856359127576052,1.0,14/45,17.55%,Glp2r;Gnas;Gnb2;Ramp2;Gng2;Gng13;Gng10;Adrb1;Gng3;Gnai2;Chga;Gnai1;Ptrh2;Prkar1b
prerank,Cilium Assembly R-HSA-5617833,-0.5923274049221028,-1.1219033532526677,0.27911857292759706,0.4858651642140003,1.0,19/152,11.96%,Tuba4a;Dynll2;Dynll1;Tuba1a;Ywhag;Hsp90aa1;Cetn2;Csnk1e;Arf4;Cct2;Ywhae;Ppp2r1a;Bbip1;Tubb4b;Tubb4a;Dctn3;Tmem216;Rab11a;Dynlrb1
prerank,Pausing And Recovery Of Tat-mediated HIV Elongation R-HSA-167238,-0.6717549500671632,-1.1214646804000743,0.3341772151898734,0.4859564537471657,1.0,6/25,10.90%,Elob;Polr2f;Polr2i;Polr2e;Polr2c;Polr2g
prerank,MAP2K And MAPK Activation R-HSA-5674135,-0.6730508677516629,-1.1199562586073402,0.31746031746031744,0.4887917087833915,1.0,4/27,7.69%,Pebp1;Ywhab;Lamtor2;Lamtor3
prerank,Transport To Golgi And Subsequent Modification R-HSA-948021,-0.6022552497323587,-1.1193569974765147,0.2698072805139186,0.48939000499024476,1.0,27/133,15.01%,Cnih2;Dynll2;Dynll1;Trappc6b;Tmed9;Cnih1;Arf4;Bet1l;Fuca1;Capza2;Dctn6;Tmed2;Trappc2;Rab1b;Trappc2l;Dctn3;Trappc1;Lman2;Arf3;Mcfd2;Arfgap2;Actr10;Napg;Chga;Sec13;Tmed7;Arf5
prerank,Diseases Of Glycosylation R-HSA-3781865,0.503914370871526,1.1186912306108026,0.27450980392156865,0.8696015960975797,1.0,12/76,8.22%,Adamts17;Sema5b;Adamts20;Notch2;Spon1;Adamts18;Adamts3;Hexa;St3gal3;Alg8;Cfp;Gpc3
prerank,TBC/RABGAPs R-HSA-8854214,-0.6437879336726254,-1.1185748891820495,0.33495145631067963,0.490355566360468,1.0,7/36,14.72%,Gabarapl2;Gabarap;Map1lc3b;Rab6b;Rab11a;Rab6a;Tbc1d7
prerank,Extension Of Telomeres R-HSA-180786,-0.659238372731865,-1.1167650747507967,0.3477188655980271,0.4940004528183719,1.0,9/28,17.35%,Nop10;Pcna;Gar1;Rpa3;Ruvbl1;Dkc1;Nhp2;Terf1;Lrig1
prerank,Early SARS-CoV-2 Infection Events R-HSA-9772572,-0.6665765880765934,-1.116014733422128,0.3354350567465322,0.49487111591418037,1.0,7/26,17.62%,Ddx5;Map1lc3b;Zcrb1;Chmp4b;Chmp2a;Gpc1;Chmp7
prerank,Antigen Processing: Ubiquitination And Proteasome Degradation R-HSA-983168,-0.5805666222980077,-1.1157684667951941,0.23541453428863868,0.49457244419033103,1.0,39/239,13.16%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Pja1;Psmc2;Elob;Rnf220;Anapc13;Psma5;Ube3a;Sem1;Psma4;Ube2s;Uba52;Ube2j1;Klhl9;Fbxl16;Rnf6;Asb13;Psmd2;Psmc5;Psmd4;Psmd7;Asb5;Fbxo32;Rbx1;Psmb3;Rnf7;Fbxw2;Anapc11;Fbxo9;Uba1;Psmb1;Psma3;Psmd6;Psme3;Ube2n
prerank,Transcriptional Regulation Of White Adipocyte Differentiation R-HSA-381340,-0.6220066623644348,-1.1134060408054187,0.33141542002301494,0.49964081598654353,1.0,13/55,18.66%,Nr2f2;Cebpd;Med10;Cdk4;Med4;Med19;Med31;Cebpb;Tbl1xr1;Ccnd3;Med22;Tbl1x;Med21
prerank,Integrin Signaling R-HSA-354192,-0.6936077691618918,-1.1092208855184924,0.3767741935483871,0.5091639747166076,1.0,1/15,1.95%,Rasgrp1
prerank,Formation Of beta-catenin:TCF Transactivating Complex R-HSA-201722,-0.6661995977624504,-1.1071954101962531,0.36486486486486486,0.5132093842249301,1.0,5/27,13.76%,H2az1;H2bc4;Tle4;Ruvbl1;H2aj
prerank,Interferon Signaling R-HSA-913531,-0.6046373777837443,-1.1068441455295068,0.29955947136563876,0.5130714558865167,1.0,19/91,17.95%,Ubb;Rps27a;Eif4a1;Egr1;Pml;Uba52;Eif4a2;Ifngr2;Trim35;Nup37;Ube2n;Nup50;Sec13;Nup107;Seh1l;Smad7;Samhd1;Nup205;Mapk3
prerank,Hemostasis R-HSA-109582,-0.5760692146752556,-1.1065419232149933,0.23935091277890466,0.5128120623826632,1.0,42/285,12.28%,Calm1;Ttr;Atp1b1;Tuba4a;Ppia;Tmsb4x;Gnas;Rasgrp1;Gnb2;Timp3;Vegfc;Aplp2;Tspan7;P2ry12;Fam3c;Bsg;Orai2;Manf;Capza2;Cdc42;Atp1b2;Sod1;Pdgfa;Gng2;Hmg20b;Gng13;Angpt2;Adra2c;Ppp2r1a;Tek;Sccpdh;Vegfb;Gng10;Itgav;Sparc;C1qbp;Cd63;Ppp2ca;Pfn1;Cd47;Clu;Lyn
prerank,NRAGE Signals Death Thru JNK R-HSA-193648,0.5141314208642819,1.104572620653675,0.2879581151832461,0.8847812440674068,1.0,11/37,12.08%,Plekhg5;Trio;Fgd4;Kalrn;Itsn1;Abr;Rasgrf2;Sos1;Fgd1;Arhgef17;Arhgef18
prerank,Intra-Golgi And Retrograde Golgi-to-ER Traffic R-HSA-6811442,-0.5894124212322126,-1.1042163911609266,0.3035143769968051,0.5178197443695626,1.0,29/138,16.21%,Dynll2;Dynll1;Tmed9;Arf4;Bet1l;Capza2;Dctn6;Cyth2;Tmed2;Rab1b;Rab6b;Dctn3;Naa38;Stx16;Arf3;Surf4;Vamp3;Rab6a;Arfgap2;Cyth4;Actr10;Rab18;Napg;Tmed7;Arf5;Snap29;Ube2z;Scoc;Pafah1b2
prerank,NOD1/2 Signaling Pathway R-HSA-168638,0.5543185571137683,1.1041917944795503,0.3302325581395349,0.8583737846700172,1.0,4/21,9.93%,Chuk;Mapk14;Map3k7;Ikbkb
prerank,FCGR3A-mediated Phagocytosis R-HSA-9664422,-0.6350397395508885,-1.1036563296311162,0.34988179669030733,0.5182693237904087,1.0,11/42,13.51%,Actg1;Brk1;Nck1;Arpc5;Cdc42;Wasl;Arpc3;Arpc2;Arpc1a;Lyn;Actr2
prerank,Muscle Contraction R-HSA-397014,-0.6040144288114054,-1.1031012519921373,0.31842966194111233,0.5186565484474496,1.0,5/91,3.02%,Calm1;Ttr;Atp1b1;Myl6;Kcnj2
prerank,Deubiquitination R-HSA-5688426,-0.5805485678027695,-1.1027204106405943,0.2761116856256463,0.5185903212701114,1.0,51/187,18.82%,Ubb;Rps27a;Psmc3;Psmb5;Psma7;Psmc2;Vdac1;H2ac25;H2bc4;Psma5;Senp8;Sem1;Psma4;Uba52;Usp2;Adrm1;Kdm1b;Mat2b;Psmd2;Psmc5;Nedd8;Psmd4;Taf10;Psmd7;Ruvbl1;Usp14;Psmb3;Tada2b;Usp22;Psmb1;Psma3;Psmd6;Psme3;Mul1;Otub1;Psma1;Psmc4;Snx3;Psmc6;Tomm20;Ptrh2;Smad7;Ddb2;Smad2;Stam2;Psmc1;Vcpip1;Psmb6;Psmb10;Vdac2;Hcfc1
prerank,Meiosis R-HSA-1500620,-0.6432579477127542,-1.101311146756793,0.3548780487804878,0.5210277168478736,1.0,9/34,16.39%,H2az1;Hspa2;H2bc4;Smc1a;Rpa3;Cdk4;Rad21;H2aj;Terf1
prerank,Glucose Metabolism R-HSA-70326,-0.6172079003312626,-1.1005972026422912,0.34085778781038373,0.5216407255919868,1.0,20/61,18.40%,Mdh2;Aldoc;Pkm;Mdh1;G6pc3;Tpi1;Ppp2r1a;Pgk1;Ppp2ca;Nup37;Eno2;Nup50;Got2;Sec13;Pfkl;Nup107;Ppp2r5d;Seh1l;Nup205;Gnpda1
prerank,Ovarian Tumor Domain Proteases R-HSA-5689896,-0.6706001542673776,-1.099171656365818,0.3645320197044335,0.5242979438271669,1.0,2/25,1.62%,Ubb;Rps27a
prerank,ADP Signaling Thru P2Y Purinoceptor 1 R-HSA-418592,-0.6992853466372975,-1.0986998922469093,0.3898305084745763,0.5243357597636042,1.0,6/15,16.97%,Gnb2;Gng2;Gng13;Gng10;Gng3;Gna11
prerank,MicroRNA (miRNA) Biogenesis R-HSA-203927,-0.6619392465925293,-1.09679167781217,0.36270753512132825,0.528205252052225,1.0,6/23,10.90%,Ran;Polr2f;Polr2i;Polr2e;Polr2c;Polr2g
prerank,Mitochondrial Calcium Ion Transport R-HSA-8949215,-0.6660094064128146,-1.0953024012276318,0.37792207792207794,0.5309529609780644,1.0,2/19,4.38%,Smdt1;Vdac1
prerank,Signaling By NTRK1 (TRKA) R-HSA-187037,-0.5970582263413224,-1.0912951144359053,0.34623893805309736,0.5401783451281936,1.0,22/81,18.37%,Cdk5r2;Ywhab;Dusp3;Egr1;Clta;Jund;Dusp7;Ap2m1;Ppp2r1a;Irs2;Dnal4;Ppp2ca;Vgf;Hras;Mef2c;Cdk5r1;Rala;Ppp2r5d;Pik3r1;Id2;Mapk3;Egr3
prerank,Signaling By High-Kinase Activity BRAF Mutants R-HSA-6802948,-0.6605249315493255,-1.0908994174018494,0.3787128712871287,0.540164386825208,1.0,2/23,2.63%,Pebp1;Ywhab
prerank,HCMV Late Events R-HSA-9610379,-0.6124562911707359,-1.0896496891631913,0.3563892145369285,0.5421979404300886,1.0,17/52,19.52%,Cebpd;H2ac25;H2bc4;Vps28;Chmp4b;Nup37;Nup50;Chmp2a;Sec13;Tsg101;Vps4a;Nup107;Seh1l;Chmp7;Nup205;Ubap1;Hnrnpk
prerank,Intracellular Signaling By Second Messengers R-HSA-9006925,-0.5738281597239181,-1.0877079093550657,0.29411764705882354,0.5458537090020924,1.0,40/226,12.69%,Calm1;Ubb;Rps27a;Jun;Psmc3;Psmb5;Nrg4;Psma7;Lamtor2;Egr1;Psmc2;Rraga;Fgfr2;Psma5;Sem1;Rheb;Psma4;Pml;Uba52;Bad;Lamtor3;Pdgfa;Ppp2r1a;Psmd2;Psmc5;Psmd4;Psmd7;Irs2;Csnk2b;Vapa;Fgf13;Psmb3;Clstn1;Ppp2ca;Fgfr1;Rragd;Psmb1;Psma3;Pip4k2a;Psmd6
prerank,NCAM Signaling For Neurite Out-Growth R-HSA-375165,0.5068560919505583,1.0876381312922114,0.3096774193548387,0.8824108172233093,1.0,4/37,2.83%,Cacna1c;Sptbn4;Cacnb2;Sptb
prerank,Transcriptional Regulation By Small RNAs R-HSA-5578749,-0.6176748221305839,-1.0851909371780517,0.3874709976798144,0.5512511432377191,1.0,15/46,17.78%,Ran;H2az1;Polr2f;H2bc4;Polr2i;Polr2e;Polr2c;Polr2g;Nup37;Nup50;H2aj;Sec13;Nup107;Seh1l;Nup205
prerank,Inhibition Of DNA Recombination At Telomere R-HSA-9670095,-0.6553906748757221,-1.0800714692322844,0.4067357512953368,0.5627427612612196,1.0,9/22,16.39%,H2az1;Polr2f;H2bc4;Polr2i;Polr2e;Polr2c;Polr2g;H2aj;Terf1
prerank,Regulation Of TP53 Activity R-HSA-5633007,-0.5868713538047856,-1.0800431708395342,0.35053763440860214,0.5617596811263452,1.0,17/102,16.58%,Ubb;Rps27a;Pml;Uba52;Usp2;Rpa3;Ppp2r1a;Taf10;Csnk2b;Taf11;Ppp2ca;Pip4k2a;Brd7;Cdk5r1;Rbbp7;Pip4p1;Chd3
prerank,Class I Peroxisomal Membrane Protein Import R-HSA-9603798,-0.678843397119114,-1.078490163950987,0.43333333333333335,0.5646958441502634,1.0,5/18,27.61%,Atad1;Pex11b;Pex19;Fis1;Slc25a17
prerank,Reproduction R-HSA-1474165,-0.6238009446742643,-1.0776342502828058,0.38768115942028986,0.5658318025752286,1.0,9/39,16.39%,H2az1;Hspa2;H2bc4;Smc1a;Rpa3;Cdk4;Rad21;H2aj;Terf1
prerank,RHO GTPases Activate Formins R-HSA-5663220,-0.594207193653475,-1.075159326656704,0.38392857142857145,0.570921599462032,1.0,10/71,12.20%,Dynll2;Pfn2;Dynll1;Actg1;Rps27;Cdc42;Ppp2r1a;Ppp2ca;Pfn1;Nup37
prerank,DNA Damage/Telomere Stress Induced Senescence R-HSA-2559586,-0.6589052764881969,-1.0751428784801533,0.42362002567394097,0.5699248630008648,1.0,6/21,16.39%,H2az1;H2bc4;Asf1a;H2aj;Cdkn1b;Terf1
prerank,PIP3 Activates AKT Signaling R-HSA-1257604,-0.5668772362378808,-1.0748872983603326,0.35640495867768596,0.5695659403208246,1.0,56/194,18.45%,Ubb;Rps27a;Jun;Psmc3;Psmb5;Nrg4;Psma7;Lamtor2;Egr1;Psmc2;Rraga;Fgfr2;Psma5;Sem1;Rheb;Psma4;Pml;Uba52;Bad;Lamtor3;Pdgfa;Ppp2r1a;Psmd2;Psmc5;Psmd4;Psmd7;Irs2;Csnk2b;Vapa;Fgf13;Psmb3;Clstn1;Ppp2ca;Fgfr1;Rragd;Psmb1;Psma3;Pip4k2a;Psmd6;Psme3;Psma1;Psmc4;Cdkn1b;Rbbp7;Stub1;Psmc6;Ppp2r5d;Chd3;Pik3r1;Akt1s1;Pdgfb;Psmc1;Mapk3;Mkrn1;Psmb6;Psmb10
prerank,FOXO-mediated Transcription R-HSA-9614085,-0.6132244603814163,-1.0686544992881768,0.39745075318655854,0.5840790402620903,1.0,10/42,14.57%,Ywhag;Ywhab;Agrp;Cited2;Pink1;Nfyb;Fbxo32;Ywhaq;Cdkn1b;Ywhaz
prerank,Postmitotic Nuclear Pore Complex (NPC) Reformation R-HSA-9615933,-0.6495061201904601,-1.068104187812548,0.4243964421855146,0.584409101235388,1.0,6/23,17.78%,Ran;Nup37;Sec13;Nup107;Seh1l;Nup205
prerank,Regulation Of Beta-Cell Development R-HSA-186712,0.5458859178187481,1.0674595657320258,0.34497816593886466,0.9182367091774206,1.0,4/19,9.72%,Fgf10;Maml2;Akt2;Onecut1
prerank,Platelet Aggregation (Plug Formation) R-HSA-76009,-0.6582874640571723,-1.065572142764301,0.4405684754521964,0.5896476961856917,1.0,2/17,9.04%,Rasgrp1;Adra2c
prerank,Nuclear Events (Kinase And Transcription Factor Activation) R-HSA-198725,-0.620986707178501,-1.0636181825306854,0.4055354993983153,0.5934124954534828,1.0,14/37,18.37%,Cdk5r2;Dusp3;Egr1;Jund;Dusp7;Ppp2r1a;Ppp2ca;Vgf;Mef2c;Cdk5r1;Ppp2r5d;Id2;Mapk3;Egr3
prerank,COPI-dependent Golgi-to-ER Retrograde Traffic R-HSA-6811434,-0.5975992686704955,-1.0633602587572615,0.408675799086758,0.592950394913362,1.0,13/52,18.98%,Tmed9;Arf4;Tmed2;Rab1b;Arf3;Surf4;Arfgap2;Napg;Tmed7;Arf5;Ube2z;Copb2;Copg1
prerank,Resolution Of Sister Chromatid Cohesion R-HSA-2500257,-0.5913926101534358,-1.0600927545648506,0.4072810011376564,0.5995713605815622,1.0,13/60,17.37%,Dynll2;Dynll1;Rps27;Smc1a;Ppp2r1a;Ppp2ca;Nup37;Rad21;Sec13;Nup107;Ppp2r5d;Seh1l;Pafah1b1
prerank,Sialic Acid Metabolism R-HSA-4085001,0.5308286691862949,1.059053933260954,0.32547169811320753,0.917689763305984,1.0,3/23,7.53%,St6galnac3;St6galnac5;St3gal3
prerank,Fatty Acid Metabolism R-HSA-8978868,-0.5812217387968461,-1.0583773277239166,0.412348401323043,0.6027679840007104,1.0,17/88,16.87%,Tecr;Acsl3;Hsd17b8;Mcee;Hpgds;Gpx4;Ptgds;Hacd4;Ptges3;Prxl2b;Dbi;Acot13;Mid1ip1;Thrsp;Acly;Nudt19;Cbr1
prerank,Synthesis Of PC R-HSA-1483191,0.541987225009596,1.0551993320181157,0.3780487804878049,0.9035637349192485,1.0,5/17,14.12%,Slc44a5;Csnk2a2;Chka;Lpin1;Slc44a2
prerank,tRNA Processing In Nucleus R-HSA-6784531,-0.6026097817522756,-1.054538320732507,0.4329411764705882,0.6110492630790993,1.0,12/44,17.78%,Ran;Pop5;Rpp21;Fam98b;Nup37;Nup50;Zbtb8os;Sec13;Nup107;Seh1l;Rtcb;Nup205
prerank,Metal Ion SLC Transporters R-HSA-425410,-0.6592322797534116,-1.053294474915434,0.4556291390728477,0.6130004815046047,1.0,6/17,27.18%,Slc39a3;Slc41a1;Slc30a1;Slc30a6;Slc31a1;Slc39a7
prerank,Processing Of Capped Intronless Pre-mRNA R-HSA-75067,-0.6368872640895683,-1.0523879208001201,0.45226130653266333,0.614082402336394,1.0,3/25,5.72%,Snrpg;Snrpf;Cpsf2
prerank,Telomere Extension By Telomerase R-HSA-171319,-0.6667294698243157,-1.051362626030261,0.448,0.6155850655214968,1.0,6/16,16.39%,Nop10;Gar1;Ruvbl1;Dkc1;Nhp2;Terf1
prerank,Meiotic Synapsis R-HSA-1221632,-0.6343869759696839,-1.0512017289350715,0.4524714828897338,0.6149057326665465,1.0,7/24,16.39%,H2az1;Hspa2;H2bc4;Smc1a;Rad21;H2aj;Terf1
prerank,RNA Polymerase II Transcription Termination R-HSA-73856,-0.5904611370130455,-1.045944424327728,0.44040862656072643,0.6264475012168024,1.0,15/60,21.32%,Snrpg;Snrpf;Cpsf2;Magoh;Rbm8a;Magohb;Chtop;U2af1l4;U2af1;Slbp;Poldip3;Snrpe;Srsf3;Slu7;U2af2
prerank,Chondroitin Sulfate/Dermatan Sulfate Metabolism R-HSA-1793185,0.4901766172077265,1.045910829730264,0.358974358974359,0.9056087747182725,1.0,5/37,10.78%,Chst11;Hexa;Xylt1;Gpc3;Hexb
prerank,Abortive Elongation Of HIV-1 Transcript In Absence Of Tat R-HSA-167242,-0.6483128316306357,-1.0453781966425513,0.4425587467362924,0.62666439167784,1.0,5/19,10.90%,Polr2f;Polr2i;Polr2e;Polr2c;Polr2g
prerank,EGR2 And SOX10-mediated Initiation Of Schwann Cell Myelination R-HSA-9619665,0.5553746360125609,1.041743429650254,0.3815261044176707,0.8939329024050741,1.0,3/16,9.46%,Lamb1;Lamc1;Smarca4
prerank,Cristae Formation R-HSA-8949613,-0.6620310209083686,-1.041519543881531,0.46301369863013697,0.6348814043650004,1.0,7/15,25.31%,Atp5pb;Tmem11;Immt;Samm50;Mtx1;Hspa9;Micos10
prerank,Activation Of GABAB Receptors R-HSA-991365,-0.6236817003137874,-1.0414670072423209,0.46551724137931033,0.6338957967017149,1.0,9/27,14.24%,Kcnj3;Gnb2;Kcnj2;Gng2;Gng13;Gng10;Kcnj4;Gng3;Gnai2
prerank,Intraflagellar Transport R-HSA-5620924,-0.6010506770184313,-1.0414361426558056,0.45280764635603343,0.6328701662451243,1.0,2/35,1.22%,Dynll2;Dynll1
prerank,Peptide Hormone Metabolism R-HSA-2980736,-0.6008437353011967,-1.0382014262156358,0.4444444444444444,0.6395326059467232,1.0,8/40,14.83%,Vamp2;Spcs2;Pla2g7;Gng13;Cpe;Inhba;Atp6ap2;Chga
prerank,Aquaporin-mediated Transport R-HSA-445717,-0.609517725843418,-1.0365899838133465,0.4703748488512696,0.642285132984479,1.0,9/30,14.48%,Gnas;Gnb2;Aqp4;Gng2;Gng13;Gng10;Rab11a;Gng3;Aqp11
prerank,COPI-mediated Anterograde Transport R-HSA-6807878,-0.5785458599425565,-1.033495030043751,0.4459613196814562,0.6485930487599619,1.0,16/67,15.01%,Dynll2;Dynll1;Tmed9;Arf4;Bet1l;Capza2;Dctn6;Tmed2;Rab1b;Dctn3;Arf3;Arfgap2;Actr10;Napg;Tmed7;Arf5
prerank,Unattached Kinetochores Signal Amplification Via A MAD2 Inhibitory Signal R-HSA-141444,-0.5846421216530614,-1.0318828315923025,0.446242774566474,0.6513555881037334,1.0,11/51,17.37%,Dynll2;Dynll1;Rps27;Ppp2r1a;Ppp2ca;Nup37;Sec13;Nup107;Ppp2r5d;Seh1l;Pafah1b1
prerank,Vasopressin Regulates Renal Water Homeostasis Via Aquaporins R-HSA-432040,-0.6068834241343598,-1.0315623652052206,0.4807692307692308,0.6509347283389721,1.0,8/29,14.05%,Gnas;Gnb2;Aqp4;Gng2;Gng13;Gng10;Rab11a;Gng3
prerank,Triglyceride Metabolism R-HSA-8979227,-0.6539851747247267,-1.0310681690531973,0.4783748361730013,0.6509516161651998,1.0,7/17,21.92%,Ppp1ca;Gpd2;Dgat2;Fabp7;Fabp3;Gpam;Ppp1cc
prerank,Activation Of HOX Genes During Differentiation R-HSA-5619507,-0.5926815011083613,-1.0282499637888636,0.47820965842167257,0.6565253123619528,1.0,10/44,15.30%,Jun;H2az1;Polr2f;H2bc4;Polr2i;Polr2e;Polr2c;Polr2g;H2aj;Rbbp7
prerank,GPER1 Signaling R-HSA-9634597,-0.6058422043015235,-1.027656321053107,0.5006090133982948,0.6567525190328044,1.0,9/30,17.55%,Gnas;Gnb2;Gng2;Gng13;Gng10;Gng3;Gnai2;Gnai1;Prkar1b
prerank,Regulation Of Cholesterol Biosynthesis By SREBP (SREBF) R-HSA-1655829,-0.5943523144444843,-1.0268805225126165,0.4727272727272727,0.6574315372076702,1.0,14/43,22.77%,Ran;Sqle;Fdps;Hmgcs1;Nfyb;Tbl1xr1;Insig1;Hmgcr;Tbl1x;Insig2;Lin9;Gpam;Fdft1;Fasn
prerank,Activation Of Gene Expression By SREBF (SREBP) R-HSA-2426168,-0.610617508882107,-1.0266936785140193,0.473551637279597,0.6567304252988774,1.0,11/30,22.77%,Sqle;Fdps;Hmgcs1;Nfyb;Tbl1xr1;Hmgcr;Tbl1x;Lin9;Gpam;Fdft1;Fasn
prerank,MECP2 Regulates Neuronal Receptors And Channels R-HSA-9022699,0.5347276501391838,1.0260790255013859,0.3902439024390244,0.916985265690107,1.0,2/15,8.39%,Grin2a;Hdac1
prerank,Glucagon-like Peptide-1 (GLP1) Regulates Insulin Secretion R-HSA-381676,-0.6117921865435058,-1.02133229710941,0.49572649572649574,0.6682076807396438,1.0,5/30,10.10%,Gnas;Gnb2;Gng2;Gng13;Gng10
prerank,FGFR2 Alternative Splicing R-HSA-6803529,-0.615295033777574,-1.0199597297131104,0.4758269720101781,0.6702287905872006,1.0,7/24,13.73%,Polr2f;Polr2i;Polr2e;Hnrnpa1;Polr2c;Polr2g;Hnrnpf
prerank,Signaling By ALK Fusions And Activated Point Mutants R-HSA-9725370,-0.5779175359563525,-1.0191948905008121,0.48891481913652274,0.6708833963358946,1.0,10/45,17.95%,Rps6;Eef1g;Sqstm1;Rbx1;Atic;Cebpb;Npm1;Pik3r1;Vcl;Mapk3
prerank,Metabolism Of Steroids R-HSA-8957322,-0.561803476394782,-1.019055995145549,0.47197309417040356,0.6700585845402872,1.0,19/78,22.77%,Ran;Sumo2;Sqle;Fdps;Msmo1;Hmgcs1;Nfyb;Fdx2;Tbl1xr1;Chga;Insig1;Hmgcr;Tbl1x;Fdx1;Insig2;Lin9;Gpam;Fdft1;Fasn
prerank,Class A/1 (Rhodopsin-like Receptors) R-HSA-373076,-0.5766343492612765,-1.0159136729915623,0.4833524684270953,0.6759036300340439,1.0,19/46,23.45%,Plppr4;Npy1r;P2ry14;P2ry12;Npy5r;Adra2c;Adrb1;Sstr2;Chga;Gpr37l1;Oprm1;Hebp1;Gpr37;Cx3cl1;Plppr3;Npy;Cxcl12;Lpar1;Plppr5
prerank,SUMO E3 Ligases SUMOylate Target Proteins R-HSA-3108232,-0.5475825156142006,-1.0139497582884873,0.4908108108108108,0.6791855256915046,1.0,20/119,16.88%,Ddx5;Park7;Nfkb2;Cetn2;Sumo2;Pml;Pcna;Smc1a;Nsmce3;Nup37;Rad21;Nup50;Parp1;Nr4a2;Sec13;Npm1;Rnf168;Nup107;Chd3;Seh1l
prerank,Ca2+ Pathway R-HSA-4086398,-0.5877491997266441,-1.013016594983594,0.48201438848920863,0.680013047212257,1.0,6/37,10.10%,Calm1;Gnb2;Ppp3ca;Gng2;Gng13;Gng10
prerank,RNA Polymerase III Chain Elongation R-HSA-73780,-0.6262239315549076,-1.0119762503684393,0.5225464190981433,0.681131115891824,1.0,4/17,12.68%,Polr2f;Polr2e;Polr3h;Polr3d
prerank,Signaling By Rho GTPases R-HSA-194315,-0.5230327941664745,-1.011054549289216,0.4924165824064712,0.6820824214287438,1.0,75/429,17.95%,Calm1;Hsp90ab1;Dynll2;Pfn2;Dynll1;Arhgdia;Myl6;Ywhag;Actg1;Rps27;Ywhah;Ywhab;Hsp90aa1;H2az1;Basp1;Brk1;Tmem59;H2bc4;Nck1;Ckb;Cct2;Arpc5;Emc3;Cdc42;Kctd13;Lrrc1;Cdc37;Wasl;Ywhae;Cct6a;Emd;Rasal2;Myl12b;Ppp2r1a;Gja1;Arpc3;C1qbp;Efhd2;Lin7b;Ppp2ca;Pfn1;Ctnna1;Ywhaq;Arpc2;Nup37;Arpc1a;Jag1;Vamp3;Twf1;Actr2;H2aj;Arfgap2;Hmox2;Cdkn1b;Ywhaz;Sec13;Gps1;Tuba1b;Nup107;Ppp2r5d;Abi1;Pik3r1;Samm50;Seh1l;Hspe1;Arhgef1;Slitrk3;Pafah1b1;Slitrk5;Pgrmc2;Stam2;Lman1;Cct7;Ndufa5;Mapk3
prerank,Glucagon Signaling In Metabolic Regulation R-HSA-163359,-0.6121338971530297,-1.0100816838630475,0.5168961201501877,0.6831583837858832,1.0,5/23,10.10%,Gnas;Gnb2;Gng2;Gng13;Gng10
prerank,"Signaling By Rho GTPases, Miro GTPases And RHOBTB3 R-HSA-9716542",-0.5203712408958383,-1.0070867544848014,0.5035317860746721,0.6887147999556388,1.0,75/442,17.95%,Calm1;Hsp90ab1;Dynll2;Pfn2;Dynll1;Arhgdia;Myl6;Ywhag;Actg1;Rps27;Ywhah;Ywhab;Hsp90aa1;H2az1;Basp1;Brk1;Tmem59;H2bc4;Nck1;Ckb;Cct2;Arpc5;Emc3;Cdc42;Kctd13;Lrrc1;Cdc37;Wasl;Ywhae;Cct6a;Emd;Rasal2;Myl12b;Ppp2r1a;Gja1;Arpc3;C1qbp;Efhd2;Lin7b;Ppp2ca;Pfn1;Ctnna1;Ywhaq;Arpc2;Nup37;Arpc1a;Jag1;Vamp3;Twf1;Actr2;H2aj;Arfgap2;Hmox2;Cdkn1b;Ywhaz;Sec13;Gps1;Tuba1b;Nup107;Ppp2r5d;Abi1;Pik3r1;Samm50;Seh1l;Hspe1;Arhgef1;Slitrk3;Pafah1b1;Slitrk5;Pgrmc2;Stam2;Lman1;Cct7;Ndufa5;Mapk3
prerank,Cellular Senescence R-HSA-2559583,-0.5456844773649905,-1.0056754816126048,0.5076252723311547,0.6906954449767679,1.0,8/99,6.60%,Ubb;Rps27a;Jun;H2az1;Ets2;H2bc4;Ube2s;Uba52
prerank,RAC1 GTPase Cycle R-HSA-9013149,0.42716531079095,1.0049491037086131,0.4375,0.9559547589386714,1.0,26/120,12.11%,Dock9;Dock11;Trio;Cyfip1;Myo9b;Arhgap15;Iqgap2;Dock3;Fmnl1;Dock10;Sh3bp1;Dlc1;Kalrn;Dock7;Srgap2;Abr;Dock4;Lbr;Rasgrf2;Sos1;Pik3r3;Abl2;Dhdds;Prex2;Arhgef18;Arhgap31
prerank,SUMOylation R-HSA-2990846,-0.5381890771061655,-1.002473953881768,0.5139186295503212,0.6968200009502606,1.0,20/125,16.88%,Ddx5;Park7;Nfkb2;Cetn2;Sumo2;Pml;Pcna;Smc1a;Nsmce3;Nup37;Rad21;Nup50;Parp1;Nr4a2;Sec13;Npm1;Rnf168;Nup107;Chd3;Seh1l
prerank,Mitotic Spindle Checkpoint R-HSA-69618,-0.5572625769093769,-1.0013564042478544,0.5124153498871332,0.6982628204057479,1.0,13/66,17.37%,Dynll2;Dynll1;Rps27;Ube2s;Ppp2r1a;Ppp2ca;Anapc11;Nup37;Sec13;Nup107;Ppp2r5d;Seh1l;Pafah1b1
prerank,Interconversion Of Nucleotide Di- And Triphosphates R-HSA-499943,-0.6290614943097244,-1.0011056784113683,0.546916890080429,0.697673223463766,1.0,2/17,3.08%,Dtymk;Nme2
prerank,Potassium Channels R-HSA-1296071,-0.5581031036499994,-0.9936256252996953,0.5242937853107345,0.7132184700437525,1.0,11/57,10.26%,Kcna1;Kcnj3;Gnb2;Kcnj2;Kcnk2;Kcna2;Gng2;Gng13;Kcnk1;Gng10;Kcnj4
prerank,Positive Epigenetic Regulation Of rRNA Expression R-HSA-5250913,-0.5653926584199409,-0.9919884318464811,0.5337995337995338,0.7156139051883453,1.0,11/45,17.94%,H2az1;Polr2f;H2bc4;Dek;Polr1g;Cbx3;Polr2e;H2aj;Rbbp7;Chd3;Taf1c
prerank,RNA Polymerase III Transcription Initiation From Type 3 Promoter R-HSA-76071,-0.5905250322010529,-0.9880214294162186,0.5344180225281602,0.7230794288402267,1.0,5/25,12.68%,Polr2f;Snapc5;Polr2e;Polr3h;Polr3d
prerank,Cardiac Conduction R-HSA-5576891,-0.5515634934576109,-0.9869440468407521,0.5302690582959642,0.7241525659056252,1.0,7/66,7.53%,Calm1;Atp1b1;Kcnj2;Orai2;Kcnk2;Atp1b2;Atp1a3
prerank,Interactions Of Rev With Host Cellular Proteins R-HSA-177243,-0.5810194673178912,-0.9863423411245325,0.5378048780487805,0.7242770635157375,1.0,9/30,17.78%,Ran;Ranbp1;Nup37;Nup50;Sec13;Npm1;Nup107;Seh1l;Nup205
prerank,tRNA Processing R-HSA-72306,-0.5406630362598409,-0.9843793284058651,0.5611672278338945,0.7273067602768567,1.0,15/76,17.78%,Ran;Trmt112;Pop5;Rpp21;Fam98b;Wdr4;Nup37;Nup50;Zbtb8os;Sec13;Nup107;Seh1l;Trdmt1;Rtcb;Nup205
prerank,EML4 And NUDC In Mitotic Spindle Formation R-HSA-9648025,-0.5516049580768106,-0.9817735328622434,0.5341685649202733,0.7318196145056799,1.0,11/55,17.37%,Dynll2;Dynll1;Rps27;Ppp2r1a;Ppp2ca;Nup37;Sec13;Nup107;Ppp2r5d;Seh1l;Pafah1b1
prerank,RNA Polymerase II Pre-transcription Events R-HSA-674695,-0.5447351095929742,-0.9816524723202036,0.5677200902934537,0.7308634403122093,1.0,21/66,24.60%,Elob;Polr2f;Polr2i;Taf10;Polr2e;Taf11;Polr2c;Polr2g;Tcea1;Gtf2b;Taf5;Gtf2h5;Polr2j;Skic8;Ercc3;Ncbp2;Gtf2h4;Polr2b;Polr2l;Rtf1;Eloc
prerank,G Alpha (Z) Signaling Events R-HSA-418597,-0.5804915618171169,-0.9812284346234547,0.5536585365853659,0.7305297181363738,1.0,9/30,14.24%,Gnas;Gnb2;Rgs4;Gng2;Gng13;Adra2c;Gng10;Gng3;Gnai2
prerank,RNA Polymerase I Promoter Escape R-HSA-73772,-0.5707283875440641,-0.9795851202384136,0.5428226779252111,0.7329211697679454,1.0,13/33,23.87%,H2az1;Polr2f;H2bc4;Polr1g;Cbx3;Polr2e;H2aj;Taf1c;Gtf2h5;H2ax;Ercc3;Gtf2h4;Polr2l
prerank,FCERI Mediated MAPK Activation R-HSA-2871796,-0.5997491913043566,-0.9781040649485734,0.5662337662337662,0.7349168974226145,1.0,3/20,12.78%,Jun;Lyn;Hras
prerank,Neurotransmitter Receptors And Postsynaptic Signal Transmission R-HSA-112314,-0.5223712235968497,-0.977138172415126,0.5635593220338984,0.7357500208242087,1.0,7/127,3.02%,Nrgn;Calm1;Nefl;Kcnj3;Lin7c;Gnb2;Kcnj2
prerank,Regulation Of PTEN Gene Transcription R-HSA-8943724,-0.5599568239018525,-0.976390507249029,0.560233918128655,0.7360875608496436,1.0,6/49,7.69%,Jun;Lamtor2;Egr1;Rraga;Rheb;Lamtor3
prerank,HDACs Deacetylate Histones R-HSA-3214815,-0.5851885745442371,-0.9758703238327835,0.5621156211562116,0.7360328633017882,1.0,9/30,17.69%,H2ac25;H2bc4;Sap18;Gps2;Hmg20b;Tbl1xr1;Rbbp7;Chd3;Tbl1x
prerank,TP53 Regulates Transcription Of DNA Repair Genes R-HSA-6796648,-0.5535987084614714,-0.9737317840085428,0.5670945157526255,0.7393971468545838,1.0,7/47,10.90%,Jun;Elob;Polr2f;Polr2i;Polr2e;Polr2c;Polr2g
prerank,Transcription Of HIV Genome R-HSA-167172,-0.5490674200262617,-0.9729401622881135,0.565864833906071,0.7398751393611569,1.0,19/57,24.60%,Elob;Polr2f;Polr2i;Taf10;Polr2e;Taf11;Polr2c;Polr2g;Tcea1;Gtf2b;Taf5;Gtf2h5;Polr2j;Ercc3;Ncbp2;Gtf2h4;Polr2b;Polr2l;Eloc
prerank,Transmission Across Chemical Synapses R-HSA-112315,-0.5104269005348827,-0.9719113441258456,0.5960539979231568,0.7408199726224112,1.0,13/175,5.70%,Nrgn;Calm1;Nefl;Rab3a;Kcnj3;Vamp2;Lin7c;Gnb2;Kcnj2;Hspa8;Tspan7;Arl6ip5;Ap2m1
prerank,Formation Of RNA Pol II Elongation Complex R-HSA-112382,-0.545776086941139,-0.9717962749024653,0.5672514619883041,0.7398682409546781,1.0,17/50,24.60%,Elob;Polr2f;Polr2i;Polr2e;Polr2c;Polr2g;Tcea1;Gtf2h5;Polr2j;Skic8;Ercc3;Ncbp2;Gtf2h4;Polr2b;Polr2l;Rtf1;Eloc
prerank,Energy Dependent Regulation Of mTOR By LKB1-AMPK R-HSA-380972,-0.5795038163262234,-0.9703392387604138,0.5568039950062422,0.7416489478107325,1.0,5/27,12.27%,Lamtor2;Rraga;Rheb;Lamtor3;Rragd
prerank,Unfolded Protein Response (UPR) R-HSA-381119,-0.5386756527063158,-0.9692185590838287,0.5754189944134078,0.7427106143325428,1.0,13/66,19.39%,Calr;Dnajb9;Pdia6;Exosc3;Nfyb;Exosc4;Eif2s2;Mydgf;Cebpb;Srprb;Hdgf;Cxxc1;Tln1
prerank,Deadenylation-dependent mRNA Decay R-HSA-429914,-0.551698159009356,-0.9668833027525217,0.5691244239631337,0.7463246887508245,1.0,13/52,23.20%,Eif4a1;Lsm2;Eif4a2;Exosc3;Lsm4;Exosc4;Lsm7;Cnot8;Pabpc1;Lsm1;Skic8;Cnot11;Exosc9
prerank,Formation Of HIV-1 Elongation Complex Containing HIV-1 Tat R-HSA-167200,-0.5564857996650132,-0.9656189841256756,0.5531914893617021,0.7476913341734669,1.0,15/37,24.60%,Elob;Polr2f;Polr2i;Polr2e;Polr2c;Polr2g;Tcea1;Gtf2h5;Polr2j;Ercc3;Ncbp2;Gtf2h4;Polr2b;Polr2l;Eloc
prerank,Retrograde Transport At Trans-Golgi-Network R-HSA-6811440,-0.5607819160258101,-0.964796952929624,0.5688405797101449,0.7480700660731991,1.0,11/40,23.17%,Rab6b;Naa38;Stx16;Vamp3;Rab6a;Napg;Scoc;Arfrp1;Tmf1;Vps52;Sys1
prerank,Rev-mediated Nuclear Export Of HIV RNA R-HSA-165054,-0.5711067674692375,-0.9646059395056731,0.5618115055079559,0.7472167872047211,1.0,8/28,17.78%,Ran;Ranbp1;Nup37;Nup50;Sec13;Nup107;Seh1l;Nup205
prerank,Formation Of HIV Elongation Complex In Absence Of HIV Tat R-HSA-167152,-0.555711480822931,-0.9642467015412173,0.569047619047619,0.7467868880393183,1.0,15/39,24.60%,Elob;Polr2f;Polr2i;Polr2e;Polr2c;Polr2g;Tcea1;Gtf2h5;Polr2j;Ercc3;Ncbp2;Gtf2h4;Polr2b;Polr2l;Eloc
prerank,Metabolism Of Nucleotides R-HSA-15869,-0.539911692945254,-0.9632025660368372,0.5809414466130884,0.7476805875076226,1.0,13/57,17.61%,Dtymk;Nme2;Paics;Aprt;Sco2;Uckl1;Itpa;Tk2;Atic;Nudt18;Dut;Impdh2;Samhd1
prerank,Glycolysis R-HSA-70171,-0.5451874846628885,-0.9602117078220647,0.566320645905421,0.7526302695979725,1.0,16/52,18.40%,Aldoc;Pkm;Tpi1;Ppp2r1a;Pgk1;Ppp2ca;Nup37;Eno2;Nup50;Sec13;Pfkl;Nup107;Ppp2r5d;Seh1l;Nup205;Gnpda1
prerank,Interferon Alpha/Beta Signaling R-HSA-909733,-0.6067623042855305,-0.9594123765532314,0.5904887714663144,0.7530532547339698,1.0,3/17,19.92%,Egr1;Samhd1;Irf3
prerank,Nuclear Import Of Rev Protein R-HSA-180746,-0.5697310615097211,-0.9564836963291543,0.5796019900497512,0.7577519829095293,1.0,8/27,17.78%,Ran;Nup37;Nup50;Sec13;Npm1;Nup107;Seh1l;Nup205
prerank,HIV Transcription Initiation R-HSA-167161,-0.5537169601854298,-0.9550702961980936,0.5844155844155844,0.7592651837395221,1.0,15/40,23.87%,Polr2f;Polr2i;Taf10;Polr2e;Taf11;Polr2c;Polr2g;Gtf2b;Taf5;Gtf2h5;Polr2j;Ercc3;Gtf2h4;Polr2b;Polr2l
prerank,Telomere C-strand (Lagging Strand) Synthesis R-HSA-174417,-0.5896647698398887,-0.9518823455989935,0.5894308943089431,0.7641951465349074,1.0,4/16,17.35%,Pcna;Rpa3;Terf1;Lrig1
prerank,Mitochondrial Fatty Acid Beta-Oxidation R-HSA-77289,-0.5880696956715245,-0.9433991930433708,0.6036505867014341,0.7793919708091833,1.0,3/19,14.87%,Mcee;Dbi;Acot13
prerank,Signaling By ERBB2 TMD/JMD Mutants R-HSA-9665686,-0.6012118274103544,-0.9427306163996018,0.6258503401360545,0.7794647928907122,1.0,4/15,12.78%,Nrg4;Hsp90aa1;Cdc37;Hras
prerank,Chromatin Modifying Enzymes R-HSA-3247509,-0.49945543474818765,-0.9425303671806948,0.641213389121339,0.77862956973016,1.0,19/183,14.27%,Rps2;Nfkb2;H2az1;Morf4l1;H2ac25;H2bc4;Sap18;Morf4l2;Gps2;Hmg20b;Kdm1b;Cdk4;Taf10;Ruvbl1;Tada2b;Usp22;Mrgbp;H2aj;Tbl1xr1
prerank,Signaling By WNT In Cancer R-HSA-4791275,-0.5715864734576329,-0.942057475882536,0.5805194805194805,0.7783476806269527,1.0,6/21,23.90%,Ppp2r1a;Ppp2ca;Ppp2r5d;Kremen1;Gsk3b;Ppp2r5a
prerank,NEP/NS2 Interacts With Cellular Export Machinery R-HSA-168333,-0.5554461108306662,-0.9416446454131282,0.5956416464891041,0.7766768948014714,1.0,7/29,17.78%,Ran;Nup37;Nup50;Sec13;Nup107;Seh1l;Nup205
prerank,Export Of Viral Ribonucleoproteins From Nucleus R-HSA-168274,-0.5554461108306662,-0.9416446454131282,0.5956416464891041,0.7766768948014714,1.0,7/29,17.78%,Ran;Nup37;Nup50;Sec13;Nup107;Seh1l;Nup205
prerank,Carboxyterminal Post-Translational Modifications Of Tubulin R-HSA-8955332,-0.5653089176478374,-0.9411948792524828,0.5913154533844189,0.7762922557920382,1.0,6/24,9.95%,Tubb2a;Tuba1a;Tubb2b;Tubb4b;Tubb4a;Tpgs1
prerank,Arachidonic Acid Metabolism R-HSA-2142753,-0.5867636321346752,-0.9409159303121238,0.60546875,0.7756607616680248,1.0,5/17,11.44%,Hpgds;Gpx4;Ptgds;Ptges3;Prxl2b
prerank,Synthesis Of PIPs At Early Endosome Membrane R-HSA-1660516,0.5016795152640797,0.9353966689935829,0.5274725274725275,1.0,1.0,2/15,8.83%,Mtmr12;Pikfyve
prerank,Insulin Processing R-HSA-264876,-0.565559602454351,-0.9316645181412139,0.6075471698113207,0.7921233780328875,1.0,2/23,9.10%,Vamp2;Cpe
prerank,RHOA GTPase Cycle R-HSA-8980692,0.3942994489090814,0.9297463490054177,0.5421686746987951,1.0,1.0,19/101,12.11%,Tjp2;Plekhg5;Trio;Myo9b;Arhgef28;Stk10;Dlc1;Myo9a;Kalrn;Rock1;Abr;Arhgap18;Lbr;Rasgrf2;Dhdds;Prex2;Arhgef17;Arhgef18;Arhgap31
prerank,Negative Epigenetic Regulation Of rRNA Expression R-HSA-5250941,-0.5310818478725632,-0.9279739538634405,0.6311475409836066,0.7978153511525905,1.0,7/46,10.33%,H2az1;Polr2f;H2bc4;Sap18;Polr1g;Sin3b;Polr2e
prerank,NoRC Negatively Regulates rRNA Expression R-HSA-427413,-0.531232603635508,-0.9269599672050267,0.6311475409836066,0.7984531568754074,1.0,7/45,10.33%,H2az1;Polr2f;H2bc4;Sap18;Polr1g;Sin3b;Polr2e
prerank,EPHB-mediated Forward Signaling R-HSA-3928662,-0.5584052000673168,-0.9266976491070407,0.6134347275031685,0.7976656024734115,1.0,10/29,13.51%,Actg1;Arpc5;Cdc42;Wasl;Arpc3;Arpc2;Arpc1a;Lyn;Hras;Actr2
prerank,ERCC6 (CSB) And EHMT2 (G9a) Positively Regulate rRNA Expression R-HSA-427389,-0.5742569735416382,-0.9247427970314434,0.594147582697201,0.8000042332920886,1.0,6/20,16.58%,H2az1;H2bc4;Cbx3;H2aj;Rbbp7;Chd3
prerank,Degradation Of Extracellular Matrix R-HSA-1474228,0.43074009898792087,0.9227191167931137,0.5370370370370371,1.0,1.0,6/41,9.65%,Col23a1;Lamb1;Col19a1;Adamts18;Lamc1;Erc2
prerank,"Antigen Presentation: Folding, Assembly, Peptide Loading Of Class I MHC R-HSA-983170",-0.5722947896356759,-0.9211478952094905,0.6276595744680851,0.8055619507868309,1.0,4/18,14.89%,Calr;Pdia3;Canx;Sec13
prerank,Assembly And Cell Surface Presentation Of NMDA Receptors R-HSA-9609736,-0.559939717903079,-0.9173754834738163,0.6452830188679245,0.8111155794994377,1.0,2/23,2.09%,Nefl;Lin7c
prerank,Rab Regulation Of Trafficking R-HSA-9007101,-0.4958710377115283,-0.9170738517025678,0.6629834254143646,0.8104422346816496,1.0,17/95,14.72%,Rab3a;Trappc6b;Gabarapl2;Gabarap;Map1lc3b;Trappc2;Ywhae;Rab1b;Trappc2l;Rab6b;Rab31;Rab11a;Trappc1;Rab14;Rab6a;Rab18;Tbc1d7
prerank,GABA Receptor Activation R-HSA-977443,-0.5333773716890671,-0.9159323002083782,0.6369119420989143,0.8111680797639271,1.0,8/38,10.26%,Kcnj3;Gnb2;Kcnj2;Gabrg2;Gng2;Gng13;Gng10;Kcnj4
prerank,Signaling By ERBB2 In Cancer R-HSA-1227990,-0.57402655905389,-0.9118426677387147,0.6476063829787234,0.8172269754305045,1.0,6/19,18.83%,Nrg4;Hsp90aa1;Cdc37;Hras;Pik3r1;Erbin
prerank,Signaling By ERBB2 KD Mutants R-HSA-9664565,-0.5746593680932788,-0.9116819028247858,0.6464237516869096,0.8162366172398067,1.0,6/18,18.83%,Nrg4;Hsp90aa1;Cdc37;Hras;Pik3r1;Erbin
prerank,RNA Pol II CTD Phosphorylation And Interaction With CE R-HSA-77075,-0.5496094342395316,-0.9116028796707654,0.6386449184441656,0.8150842978140936,1.0,11/26,23.87%,Polr2f;Polr2i;Polr2e;Polr2c;Polr2g;Gtf2h5;Polr2j;Ercc3;Gtf2h4;Polr2b;Polr2l
prerank,NCAM1 Interactions R-HSA-419037,0.463436774956206,0.9111558395347232,0.5819672131147541,1.0,1.0,2/19,2.58%,Cacna1c;Cacnb2
prerank,Defective Homologous Recombination Repair (HRR) Due To BRCA2 Loss Of Function R-HSA-9701190,-0.572985029725199,-0.9093013593699242,0.6604774535809018,0.815276526113993,1.0,2/16,8.11%,Sem1;Rpa3
prerank,Homologous DNA Pairing And Strand Exchange R-HSA-5693579,-0.572985029725199,-0.9093013593699242,0.6604774535809018,0.815276526113993,1.0,2/16,8.11%,Sem1;Rpa3
prerank,Presynaptic Phase Of Homologous DNA Pairing And Strand Exchange R-HSA-5693616,-0.572985029725199,-0.9093013593699242,0.6604774535809018,0.815276526113993,1.0,2/16,8.11%,Sem1;Rpa3
prerank,Diseases Of Metabolism R-HSA-5668914,-0.4871222220772293,-0.9079109330985274,0.6972972972972973,0.8165105346551503,1.0,4/121,2.69%,Ubb;Prnp;Rps27a;Dpm3
prerank,MAPK Targets/ Nuclear Events Mediated By MAP Kinases R-HSA-450282,-0.5497219847023803,-0.9067274741931493,0.6376089663760897,0.8173155461184,1.0,8/23,17.95%,Jun;Dusp3;Dusp7;Ppp2r1a;Ppp2ca;Mef2c;Ppp2r5d;Mapk3
prerank,Nucleotide Salvage R-HSA-8956321,-0.5677090887879473,-0.9054655243480468,0.6317934782608695,0.8182502032378203,1.0,4/15,11.22%,Aprt;Sco2;Uckl1;Tk2
prerank,Signaling By GPCR R-HSA-372790,-0.47316816300536196,-0.9051747628417224,0.7264344262295082,0.8174816252198293,1.0,20/233,9.20%,Calm1;Plppr4;Glp2r;Gnas;Rasgrp1;Gnb2;Npy1r;Ramp2;Grm3;P2ry14;P2ry12;Rgs4;Ppp1ca;Cdc42;Ppp3ca;Gng2;Npy5r;Gng13;Adra2c;Ppp2r1a
prerank,mRNA 3-End Processing R-HSA-72187,-0.5135826352528985,-0.9050137897010846,0.6567505720823799,0.8164733630098536,1.0,16/54,27.38%,Cpsf2;Magoh;Rbm8a;Magohb;Chtop;U2af1l4;U2af1;Poldip3;Srsf3;Slu7;U2af2;Ncbp2;Cstf1;Ddx39b;Thoc7;Cdc40
prerank,Impaired BRCA2 Binding To RAD51 R-HSA-9709570,-0.5740495410947379,-0.903502260460987,0.6569148936170213,0.817919603991388,1.0,2/15,8.11%,Sem1;Rpa3
prerank,IRE1alpha Activates Chaperones R-HSA-381070,-0.5148070970157875,-0.9034323974545685,0.6425233644859814,0.8168103537415243,1.0,15/39,31.75%,Dnajb9;Pdia6;Mydgf;Srprb;Hdgf;Cxxc1;Tln1;Ssr1;Edem1;Dnajb11;Tspyl2;Lmna;Fkbp14;Ppp2r5b;Extl2
prerank,XBP1(S) Activates Chaperone Genes R-HSA-381038,-0.5184067327632024,-0.9016845087364617,0.6374407582938388,0.8186073037889311,1.0,15/37,31.75%,Dnajb9;Pdia6;Mydgf;Srprb;Hdgf;Cxxc1;Tln1;Ssr1;Edem1;Dnajb11;Tspyl2;Lmna;Fkbp14;Ppp2r5b;Extl2
prerank,RHOC GTPase Cycle R-HSA-9013106,0.41006659602876333,0.9008007275057894,0.5035971223021583,1.0,1.0,10/54,8.89%,Tjp2;Myo9b;Arhgef28;Stk10;Fmnl2;Dlc1;Rock1;Abr;Arhgap18;Lbr
prerank,Gene Silencing By RNA R-HSA-211000,-0.49839780750383866,-0.8971848739456317,0.6605504587155964,0.8251594542508263,1.0,16/61,17.78%,Ran;Hsp90aa1;H2az1;Polr2f;H2bc4;Polr2i;Polr2e;Polr2c;Polr2g;Nup37;Nup50;H2aj;Sec13;Nup107;Seh1l;Nup205
prerank,RHOD GTPase Cycle R-HSA-9013405,-0.5141780516963574,-0.8967593212164694,0.6555423122765197,0.8246569684511713,1.0,6/39,17.72%,Emd;Efhd2;Vamp3;Pik3r1;Pgrmc2;Lman1
prerank,NR1H3 And NR1H2 Regulate Gene Expression Linked To Cholesterol Transport And Efflux R-HSA-9029569,-0.5314547338146663,-0.896074969160556,0.6550435865504358,0.8245182227802429,1.0,3/26,8.96%,Apoe;Gps2;Kdm1b
prerank,CTLA4 Inhibitory Signaling R-HSA-389513,-0.5619076708140892,-0.8942676334498464,0.6635761589403973,0.8263298645382446,1.0,6/17,23.90%,Ppp2r1a;Ppp2ca;Lyn;Ppp2r5d;Akt1;Ppp2r5a
prerank,Adherens Junctions Interactions R-HSA-418990,-0.550891712026918,-0.893638902993793,0.6833976833976834,0.8261597104921174,1.0,3/19,11.66%,Cadm2;Cdh18;Ctnna1
prerank,Sensory Processing Of Sound R-HSA-9659379,-0.5156583344749797,-0.8935739815827046,0.6642599277978339,0.8250091337338877,1.0,3/35,6.23%,Rab3a;Vamp2;Capza2
prerank,BBSome-mediated Cargo-Targeting To Cilium R-HSA-5620922,-0.5516386996264475,-0.8930192373874085,0.6531413612565445,0.8247279956719836,1.0,6/19,21.40%,Cct2;Bbip1;Bbs2;Cct8;Cct5;Smox
prerank,mRNA Capping R-HSA-72086,-0.5339962662317472,-0.8917626320136842,0.6629491945477075,0.8255454883003148,1.0,12/28,23.87%,Polr2f;Polr2i;Polr2e;Polr2c;Polr2g;Gtf2h5;Polr2j;Ercc3;Ncbp2;Gtf2h4;Polr2b;Polr2l
prerank,NR1H2 And NR1H3-mediated Signaling R-HSA-9024446,-0.5209703249707682,-0.8889230278303685,0.6670761670761671,0.8291234093312605,1.0,3/29,8.96%,Apoe;Gps2;Kdm1b
prerank,Sensory Processing Of Sound By Inner Hair Cells Of Cochlea R-HSA-9662360,-0.5169845971766629,-0.8845116748459045,0.682716049382716,0.8352022338045263,1.0,3/33,6.23%,Rab3a;Vamp2;Capza2
prerank,Extracellular Matrix Organization R-HSA-1474244,-0.4743352089802151,-0.8832336644458194,0.698051948051948,0.83601951161388,1.0,12/107,12.28%,Ttr;Icam5;Bsg;Plod2;Pdgfa;Ppib;Ctsb;Fgf13;Itgav;Sparc;Cd47;P4hb
prerank,Formation Of Early Elongation Complex R-HSA-113418,-0.5245932571492439,-0.882241523073065,0.6793145654834761,0.8362887487666714,1.0,12/29,23.87%,Polr2f;Polr2i;Polr2e;Polr2c;Polr2g;Gtf2h5;Polr2j;Ercc3;Ncbp2;Gtf2h4;Polr2b;Polr2l
prerank,GPCR Downstream Signaling R-HSA-388396,-0.46245112714603487,-0.8821672832639866,0.7633744855967078,0.835152718503641,1.0,19/218,9.20%,Calm1;Glp2r;Gnas;Rasgrp1;Gnb2;Npy1r;Ramp2;Grm3;P2ry14;P2ry12;Rgs4;Ppp1ca;Cdc42;Ppp3ca;Gng2;Npy5r;Gng13;Adra2c;Ppp2r1a
prerank,Metabolism Of Non-Coding RNA R-HSA-194441,-0.5025217729663122,-0.8820872488594458,0.6858823529411765,0.8340393641159113,1.0,12/44,17.78%,Snrpg;Snrpf;Snrpd2;Ddx20;Nup37;Gemin7;Nup50;Sec13;Nup107;Seh1l;Snrpe;Nup205
prerank,HATs Acetylate Histones R-HSA-3214847,-0.48326219428771283,-0.876825801643162,0.7247191011235955,0.8412938978411493,1.0,14/72,20.91%,Morf4l1;H2ac25;H2bc4;Morf4l2;Taf10;Ruvbl1;Tada2b;Usp22;Mrgbp;Rbbp7;Hcfc1;Phf20;Eny2;Tada3
prerank,Viral Messenger RNA Synthesis R-HSA-168325,-0.4991165280334888,-0.8746253947990752,0.6901408450704225,0.843519617187338,1.0,12/41,19.71%,Polr2f;Polr2i;Polr2e;Polr2c;Polr2g;Nup37;Nup50;Sec13;Nup107;Seh1l;Nup205;Polr2j
prerank,RNA Polymerase I Promoter Clearance R-HSA-73854,-0.4944849954402748,-0.874260073987729,0.7018348623853211,0.8415714632541169,1.0,12/50,18.32%,H2az1;Polr2f;H2bc4;Polr1g;Cbx3;Polr2e;H2aj;Rbbp7;Chd3;Taf1c;Mapk3;Gtf2h5
prerank,RNA Polymerase I Transcription R-HSA-73864,-0.4944849954402748,-0.874260073987729,0.7018348623853211,0.8415714632541169,1.0,12/50,18.32%,H2az1;Polr2f;H2bc4;Polr1g;Cbx3;Polr2e;H2aj;Rbbp7;Chd3;Taf1c;Mapk3;Gtf2h5
prerank,Peptide Ligand-Binding Receptors R-HSA-375276,-0.5277117145023423,-0.8740398370620239,0.707286432160804,0.8406288271223652,1.0,10/25,22.56%,Npy1r;Npy5r;Sstr2;Gpr37l1;Oprm1;Hebp1;Gpr37;Cx3cl1;Npy;Cxcl12
prerank,Activated TAK1 Mediates P38 MAPK Activation R-HSA-450302,0.4694751858176459,0.869695518843756,0.6228813559322034,1.0,1.0,3/15,8.33%,Mapk14;Mapkapk2;Map3k7
prerank,RND1 GTPase Cycle R-HSA-9696273,0.4105975026242662,0.8687396111628501,0.6453488372093024,1.0,1.0,5/30,9.15%,Plekhg5;Dst;Dlg5;Pkp4;Ccdc88a
prerank,Aberrant Regulation Of Mitotic Cell Cycle Due To RB1 Defects R-HSA-9687139,-0.5164531124904863,-0.8650394485983982,0.7053789731051344,0.8534993654080557,1.0,5/28,14.58%,Ube2s;Cdk4;Anapc11;Cdkn1b;Ccnd3
prerank,PERK Regulates Gene Expression R-HSA-381042,-0.5330013645657263,-0.8643198672471779,0.6901408450704225,0.8534197991935596,1.0,5/23,13.38%,Exosc3;Nfyb;Exosc4;Eif2s2;Cebpb
prerank,Costimulation By CD28 Family R-HSA-388841,-0.5126035718408083,-0.8638858088177603,0.7128953771289538,0.852823627156841,1.0,6/33,16.68%,Cdc42;Ppp2r1a;Ppp2ca;Lyn;Ppp2r5d;Pik3r1
prerank,RNA Polymerase III Transcription Termination R-HSA-73980,-0.5284465753620051,-0.8637376930858233,0.7183833116036505,0.8518350470816366,1.0,4/21,12.68%,Polr2f;Polr2e;Polr3h;Polr3d
prerank,Epigenetic Regulation Of Gene Expression R-HSA-212165,-0.4747973405072518,-0.8632949808105617,0.7216035634743875,0.851238253258593,1.0,14/78,18.32%,H2az1;Polr2f;H2bc4;Sap18;Dek;Polr1g;Sin3b;Cbx3;Polr2e;H2aj;Rbbp7;Chd3;Taf1c;Gtf2h5
prerank,Transport Of Mature Transcript To Cytoplasm R-HSA-72202,-0.4759066015621397,-0.8597002563947459,0.7342192691029901,0.8553735743627269,1.0,18/73,21.32%,Cpsf2;Magoh;Rbm8a;Magohb;Nup37;Nup50;Chtop;U2af1l4;Sec13;U2af1;Slbp;Poldip3;Nup107;Seh1l;Nup205;Srsf3;Slu7;U2af2
prerank,Voltage Gated Potassium Channels R-HSA-1296072,-0.5123446539814184,-0.8544263833391825,0.7133995037220844,0.8622153051630189,1.0,2/27,7.84%,Kcna1;Kcna2
prerank,FGFR2 Mutant Receptor Activation R-HSA-1839126,-0.5208954066521888,-0.8539983997026466,0.7179161372299873,0.8616011020980543,1.0,7/21,10.90%,Polr2f;Fgfr2;Polr2i;Polr2e;Fgf13;Polr2c;Polr2g
prerank,Vpr-mediated Nuclear Import Of PICs R-HSA-180910,-0.5052646280415142,-0.8539866251564848,0.7127139364303179,0.8603413036491282,1.0,8/28,17.78%,Banf1;Psip1;Nup37;Nup50;Sec13;Nup107;Seh1l;Nup205
prerank,RNA Polymerase III Transcription Initiation R-HSA-76046,-0.49295787148494835,-0.8482629105236656,0.7158273381294964,0.8677119211827136,1.0,5/32,12.68%,Polr2f;Snapc5;Polr2e;Polr3h;Polr3d
prerank,RHOH GTPase Cycle R-HSA-9013407,-0.5187302282931816,-0.8481194587288704,0.7333333333333333,0.8666708874874719,1.0,2/22,4.94%,Arhgdia;Tmem59
prerank,Disassembly Of Destruction Complex And Recruitment Of AXIN To Membrane R-HSA-4641262,-0.530733736165435,-0.8463177105533486,0.7080581241743725,0.8679795926344828,1.0,9/18,33.21%,Ppp2r1a;Ppp2ca;Ppp2r5d;Gsk3b;Ppp2r5a;Csnk1g2;Ppp2r5b;Csnk1a1;Ppp2r1b
prerank,Cell Junction Organization R-HSA-446728,0.3912945382901106,0.8418845533139292,0.6842105263157895,1.0,1.0,7/44,8.94%,Sdk2;Dst;Cdh12;Nectin1;Flna;Parvb;Patj
prerank,SUMOylation Of DNA Replication Proteins R-HSA-4615885,-0.4906216526273636,-0.8408009593687323,0.7172330097087378,0.8748598103865866,1.0,8/32,17.78%,Sumo2;Pcna;Nup37;Nup50;Sec13;Nup107;Seh1l;Nup205
prerank,Signaling To ERKs R-HSA-187687,-0.5054729092492971,-0.8347770314063462,0.7395701643489254,0.8822533577194952,1.0,6/25,23.37%,Ywhab;Hras;Rala;Mapk3;Rap1a;Nras
prerank,Neuronal System R-HSA-112316,-0.43442002931598744,-0.8341621794838889,0.8634046890927625,0.8817983833028704,1.0,20/272,7.88%,Nrgn;Calm1;Nefl;Kcna1;Rab3a;Kcnj3;Vamp2;Lin7c;Gnb2;Kcnj2;Hspa8;Tspan7;Arl6ip5;Ap2m1;Kcnk2;Glul;Slitrk2;Gabrg2;Kcna2;Gng2
prerank,G Alpha (12/13) Signaling Events R-HSA-416482,0.3755912696212311,0.8322834642557373,0.7283950617283951,1.0,1.0,13/49,12.08%,Plekhg5;Trio;Fgd4;Kalrn;Rock1;Itsn1;Abr;Gna12;Rasgrf2;Sos1;Fgd1;Arhgef17;Arhgef18
prerank,SUMOylation Of DNA Damage Response And Repair Proteins R-HSA-3108214,-0.46755308606455687,-0.83129622790392,0.764774044032445,0.884564247229321,1.0,14/62,17.78%,Cetn2;Sumo2;Pml;Smc1a;Nsmce3;Nup37;Rad21;Nup50;Parp1;Sec13;Rnf168;Nup107;Seh1l;Nup205
prerank,Metabolism Of Lipids R-HSA-556833,-0.42781278648735155,-0.8286478800375768,0.9054325955734407,0.8870098840433323,1.0,72/423,20.10%,Ran;Tecr;Acsl3;Hsd17b8;Sumo2;Mcee;Sqle;Sptssa;Hpgds;Ppp1ca;Fdps;Msmo1;Gps2;Gde1;Med10;Hmgcs1;Gpx4;Sin3b;Ptgds;Hacd4;Gpd2;Cdipt;Ptges3;Med4;Dgat2;Csnk2b;Nfyb;Vapa;Med19;Clstn1;Prxl2b;Inpp5f;Arsj;Dbi;Pip4k2a;Fabp7;Med31;Arf3;Plekha2;Rab14;Fdx2;Tbl1xr1;Fabp3;Chga;Acot13;Gpd1;Mid1ip1;Plekha3;Prkd1;Pip4p1;Sbf1;Thrsp;Acly;Nudt19;Med22;Cidea;Egfl7;Pik3r1;Cbr1;Insig1;Hmgcr;Tbl1x;Fitm2;Med21;Gpd1l;Plpp3;Cds2;Rufy1;Fdx1;Inpp4b;Med7;Stard7
prerank,Platelet Homeostasis R-HSA-418346,-0.46884920468420105,-0.8248720219060262,0.7608200455580866,0.8908937382741479,1.0,8/52,10.10%,Calm1;Gnas;Gnb2;Orai2;Gng2;Gng13;Ppp2r1a;Gng10
prerank,Myogenesis R-HSA-525793,-0.5028047481684919,-0.822962900133276,0.7503267973856209,0.8922592209846286,1.0,3/19,13.57%,Cdc42;Ctnna1;Mef2c
prerank,Regulation Of Insulin Secretion R-HSA-422356,-0.46600289956445373,-0.8207101866587257,0.7908045977011494,0.8940506084800842,1.0,10/55,10.99%,Vamp2;Gnas;Acsl3;Gnb2;Syt5;Gng2;Gng13;Adra2c;Gng10;Marcks
prerank,RAB GEFs Exchange GTP For GDP On RABs R-HSA-8876198,-0.4541566580563135,-0.8197370269432473,0.7834467120181405,0.8940858526731723,1.0,12/69,14.49%,Rab3a;Trappc6b;Trappc2;Ywhae;Rab1b;Trappc2l;Rab6b;Rab31;Trappc1;Rab14;Rab6a;Rab18
prerank,ERK/MAPK Targets R-HSA-198753,-0.5119792177753694,-0.8190127391809631,0.7480916030534351,0.8937386250153613,1.0,7/17,17.95%,Dusp3;Dusp7;Ppp2r1a;Ppp2ca;Mef2c;Ppp2r5d;Mapk3
prerank,NOTCH3 Intracellular Domain Regulates Transcription R-HSA-9013508,-0.518288517300344,-0.8184742043880654,0.7256176853055917,0.8931753193046637,1.0,3/15,14.65%,Snw1;Fabp7;Hey1
prerank,Signaling By Erythropoietin R-HSA-9006335,-0.5175933198349933,-0.8167486672514653,0.760778859527121,0.8942893662720728,1.0,5/16,16.68%,Irs2;Clstn1;Lyn;Hras;Pik3r1
prerank,ATF4 Activates Genes In Response To Endoplasmic Reticulum Stress R-HSA-380994,-0.5077439841021932,-0.8142549665821855,0.7664516129032258,0.8963412490518761,1.0,4/19,13.38%,Exosc3;Nfyb;Exosc4;Cebpb
prerank,Pre-NOTCH Expression And Processing R-HSA-1912422,-0.4644782875321519,-0.8133659005692878,0.7764842840512224,0.8962457097732202,1.0,8/43,13.87%,Jun;H2az1;Snw1;H2bc4;Tmed2;Sirt6;H2aj;Rab6a
prerank,RNA Polymerase III Transcription Initiation From Type 1 Promoter R-HSA-76061,-0.4837304069732101,-0.8119967080304371,0.7608426270136307,0.8968484613913302,1.0,4/26,12.68%,Polr2f;Polr2e;Polr3h;Polr3d
prerank,RNA Polymerase III Transcription Initiation From Type 2 Promoter R-HSA-76066,-0.4849746058080004,-0.8106553388242511,0.7676143386897404,0.8973333142994905,1.0,4/25,12.68%,Polr2f;Polr2e;Polr3h;Polr3d
prerank,Diseases Of DNA Repair R-HSA-9675135,-0.4999704235386242,-0.8104417895688903,0.776500638569604,0.896317900711574,1.0,2/21,8.11%,Sem1;Rpa3
prerank,Cargo Trafficking To Periciliary Membrane R-HSA-5620920,-0.4655573816680085,-0.8092403356459902,0.7706310679611651,0.896637515234616,1.0,9/40,21.40%,Arf4;Cct2;Bbip1;Rab11a;Bbs2;Nudt19;Cct8;Cct5;Smox
prerank,Pre-NOTCH Transcription And Translation R-HSA-1912408,-0.4806532781323566,-0.8079734140664558,0.7790123456790123,0.8970064422616665,1.0,4/31,5.09%,Jun;H2az1;Snw1;H2bc4
prerank,Signaling By NTRKs R-HSA-166520,-0.43480978528699626,-0.8036272255855008,0.8184782608695652,0.9014519921273126,1.0,23/94,18.37%,Cdk5r2;Ywhab;Dusp3;Egr1;Clta;Bax;Jund;Dusp7;Ap2m1;Ppp2r1a;Irs2;Dnal4;Ppp2ca;Vgf;Hras;Mef2c;Cdk5r1;Rala;Ppp2r5d;Pik3r1;Id2;Mapk3;Egr3
prerank,Nuclear Envelope Breakdown R-HSA-2980766,-0.4584924486192693,-0.8025827645513166,0.7772567409144197,0.9015443850220548,1.0,9/42,17.78%,Banf1;Emd;Nup37;Nup50;Sec13;Ctdnep1;Nup107;Seh1l;Nup205
prerank,RUNX2 Regulates Bone Development R-HSA-8941326,-0.5090305907643274,-0.7981730524638979,0.77088948787062,0.9058753561878042,1.0,3/15,19.81%,Hey1;Mapk3;Cbfb
prerank,Transport Of Mature mRNA Derived From An Intron-Containing Transcript R-HSA-159236,-0.4427051845034454,-0.7918110470111883,0.8175675675675675,0.912745519558512,1.0,22/64,27.38%,Magoh;Rbm8a;Magohb;Nup37;Nup50;Chtop;U2af1l4;Sec13;U2af1;Poldip3;Nup107;Seh1l;Nup205;Srsf3;Slu7;U2af2;Ncbp2;Nup85;Nup35;Ddx39b;Thoc7;Cdc40
prerank,G1/S-Specific Transcription R-HSA-69205,-0.4986612283852582,-0.7909252593575518,0.7891963109354414,0.9125781975003212,1.0,3/15,21.26%,Pcna;E2f4;Lin9
prerank,G Alpha (Q) Signaling Events R-HSA-416476,0.33005929636981707,0.7902260659671775,0.8571428571428571,1.0,1.0,15/67,10.70%,Dgkg;Rps6ka2;Trio;Chrm3;Trhr;Kalrn;Rgs17;Dgkq;Prkce;Gpr68;Dgkh;Sos1;Trpc6;Pik3r3;Grk5
prerank,Downstream Signal Transduction R-HSA-186763,-0.4872336482103986,-0.7887863772284452,0.7971204188481675,0.9139732221874605,1.0,5/22,17.59%,Nck1;Pdgfa;Hras;Pik3r1;Pdgfb
prerank,G0 And Early G1 R-HSA-1538133,-0.49701982475240936,-0.7887537674067536,0.7783572359843546,0.9127226674388286,1.0,3/15,21.26%,Pcna;E2f4;Lin9
prerank,Glycerophospholipid Biosynthesis R-HSA-1483206,0.3419717528236441,0.7869731594996842,0.8589743589743589,1.0,1.0,12/76,12.81%,Slc44a5;Miga2;Pla2g4e;Pcyt2;Osbpl10;Pitpnm2;Csnk2a2;Chka;Tafazzin;Lpin1;Mboat2;Dgat1
prerank,Signaling By FGFR2 In Disease R-HSA-5655253,-0.470855758014037,-0.7860765108449247,0.8115577889447236,0.9147636178673973,1.0,8/30,12.78%,Polr2f;Fgfr2;Polr2i;Polr2e;Fgf13;Polr2c;Polr2g;Hras
prerank,RND3 GTPase Cycle R-HSA-9696264,0.3765851663928559,0.7852883376498044,0.7430167597765364,1.0,1.0,5/32,6.19%,Plekhg5;Dst;Dlg5;Rock1;Pkp4
prerank,Integrin Cell Surface Interactions R-HSA-216083,-0.48323047687501985,-0.7829408559386581,0.7787610619469026,0.9173262483789586,1.0,4/21,12.08%,Icam5;Bsg;Itgav;Cd47
prerank,Post-translational Modification: Synthesis Of GPI-anchored Proteins R-HSA-163125,-0.45396192658632256,-0.7815850370670929,0.8188405797101449,0.9175888135945883,1.0,5/39,4.69%,Nrn1;Pigk;Dpm3;Cntn3;Opcml
prerank,Signaling By ALK R-HSA-201556,0.39675413575775204,0.7800978061268533,0.7790697674418605,1.0,1.0,3/17,13.09%,Ptprz1;Hdac1;Plcg1
prerank,Activation Of Kainate Receptors Upon Glutamate Binding R-HSA-451326,-0.48314374194784054,-0.7791148660379741,0.8154235145385588,0.919251684982806,1.0,2/21,2.94%,Calm1;Gnb2
prerank,Peroxisomal Lipid Metabolism R-HSA-390918,-0.4803601111056528,-0.7774451610124832,0.7894039735099337,0.9200659501709819,1.0,7/19,34.15%,Nudt19;Acox1;Slc25a17;Crot;Crat;Acox3;Sycp2
prerank,Regulation Of Lipid Metabolism By PPARalpha R-HSA-400206,-0.4237968724416819,-0.777346982984245,0.8348314606741573,0.9188816261604353,1.0,20/81,23.78%,Gps2;Med10;Hmgcs1;Sin3b;Med4;Nfyb;Med19;Med31;Tbl1xr1;Med22;Hmgcr;Tbl1x;Med21;Med7;Lin9;Acox1;Fdft1;Esrra;Med25;Arnt2
prerank,Diseases Of Mitotic Cell Cycle R-HSA-9675126,-0.46232536157450954,-0.7772014869294464,0.7958435207823961,0.917800593473579,1.0,5/29,14.58%,Ube2s;Cdk4;Anapc11;Cdkn1b;Ccnd3
prerank,PI3K Cascade R-HSA-109704,0.38841336298574647,0.7755227849325739,0.8009049773755657,1.0,1.0,5/25,10.41%,Fgf10;Flt3;Gab2;Akt2;Kl
prerank,Integration Of Energy Metabolism R-HSA-163685,-0.42756121431948657,-0.7715139277435757,0.8491189427312775,0.9232103088749236,1.0,19/75,17.55%,Vamp2;Gnas;Acsl3;Gnb2;Syt5;Gng2;Gng13;Adra2c;Ppp2r1a;Gng10;Marcks;Ppp2ca;Gng3;Gnai2;Acly;Ppp2r5d;Gnai1;Gna11;Prkar1b
prerank,G Alpha (S) Signaling Events R-HSA-418555,-0.4280331729644346,-0.7714044971391539,0.8584269662921349,0.9220503632268896,1.0,14/62,17.55%,Glp2r;Gnas;Gnb2;Ramp2;Gng2;Gng13;Gng10;Adrb1;Gng3;Gnai2;Chga;Gnai1;Ptrh2;Prkar1b
prerank,RAC2 GTPase Cycle R-HSA-9013404,-0.42683181825810274,-0.7711970579233407,0.8239355581127733,0.9210140113805879,1.0,12/60,18.83%,Arhgdia;Brk1;Cdc42;Emd;Vamp3;Abi1;Pik3r1;Samm50;Slitrk5;Pgrmc2;Lman1;Erbin
prerank,GPVI-mediated Activation Cascade R-HSA-114604,-0.4847924498803853,-0.7701220140297312,0.8013422818791947,0.9209316844177593,1.0,4/16,20.20%,Cdc42;Lyn;Pik3r1;Rhob
prerank,Signaling By BMP R-HSA-201451,-0.4780483126886935,-0.7655886455706766,0.787917737789203,0.9247570167343748,1.0,4/17,27.63%,Bmpr1b;Smad7;Smad5;Bmpr2
prerank,Branched-chain Amino Acid Catabolism R-HSA-70895,-0.47654124401144027,-0.7625194473079809,0.8126582278481013,0.9269913896001962,1.0,2/19,8.38%,Aldh6a1;Acad8
prerank,RNA Polymerase III Abortive And Retractive Initiation R-HSA-749476,-0.43781237626040737,-0.7553623771840969,0.8444976076555024,0.9338727181354547,1.0,5/36,12.68%,Polr2f;Snapc5;Polr2e;Polr3h;Polr3d
prerank,"PI5P, PP2A And IER3 Regulate PI3K/AKT Signaling R-HSA-6811558",-0.42280956091414224,-0.7526774106153363,0.8640552995391705,0.9356042745485414,1.0,14/58,17.95%,Nrg4;Fgfr2;Pdgfa;Ppp2r1a;Irs2;Fgf13;Clstn1;Ppp2ca;Fgfr1;Pip4k2a;Ppp2r5d;Pik3r1;Pdgfb;Mapk3
prerank,RUNX1 Regulates Genes Involved In Megakaryocyte Differentiation And Platelet Function R-HSA-8936459,0.3596277946153707,0.7510841504158101,0.8481675392670157,1.0,1.0,7/31,10.65%,Tnrc6c;Mov10;Kmt2a;Ago4;Hdac1;Ago1;Kmt2b
prerank,FGFR1 Mutant Receptor Activation R-HSA-1839124,0.37636491360993357,0.748255709660157,0.8217391304347826,1.0,1.0,3/21,7.67%,Lrrfip1;Zmym2;Gab2
prerank,PPARA Activates Gene Expression R-HSA-1989781,-0.4069841699189036,-0.7471020245459907,0.8648648648648649,0.9403548131501995,1.0,20/79,24.71%,Gps2;Med10;Hmgcs1;Med4;Nfyb;Med19;Med31;Tbl1xr1;Med22;Hmgcr;Tbl1x;Med21;Med7;Lin9;Acox1;Fdft1;Esrra;Med25;Arnt2;Txnrd1
prerank,Glycosaminoglycan Metabolism R-HSA-1630316,-0.4071614163942471,-0.7445994401294587,0.8842224744608399,0.9416002694447005,1.0,1/74,1.00%,Ndst4
prerank,IRS-mediated Signaling R-HSA-112399,0.36429587790204077,0.7445150098596878,0.8737864077669902,1.0,1.0,6/28,10.41%,Fgf10;Flt3;Gab2;Akt2;Sos1;Kl
prerank,SUMOylation Of SUMOylation Proteins R-HSA-4085377,-0.43733040996190986,-0.743998312999086,0.8217338217338217,0.9409760146809977,1.0,7/29,17.78%,Sumo2;Nup37;Nup50;Sec13;Nup107;Seh1l;Nup205
prerank,RNA Polymerase I Transcription Termination R-HSA-73863,-0.43368340424243756,-0.7369751321227782,0.8479318734793188,0.9471582029702336,1.0,8/27,23.87%,Polr2f;Polr1g;Polr2e;Taf1c;Gtf2h5;Ercc3;Gtf2h4;Polr2l
prerank,IGF1R Signaling Cascade R-HSA-2428924,0.35846840704315835,0.7362432069556704,0.8855721393034826,1.0,1.0,6/29,10.41%,Fgf10;Flt3;Gab2;Akt2;Sos1;Kl
prerank,IRS-related Events Triggered By IGF1R R-HSA-2428928,0.35846840704315835,0.7362432069556704,0.8855721393034826,1.0,1.0,6/29,10.41%,Fgf10;Flt3;Gab2;Akt2;Sos1;Kl
prerank,Signaling By Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) R-HSA-2404192,0.35846840704315835,0.7362432069556704,0.8855721393034826,1.0,1.0,6/29,10.41%,Fgf10;Flt3;Gab2;Akt2;Sos1;Kl
prerank,Negative Regulation Of PI3K/AKT Network R-HSA-199418,-0.409600800365532,-0.7346535628705333,0.8837471783295711,0.9482367532520702,1.0,14/64,17.95%,Nrg4;Fgfr2;Pdgfa;Ppp2r1a;Irs2;Fgf13;Clstn1;Ppp2ca;Fgfr1;Pip4k2a;Ppp2r5d;Pik3r1;Pdgfb;Mapk3
prerank,Synthesis Of Substrates In N-glycan Biosythesis R-HSA-446219,-0.42645306342325845,-0.7334186948129162,0.8598351001177856,0.9482103607827752,1.0,10/42,18.59%,Dpm3;Pmm1;Cmas;Nanp;Dpm2;Slc35a1;Egfl7;Gnpnat1;St6gal1;Gne
prerank,Downstream Signaling Of Activated FGFR2 R-HSA-5654696,0.3990217604693234,0.7329316310044802,0.8178294573643411,1.0,1.0,1/15,0.59%,Fgf10
prerank,Nucleotide Catabolism R-HSA-8956319,-0.4577196691050279,-0.730352261672294,0.845859872611465,0.9501014565328281,1.0,4/17,17.61%,Sco2;Itpa;Nudt18;Samhd1
prerank,"Transport Of Bile Salts And Organic Acids, Metal Ions And Amine Compounds R-HSA-425366",0.34238319061704586,0.7294479091601723,0.9036144578313253,1.0,1.0,5/35,10.52%,Slc44a5;Slc6a1;Slc22a4;Slc5a3;Slc6a7
prerank,Keratan Sulfate/Keratin Metabolism R-HSA-1638074,0.3708425298581209,0.7243756829903385,0.8388429752066116,1.0,1.0,3/21,10.78%,Hexa;St3gal3;Hexb
prerank,RAC3 GTPase Cycle R-HSA-9013423,0.3265483936689659,0.7211841405505461,0.9420289855072463,1.0,1.0,7/63,6.86%,Trio;Cyfip1;Arhgap15;Dock10;Srgap2;Abr;Ocrl
prerank,Insulin Receptor Signaling Cascade R-HSA-74751,0.34195238405333245,0.7175431318805844,0.8956043956043956,1.0,1.0,6/32,10.41%,Fgf10;Flt3;Gab2;Akt2;Sos1;Kl
prerank,RHO GTPase Cycle R-HSA-9012999,-0.3703980190592611,-0.714697418906958,0.9683350357507661,0.9641926930013984,1.0,19/314,8.35%,Hsp90ab1;Arhgdia;Actg1;Hsp90aa1;Basp1;Brk1;Tmem59;Nck1;Ckb;Cct2;Emc3;Cdc42;Kctd13;Lrrc1;Cdc37;Wasl;Cct6a;Emd;Rasal2
prerank,PKMTs Methylate Histone Lysines R-HSA-3214841,-0.41609695759752463,-0.7122645969927434,0.8796728971962616,0.9652522406328489,1.0,1/39,2.53%,Nfkb2
prerank,Signaling By NTRK2 (TRKB) R-HSA-9006115,0.3650210400121143,0.7112113863979966,0.869198312236287,1.0,1.0,7/19,17.19%,Dock3;Ntf3;Sos1;Ntrk2;Plcg1;Fyn;Tiam1
prerank,Signaling By PDGFR In Disease R-HSA-9671555,-0.4455852998996457,-0.7106519420531946,0.852,0.9655229473823745,1.0,5/15,31.83%,Hras;Pik3r1;Nras;Pik3r2;Pik3cb
prerank,Recycling Pathway Of L1 R-HSA-437239,0.3622280397596213,0.708677740939155,0.8820754716981132,1.0,1.0,5/21,6.58%,Rps6ka2;Shtn1;Dnm1;Dnm3;Rps6ka6
prerank,Association Of TriC/CCT With Target Proteins During Biosynthesis R-HSA-390471,-0.42299265545495424,-0.7063995792876206,0.8793532338308457,0.9683190460792058,1.0,6/29,19.50%,Cct2;Cct6a;Fbxw2;Cct7;Cct8;Cct5
prerank,CD28 Co-Stimulation R-HSA-389356,-0.4254813334200154,-0.7033343007051523,0.8530150753768844,0.9699535917215261,1.0,3/23,16.68%,Cdc42;Lyn;Pik3r1
prerank,tRNA Modification In Nucleus And Cytosol R-HSA-6782315,-0.4230912124881938,-0.7031245454979265,0.8741976893453145,0.9688136668080172,1.0,4/27,19.44%,Trmt112;Wdr4;Trdmt1;Lage3
prerank,Processing Of Intronless Pre-mRNAs R-HSA-77595,-0.43658875518158924,-0.7019460987809238,0.8741808650065531,0.9686872261820995,1.0,1/19,5.72%,Cpsf2
prerank,RHOF GTPase Cycle R-HSA-9035034,0.3328609243461396,0.6999611083083855,0.9068627450980392,1.0,1.0,8/29,16.42%,Myo9b;Srgap2;Senp1;Fam169a;Steap3;Mtmr1;Farp1;Slc4a7
prerank,RHOV GTPase Cycle R-HSA-9013424,-0.41675418733070235,-0.699594893959989,0.8872180451127819,0.969552797423778,1.0,3/27,7.56%,Nck1;Cdc42;Wasl
prerank,Intra-Golgi Traffic R-HSA-6811438,0.3293113642641714,0.696730495631224,0.9210526315789473,1.0,1.0,6/34,8.99%,Man2a1;Man1c1;Trip11;Vps45;Man2a2;Cog4
prerank,Constitutive Signaling By Aberrant PI3K In Cancer R-HSA-2219530,-0.4055089860025393,-0.6957612250816629,0.8936430317848411,0.9718798561375768,1.0,7/36,11.74%,Nrg4;Fgfr2;Pdgfa;Irs2;Fgf13;Clstn1;Fgfr1
prerank,Biosynthesis Of N-glycan Precursor (Dolichol LLO) And Transfer To Protein R-HSA-446193,-0.3918351936433757,-0.694062119628767,0.9030786773090079,0.9721001052629257,1.0,10/54,18.59%,Dpm3;Pmm1;Cmas;Nanp;Dpm2;Slc35a1;Egfl7;Gnpnat1;St6gal1;Gne
prerank,Metabolism Of Water-Soluble Vitamins And Cofactors R-HSA-196849,0.2954458338338026,0.6934421433778192,1.0,1.0,1.0,1/57,0.67%,Hlcs
prerank,Transport Of Mature mRNAs Derived From Intronless Transcripts R-HSA-159234,-0.398276430526286,-0.6893332648172938,0.8933649289099526,0.9751200160696806,1.0,8/37,17.78%,Cpsf2;Nup37;Nup50;Sec13;Slbp;Nup107;Seh1l;Nup205
prerank,SLC Transporter Disorders R-HSA-5619102,-0.3913046612177722,-0.688671844279281,0.911660777385159,0.9743921157730783,1.0,10/49,17.78%,Bsg;Slc24a5;Nup37;Nup50;Slc16a1;Sec13;Nup107;Slc35a1;Seh1l;Nup205
prerank,Regulation Of TP53 Activity Thru Acetylation R-HSA-6804758,-0.4124074088267581,-0.6853335649488219,0.8857142857142857,0.9759046522618596,1.0,6/27,16.58%,Pml;Pip4k2a;Brd7;Rbbp7;Pip4p1;Chd3
prerank,Nephrin Family Interactions R-HSA-373753,-0.4262502488633334,-0.6830397930735087,0.8794233289646134,0.9765355658336498,1.0,2/18,7.56%,Nck1;Wasl
prerank,Interferon Gamma Signaling R-HSA-877300,-0.40332840916588636,-0.6803365503345055,0.8972431077694235,0.9775256424524819,1.0,3/28,9.56%,Pml;Ifngr2;Trim35
prerank,Signaling By FGFR In Disease R-HSA-1226099,-0.38386595699913617,-0.6748393273322162,0.92,0.9808826676526435,1.0,13/45,19.71%,Polr2f;Fgfr2;Polr2i;Polr2e;Fgf13;Polr2c;Polr2g;Fgfr1;Hras;Bag4;Pik3r1;Trim24;Polr2j
prerank,N-glycan Antennae Elongation In medial/trans-Golgi R-HSA-975576,0.3558627570488926,0.6748299411795926,0.9132653061224489,1.0,1.0,2/19,7.68%,Man2a1;Man2a2
prerank,Notch-HLH Transcription Pathway R-HSA-350054,0.32933658408903765,0.6738167888443914,0.9306930693069307,1.0,1.0,2/24,2.59%,Maml2;Notch2
prerank,PI Metabolism R-HSA-1483255,-0.3701229911871881,-0.6705422292909513,0.9469525959367946,0.9831324521465158,1.0,13/63,19.90%,Gde1;Clstn1;Inpp5f;Pip4k2a;Arf3;Plekha2;Rab14;Plekha3;Pip4p1;Sbf1;Pik3r1;Rufy1;Inpp4b
prerank,Effects Of PIP2 Hydrolysis R-HSA-114508,-0.41773721172830347,-0.6681861560518295,0.9105058365758755,0.9837859672987137,1.0,1/19,1.95%,Rasgrp1
prerank,SUMOylation Of Intracellular Receptors R-HSA-4090294,-0.42338987692137486,-0.6678453307352489,0.8883048620236531,0.9827427910555149,1.0,2/16,14.76%,Sumo2;Nr4a2
prerank,Aberrant Regulation Of Mitotic Exit In Cancer Due To RB1 Defects R-HSA-9687136,-0.41919068158015854,-0.666439507461472,0.8949468085106383,0.982618439505635,1.0,2/18,12.06%,Ube2s;Anapc11
prerank,VxPx Cargo-Targeting To Cilium R-HSA-5620916,-0.4096431663586797,-0.6662655087577497,0.9023066485753053,0.9814276056459131,1.0,2/16,11.25%,Arf4;Rab11a
prerank,RHOBTB1 GTPase Cycle R-HSA-9013422,-0.4084390800308415,-0.6662470396070554,0.888745148771022,0.9801448947031367,1.0,3/20,17.81%,Cct2;Gps1;Cct7
prerank,Phospholipid Metabolism R-HSA-1483257,0.2688628086043228,0.666173685985939,1.0,1.0,1.0,22/138,12.81%,Slc44a5;Mtmr12;Miga2;Pla2g4e;Pcyt2;Osbpl10;Pitpnm2;Ocrl;Plekha6;Pikfyve;Csnk2a2;Mtmr7;Plekha5;Synj1;Pip5k1b;Chka;Pik3r3;Tafazzin;Lpin1;Mboat2;Mtmr1;Dgat1
prerank,Downstream Signaling Of Activated FGFR1 R-HSA-5654687,0.34575998670214614,0.6657761172088342,0.9233870967741935,1.0,1.0,1/18,0.59%,Fgf10
prerank,Conversion From APC/C:Cdc20 To APC/C:Cdh1 In Late Anaphase R-HSA-176407,-0.419910916518629,-0.6615519809558419,0.8924731182795699,0.982656808935984,1.0,2/16,12.06%,Ube2s;Anapc11
prerank,RHOG GTPase Cycle R-HSA-9013408,-0.37236592445107475,-0.6613448724166536,0.9418052256532067,0.9815088698354442,1.0,10/52,18.83%,Arhgdia;Cdc42;Emd;Vamp3;Pik3r1;Hspe1;Pgrmc2;Lman1;Ndufa5;Erbin
prerank,RHOQ GTPase Cycle R-HSA-9013406,-0.3773902444904114,-0.65893166577925,0.9393939393939394,0.9820962996655063,1.0,4/43,13.32%,Cdc42;Wasl;Gja1;Vamp3
prerank,Phosphorylation Of APC/C R-HSA-176412,-0.4208192241458681,-0.6589155161463472,0.8983739837398373,0.9808082099182739,1.0,2/15,12.06%,Ube2s;Anapc11
prerank,Sphingolipid De Novo Biosynthesis R-HSA-1660661,-0.38969263537272725,-0.6570833248450081,0.9084158415841584,0.9809553263392711,1.0,4/27,18.85%,Sptssa;Vapa;Prkd1;Plpp3
prerank,SUMOylation Of Chromatin Organization Proteins R-HSA-4551638,0.2987771429400231,0.6487339656267838,0.9871794871794872,1.0,1.0,7/45,8.59%,Phc2;Satb1;Ranbp2;Nup188;Nup210;Hdac1;Pias2
prerank,Synthesis Of Bile Acids And Bile Salts R-HSA-192105,0.354402564911821,0.6486922412906612,0.9385245901639344,1.0,1.0,6/16,21.29%,Osbpl7;Ncoa2;Osbpl2;Ncoa1;Slc27a2;Osbpl1a
prerank,Bile Acid And Bile Salt Metabolism R-HSA-194068,0.35351002673958115,0.6477051323006627,0.9393939393939394,1.0,1.0,6/17,21.29%,Osbpl7;Ncoa2;Osbpl2;Ncoa1;Slc27a2;Osbpl1a
prerank,RET Signaling R-HSA-8853659,0.31043506748321154,0.6473886972206546,0.9613259668508287,1.0,1.0,9/28,17.74%,Dok5;Shank3;Gab2;Sos1;Pik3r3;Plcg1;Dok6;Shc3;Mapk7
prerank,Inactivation Of APC/C Via Direct Inhibition Of APC/C Complex R-HSA-141430,-0.4081934740060852,-0.6473304156633263,0.8888888888888888,0.986794942136102,1.0,2/16,12.06%,Ube2s;Anapc11
prerank,Transport Of Mature mRNA Derived From An Intronless Transcript R-HSA-159231,-0.3749039268615547,-0.6470654865111757,0.9331742243436754,0.9856786320902868,1.0,7/36,17.78%,Cpsf2;Nup37;Nup50;Sec13;Nup107;Seh1l;Nup205
prerank,Synthesis Of PIPs At Plasma Membrane R-HSA-1660499,-0.3708254200813471,-0.6462340706720553,0.945321992709599,0.9849217983830926,1.0,8/40,19.90%,Clstn1;Pip4k2a;Plekha2;Rab14;Plekha3;Pik3r1;Rufy1;Inpp4b
prerank,Synthesis Of PA R-HSA-1483166,-0.3938889211077937,-0.6457959946493236,0.9014084507042254,0.9839174299970711,1.0,6/20,23.29%,Gpd2;Gpd1;Gpd1l;Gpam;Agpat5;Agpat1
prerank,"BMAL1:CLOCK,NPAS2 Activates Circadian Gene Expression R-HSA-1368108",-0.4006801893608618,-0.6448345477432761,0.913659793814433,0.9832824989366863,1.0,3/18,21.26%,Tbl1xr1;Tbl1x;Lin9
prerank,SUMOylation Of Ubiquitinylation Proteins R-HSA-3232142,-0.3757702995322626,-0.642256750010028,0.9390243902439024,0.9838446560785394,1.0,7/33,17.78%,Pml;Nup37;Nup50;Sec13;Nup107;Seh1l;Nup205
prerank,"Adrenaline,noradrenaline Inhibits Insulin Secretion R-HSA-400042",-0.39602903824627456,-0.6390314210644763,0.9138381201044387,0.9847488347925057,1.0,8/20,16.48%,Gnb2;Gng2;Gng13;Adra2c;Gng10;Gng3;Gnai2;Gnai1
prerank,Diseases Associated With Glycosaminoglycan Metabolism R-HSA-3560782,0.32001093702078276,0.6385697471577613,0.9532710280373832,1.0,1.0,5/23,14.43%,Hexa;St3gal3;Gpc3;Hexb;Vcan
prerank,Nonhomologous End-Joining (NHEJ) R-HSA-5693571,0.3160353718526064,0.638020626784104,0.9505494505494505,1.0,1.0,6/26,12.47%,Prkdc;Herc2;Brcc3;Tdp1;Paxip1;Dclre1c
prerank,RHOU GTPase Cycle R-HSA-9013420,0.29972487800428055,0.6375134113404511,0.9880952380952381,1.0,1.0,8/34,13.80%,Dst;Dlg5;Srgap2;Hgs;Itsn2;Arhgap31;Sptan1;Nck2
prerank,CD28 Dependent PI3K/Akt Signaling R-HSA-389357,0.3413105234703516,0.6368249693938026,0.9346153846153846,1.0,1.0,5/15,17.03%,Akt2;Pik3r3;Mtor;Rictor;Fyn
prerank,PI3K/AKT Signaling In Cancer R-HSA-2219528,-0.35885269020671057,-0.635518509167149,0.965034965034965,0.9858653986171376,1.0,12/58,17.59%,Nrg4;Fgfr2;Bad;Pdgfa;Irs2;Fgf13;Clstn1;Fgfr1;Cdkn1b;Pik3r1;Akt1s1;Pdgfb
prerank,Role Of Nef In HIV-1 Replication And Disease Pathogenesis R-HSA-164952,-0.38758099281515745,-0.6258145446762411,0.9194630872483222,0.9907002604927186,1.0,1/17,5.70%,Ap2m1
prerank,RHOJ GTPase Cycle R-HSA-9013409,-0.36197632427757787,-0.6254126224710905,0.9632701421800948,0.9896503173891442,1.0,6/39,19.18%,Cdc42;Wasl;Gja1;Vamp3;Pik3r1;Nipsnap2
prerank,Signaling By FGFR1 In Disease R-HSA-5655302,0.303233121461098,0.6241785224142908,0.9802955665024631,1.0,1.0,4/27,10.17%,Lrrfip1;Zmym2;Gab2;Sos1
prerank,RUNX1 Interacts With Co-Factors Whose Precise Effect On RUNX1 Targets Is Not Known R-HSA-8939243,0.2912221700466123,0.6178520692905486,0.978021978021978,1.0,1.0,4/31,10.93%,Phc2;Csnk2a2;Smarca4;Arid2
prerank,Signaling By KIT In Disease R-HSA-9669938,-0.3927206452493518,-0.6172055634441699,0.9361111111111111,0.9930869319744488,1.0,3/15,16.68%,Lyn;Hras;Pik3r1
prerank,Cell-cell Junction Organization R-HSA-421270,-0.3630195618826394,-0.6150375979891692,0.9562043795620438,0.9930146132905251,1.0,4/29,15.41%,Cadm2;Cdh18;Ctnna1;Cldn10
prerank,Signaling By SCF-KIT R-HSA-1433557,0.2984506655862153,0.600872643935451,0.9823008849557522,1.0,1.0,5/22,10.67%,Cbl;Gab2;Jak2;Sos1;Pik3r3
prerank,Nuclear Pore Complex (NPC) Disassembly R-HSA-3301854,0.29802991195084616,0.6002784783937412,0.9725274725274725,1.0,1.0,4/27,6.29%,Ranbp2;Nek7;Nup188;Nup210
prerank,RND2 GTPase Cycle R-HSA-9696270,0.28655368071183734,0.5953616116035452,0.9813664596273292,1.0,1.0,4/31,7.66%,Dst;Dlg5;Pkp4;Fnbp1
prerank,GAG Synthesis Requires Tetrasaccharide Linker Sequence R-HSA-1971475,0.2996640645071615,0.5834123742223153,0.9676113360323887,1.0,1.0,4/20,16.72%,Xylt1;Gpc3;Vcan;Xylt2
prerank,Signaling By PDGF R-HSA-186797,-0.34602260073132524,-0.5809637229059258,0.9752168525402726,1.0,1.0,6/30,18.44%,Nck1;Pdgfa;Hras;Pik3r1;Pdgfb;Cxxc1
prerank,Interleukin-2 Family Signaling R-HSA-451927,0.3073103960087952,0.5809298258525037,0.9490196078431372,1.0,1.0,4/17,10.67%,Gab2;Jak2;Sos1;Pik3r3
prerank,Cell-Cell Communication R-HSA-1500931,-0.31491339557927955,-0.5715328452484574,0.9921700223713646,1.0,1.0,9/69,16.68%,Cadm2;Nck1;Wasl;Cdh18;Ctnna1;Cd47;Ilk;Cldn10;Pik3r1
prerank,RNA Polymerase I Transcription Initiation R-HSA-73762,-0.32448835015649646,-0.5678455111185315,0.9859976662777129,1.0,1.0,7/43,18.32%,Polr2f;Polr1g;Polr2e;Rbbp7;Chd3;Taf1c;Gtf2h5
prerank,JNK (c-Jun Kinases) Phosphorylation And Activation Mediated By Activated Human TAK1 R-HSA-450321,-0.3525726454538841,-0.5627715136169058,0.9574742268041238,1.0,1.0,2/16,14.78%,Ube2n;Ube2v1
prerank,SUMOylation Of RNA Binding Proteins R-HSA-4570464,-0.3253237817817633,-0.5586604500557061,0.9878493317132442,1.0,1.0,9/38,20.45%,Sumo2;Nup37;Nup50;Sec13;Nup107;Seh1l;Nup205;Hnrnpk;Cbx4
prerank,RNA Polymerase II Transcribes snRNA Genes R-HSA-6807505,-0.31327237279096315,-0.5581714274116374,0.9942922374429224,1.0,1.0,7/65,10.90%,Polr2f;Polr2i;Snapc5;Polr2e;Taf11;Polr2c;Polr2g
prerank,Glyoxylate Metabolism And Glycine Degradation R-HSA-389661,-0.34040434867758296,-0.551370514472557,0.96484375,1.0,1.0,5/19,23.24%,Dlat;Got2;Dbt;Ndufab1;Grhpr
prerank,"Interleukin-3, Interleukin-5 And GM-CSF Signaling R-HSA-512988",-0.333758486496648,-0.543193087694704,0.9802110817941952,1.0,1.0,4/22,16.68%,Clstn1;Lyn;Ywhaz;Pik3r1
prerank,Glycosphingolipid Metabolism R-HSA-1660662,0.27663631718110415,0.5428891097810156,0.995575221238938,1.0,1.0,3/25,10.78%,Esyt3;Hexa;Hexb
prerank,Transport Of Ribonucleoproteins Into Host Nucleus R-HSA-168271,-0.3186668198878061,-0.540416347757019,0.9865525672371638,1.0,1.0,6/29,17.78%,Nup37;Nup50;Sec13;Nup107;Seh1l;Nup205
prerank,Transport Of SLBP Dependant Mature mRNA R-HSA-159230,-0.31682788846389065,-0.5343537933737844,0.9889162561576355,1.0,1.0,7/30,17.78%,Nup37;Nup50;Sec13;Slbp;Nup107;Seh1l;Nup205
prerank,Defective TPR May Confer Susceptibility Towards Thyroid Papillary Carcinoma (TPC) R-HSA-5619107,-0.3170080410257733,-0.532903851989283,0.9814356435643564,1.0,1.0,6/26,17.78%,Nup37;Nup50;Sec13;Nup107;Seh1l;Nup205
prerank,Sphingolipid Metabolism R-HSA-428157,-0.30129056396396714,-0.5326541918338971,0.9976635514018691,1.0,1.0,6/52,18.85%,Sptssa;Vapa;Arsj;Prkd1;Egfl7;Plpp3
prerank,tRNA Aminoacylation R-HSA-379724,-0.32248253273016253,-0.5297708545581049,0.986198243412798,1.0,1.0,10/22,31.36%,Wars2;Wars1;Aimp1;Mars1;Ppa1;Ppa2;Yars2;Fars2;Eef1e1;Dtd1
prerank,HDMs Demethylate Histones R-HSA-3214842,-0.3275113859863721,-0.5284215149772246,0.983225806451613,1.0,1.0,1/18,8.96%,Kdm1b
prerank,"FOXO-mediated Transcription Of Oxidative Stress, Metabolic And Neuronal Genes R-HSA-9615017",-0.3303859151848451,-0.5271765977032355,0.9763157894736842,1.0,1.0,2/17,10.53%,Agrp;Fbxo32
prerank,HDR Thru Single Strand Annealing (SSA) R-HSA-5685938,-0.3243809944211595,-0.5260291321634899,0.9777777777777777,1.0,1.0,4/17,25.73%,Rpa3;Rad9b;Rad50;Kat5
prerank,Estrogen-dependent Nuclear Events Downstream Of ESR-membrane Signaling R-HSA-9634638,-0.32047983655518786,-0.5085587947883305,0.9802631578947368,1.0,1.0,6/16,31.81%,Cdkn1b;Mapk3;Akt1;Creb1;Foxo3;Mapk1
prerank,NS1 Mediated Effects On Host Pathways R-HSA-168276,-0.2885083703646373,-0.48972613876105636,0.9987730061349693,1.0,1.0,6/31,17.78%,Nup37;Nup50;Sec13;Nup107;Seh1l;Nup205
prerank,Mitochondrial tRNA Aminoacylation R-HSA-379726,0.2576059496695154,0.48441223847752835,0.9913419913419913,0.9975156435700273,1.0,1/15,6.37%,Lars2
prerank,Miscellaneous Transport And Binding Events R-HSA-5223345,-0.29676438824253215,-0.47555275686689374,0.9960212201591512,1.0,1.0,6/18,34.67%,Nipal3;Add2;Nipa1;Ctns;Mrs2;Tusc3
prerank,Transport Of SLBP Independent Mature mRNA R-HSA-159227,-0.2809295762837694,-0.4737845277753027,0.9975339087546239,1.0,1.0,6/29,17.78%,Nup37;Nup50;Sec13;Nup107;Seh1l;Nup205
prerank,Heme Signaling R-HSA-9707616,-0.281661102235516,-0.4715796428797631,0.9962640099626401,1.0,1.0,4/28,21.26%,Mef2c;Tbl1xr1;Tbl1x;Lin9
prerank,Keratan Sulfate Biosynthesis R-HSA-2022854,-0.29077841338369415,-0.46420732413912313,0.9932523616734144,1.0,1.0,1/16,13.07%,Ogn
prerank,Constitutive Signaling By AKT1 E17K In Cancer R-HSA-5674400,-0.28294849273563316,-0.4607204826165091,0.9948783610755442,1.0,1.0,7/21,27.22%,Bad;Cdkn1b;Akt1s1;Gsk3b;Akt1;Creb1;Mlst8
prerank,Transcriptional Regulation By E2F6 R-HSA-8953750,-0.27249707879825125,-0.45476389875921264,0.9987515605493134,0.9995918957200708,1.0,4/26,23.56%,Cbx3;Rbbp7;Cbx5;Ring1
prerank,Diseases Associated With N-glycosylation Of Proteins R-HSA-3781860,-0.2680553630087483,-0.4300346752161919,1.0,0.9991401617033396,1.0,6/17,34.48%,Egfl7;Alg11;Mogs;Alg13;Alg1;Alg6
